[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US20030096806A1 - Arylphenyl-substituted cyclic ketoenols - Google Patents

Arylphenyl-substituted cyclic ketoenols Download PDF

Info

Publication number
US20030096806A1
US20030096806A1 US10/192,361 US19236102A US2003096806A1 US 20030096806 A1 US20030096806 A1 US 20030096806A1 US 19236102 A US19236102 A US 19236102A US 2003096806 A1 US2003096806 A1 US 2003096806A1
Authority
US
United States
Prior art keywords
alkyl
optionally
alkoxy
substituted
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/192,361
Inventor
Folker Lieb
Reiner Fischer
Alan Graff
Udo Schneider
Thomas Bretschneider
Christoph Erdelen
Wolfram Andersch
Mark Drewes
Markus Dollinger
Ingo Wetcholowsky
Dieter Feucht
Rolf Pontzen
Randy Myers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/192,361 priority Critical patent/US20030096806A1/en
Publication of US20030096806A1 publication Critical patent/US20030096806A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/88—Ketenes; Dimeric ketenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Definitions

  • the present invention relates to novel arylphenyl-substituted cyclic ketoenols, to a plurality of processes for their preparation and to their use as pesticides and herbicides.
  • EP-A-0 262 399 and GB-A-2 266 888 disclose compounds of a similar structure (3-aryl-pyrrolidine-2,4-diones) of which, however, no herbicidal, insecticidal or acaricidal activity has become known.
  • Unsubstituted bicyclic 3-aryl-pyrrolidine-2,4-dione derivatives EP-A-355 599 and EP-415 211) and substituted monocyclic 3-aryl-pyrrolidine-2,4-dione derivatives (EP-A-377 893 and EP-442 077) having herbicidal, insecticidal or acaricidal activity are known.
  • EP-442 073 polycyclic 3-arylpyrrolidine-2,4-dione derivatives
  • 1H-arylpyrrolidine-dione derivatives EP-456 063, EP-521 334, EP-596 298, EP-613 884, EP-613 885, WO 94/01 997, WO 95/26 954, WO 95/20 572, EP-A-0 668 267, WO 96/25 395, WO 96/35 664, WO 97/01 535, WO 97/02 243 and WO 97/36 868, DE 19 716 591).
  • 3-aryl- ⁇ 3 -dihydrofuranone derivatives having herbicidal, acaricidal and insecticidal properties are known from EP-A-528 156, EP-A-0 647 637, WO 95/26 345, WO 96/20 196, WO 96/25 395, WO 96/35 664, WO 97/01 535, WO 97/02 243 and WO 97/36 868, DE 19 716 591.
  • 3-Aryl- ⁇ 3 -dihydrothiophene-one derivatives are likewise known (WO 95/26 345, 96/25 395, WO 97/01 535, WO 97/02 243, WO 97/36 868, DE 19 716 591).
  • 3H-pyrazol-3-one derivatives such as, for example, 1,2-diethyl-1,2-dihydro-5-hydroxy-4-phenyl-3H-pyrazol-3-one or [5-oxo-1,2-diphenyl-4-(p-sulphophenyl)-3-pyrazolin-3-yl]-oxy, disodium salt, or p-(3-hydroxy-5-oxo-1,2-diphenyl-3-pyrazolin-4-yl)-benzenesulphonic acid (cf. J. Heterocycl. Chem., 25(5), 1301-1305, 1988 or J. Heterocycl. Chem., 25(5), 1307-1310, 1988 or Zh. Obshch. Khim., 34(7), 2397-2402, 1964). However, a biological activity of these compounds is not described.
  • EP-508 126 and WO 92/16 510, WO 96/21 652 describe 4-arylpyrazolidin-3,5-dione derivatives having herbicidal, acaricidal and insecticidal properties. Additionally, 4-arylpyrazolidines have become known of which fungicidal properties have been described (WO 96/36 229, WO 96/36 615, WO 96/36 616, WO 96/36 633).
  • Phenyl-pyrone derivatives which are substituted in the phenyl ring and have herbicidal, acaricidal and insecticidal properties are described in EP-A-588 137, WO 96/25 395, WO 96/35 664, WO 97/01 535, WO 97/02 243, WO 97/16 436, WO 97/19 941 and WO 97/36 868, DE 19 716 591.
  • 5-Phenyl-1,3-thiazine derivatives which are substituted in the phenyl ring and have herbicidal, acaricidal and insecticidal activity are described in WO 94/14 785, WO 96/02 539, WO 96/35 664, WO 97/01 535, WO 97/02 243, WO 97/02 243, WO 97/36 868.
  • X represents halogen, alkyl, alkoxy, alkenyloxy, alkylthio, alkylsulphinyl, alkylsulphonyl, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro, cyano or in each case optionally substituted phenyl, phenoxy, phenylthio, phenylalkoxy or phenylalkylthio,
  • Y represents in each case optionally substituted cycloalkyl, aryl or hetaryl,
  • W represents hydrogen, halogen, alkyl, alkoxy, alkenyloxy, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro or cyano,
  • Z represents halogen, alkyl, alkoxy, alkenyloxy, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro or cyano,
  • CKE represents one of the groups
  • A represents hydrogen, in each case optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, saturated or unsaturated, optionally substituted cycloalkyl in which optionally at least one ring atom is replaced by a heteroatom, or in each case optionally halogen-, alkyl-, halogenoalkyl-, alkoxy, halogenoalkoxy-, cyano- or nitro-substituted aryl, arylalkyl or hetaryl,
  • B represents hydrogen, alkyl or alkoxyalkyl, or
  • a and B together with the carbon atom to which they are attached represent a saturated or unsaturated unsubstituted or substituted ring which optionally contains at least one heteroatom,
  • D represents hydrogen or an optionally substituted radical selected from the series consisting of alkyl, alkenyl, alkinyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, saturated or unsaturated cycloalkyl in which one or more ring members are optionally replaced by heteroatoms, arylalkyl, aryl, hetarylalkyl or hetaryl or
  • a and Q 1 together represent alkanediyl or alkenediyl, each of which is optionally substituted by in each case optionally substituted alkyl, hydroxyl, alkoxy, alkylthio, cycloalkyl, benzyloxy or aryl, or
  • Q 1 represents hydrogen or alkyl
  • Q 2 , Q 4 , Q 5 and Q 6 independently of one another each represent hydrogen or alkyl
  • Q 3 represents hydrogen, alkyl, alkoxyalkyl, alkylthioalkyl, optionally substituted cycloalkyl (in which optionally one methylene group is replaced by oxygen or sulphur) or optionally substituted phenyl, or
  • Q 3 and Q 4 together with the carbon atom to which they are attached represent a saturated or unsaturated unsubstituted or substituted ring which optionally contains a heteroatom,
  • G represents hydrogen (a) or represents one of the groups
  • E represents a metal ion or an ammonium ion
  • L represents oxygen or sulphur
  • M represents oxygen or sulphur
  • R 1 represents in each case optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, alkylthioalkyl, polyalkoxyalkyl or optionally halogen-, alkyl- or alkoxy-substituted cycloalkyl, which may be interrupted by at least one heteroatom, in each case optionally substituted phenyl, phenylalkyl, hetaryl, phenoxyalkyl or hetaryloxyalkyl,
  • R 2 represents in each case optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl or represents in each case optionally substituted cycloalkyl, phenyl or benzyl,
  • R 3 , R 4 and R 5 independently of one another each represent in each case optionally halogen-substituted alkyl alkoxy, alkylamino, dialkylamino, alkylthio, alkenylthio, cycloalkylthio and represent in each case optionally substituted phenyl, benzyl, phenoxy or phenylthio,
  • R 6 and R 7 independently of one another each represent hydrogen, in each case optionally halogen-substituted alkyl, cycloalkyl, alkenyl, alkoxy, alkoxyalkyl, represent optionally substituted phenyl, represent optionally substituted benzyl, or together with the nitrogen atom to which they are attached represent a cycle which is optionally interrupted by oxygen or sulphur.
  • the compounds of the formula (I) can be present as geometrical and/or optical isomers or mixtures of isomers in varying compositions, which can be separated, if desired, in a customary manner.
  • the present invention provides both the pure isomers and the isomer mixtures, their preparation and use and also compositions comprising them.
  • compounds of the formula (I) are always referred to, although both pure compounds and, if appropriate, mixtures having different proportions of isomeric compounds are intended.
  • A, B, D, G, Q 1 , Q 2 , Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y and Z are each as defined above.
  • A, B, D, E, L, M, W, X, Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • A, B, E, L, M, W, X, Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • A, B, E, L, M, W, X, Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • A, D, E, L, M, W, X, Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • the compounds of the formula (I-5) can be present in the two isomeric forms of the formulae (I-5-A) and (I-5-B),
  • the compounds of the formulae (I-5-A) and (I-5-B) can be present both as mixtures and in the form of their pure isomers. Mixtures of the compounds of the formulae (I-5-A) and (I-5-B) can be separated, if desired, in a manner known per se by physical methods, for example by chromatographic methods.
  • A, D, E, L, M, W, X, Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • A, E, L, M, W, X, Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • the compounds of the formulae (I-7-A) and (I-7-B) can be present both as mixtures and in the form of their pure isomers. Mixtures of the compounds of the formulae (I-7-A) and (I-7-B) can be separated, if desired, by physical methods, for example by chromatographic methods.
  • A, B, Q 1 , Q 2 , E, L, M, W, X, Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • the compounds of the formulae (I-8-A) and (I-8-B) can be present both as mixtures and in the form of their pure isomers. Mixtures of the compounds of the formulae (I-8-A) and (I-8-B) can be separated, if desired, by physical methods, for example by chromatographic methods.
  • A, B, E, L, M, Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • A, B, D, W, X, Y and Z are each as defined above
  • N-acylamino acid esters of the formula (II) [0086] N-acylamino acid esters of the formula (II)
  • A, B, D, W, X, Y and Z are each as defined above
  • R 8 represents alkyl (preferably C 1 -C 6 -alkyl)
  • [0091] are condensed intramolecularly in the presence of a diluent and in the presence of a base.
  • A, B, W, X, Y and Z are each as defined above
  • A, B, W, X, Y, Z and R 8 are each as defined above
  • [0099] are condensed intramolecularly in the presence of a diluent and in the presence of a base.
  • A, B, W, X, Y and Z are each as defined above
  • A, B, W, X, Y, Z and R 8 are each as defined above and
  • W 1 represents hydrogen, halogen, alkyl (preferably C 1 -C 6 -alkyl) or alkoxy (preferably C 1 -C 8 -alkoxy)
  • [0108] are cyclized intramolecularly, if appropriate in the presence of a diluent and in the presence of an acid.
  • A, D, W, X, Y and Z are each as defined above
  • W, X, Y and Z are each as defined above
  • Hal represents halogen (in particular chlorine or bromine)
  • R 8 , W, X, Y and Z are each as defined above
  • a and D are each as defined above
  • A, D, W, X, Y and Z are each as defined above
  • a and D are each as defined above
  • A, D and R 8 are each as defined above
  • W, X, Y and Z are each as defined above and
  • Hal represents halogen (preferably represents chlorine or bromine),
  • A, W, X, Y and Z are each as defined above
  • A is as defined above
  • Hal, W, X, Y and Z are each as defined above,
  • A, B, Q 1 , Q 2 , W, X, Y and Z are each as defined above
  • ketocarboxylic esters of the formula (X) [0157] ketocarboxylic esters of the formula (X)
  • A, B, Q 1 , Q 2 , W, X, Y and Z are each as defined above and
  • R 8 represents alkyl (in particular C 1 -C 8 -alkyl)
  • [0161] are cyclized intramolecularly, if appropriate in the presence of a diluent and in the presence of a base.
  • A, B, Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y and Z are each as defined above
  • A, B, Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y and Z are each as defined above
  • R 8 represents alkyl (preferably C 1 -C 6 -alkyl)
  • [0172] are condensed intramolecularly in the presence of a diluent and in the presence of a base;
  • A, B, D, Q 1 , Q 2 , Q 3 , Q 4 , Q 5 , Q 6 , W, X and Z are each as defined above and
  • Y′ represents chlorine, bromine or iodine, preferably represents bromine
  • R 1 is as defined above and
  • Hal represents halogen (in particular chlorine or bromine)
  • R 1 is as defined above
  • R 2 and M are each as defined above,
  • R 3 is as defined above,
  • L, R 4 and R 5 are each as defined above and
  • Hal represents halogen (in particular chlorine or bromine),
  • Me represents a mono- or divalent metal (preferably an alkali metal or alkaline earth metal, such as lithium, sodium, potassium, magnesium or calcium),
  • t represents the number 1 or 2
  • R 1 1, R 11 , R 1 2 independently of one another each represent hydrogen or alkyl (preferably C 1 -C 8 -alkyl),
  • R 6 and L are each as defined above
  • novel compounds of the formula (I) have very good activity as pesticides, preferably as insecticides, acaricides and herbicides.
  • X preferably represents halogen, C 1 -C 6 -alkyl, C 1 -C 6 -halogenoalkyl, C 1 -C 6 -alkoxy, C 3 -C 6 -alkenyloxy, C 1 -C 6 -alkylthio, C 1 -C 6 -alkylsulphinyl, C 1 -C 6 -alkylsulphonyl, C 1 -C 6 -halogenoalkoxy, C 3 -C 6 -halogenoalkenyloxy, nitro, cyano or in each case optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 4 -halogenoalkyl-, C 1 -C 4 -halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenoxy, phenylthio, benzyloxy
  • Y preferably represents one of the radicals
  • V 1 preferably represents hydrogen, halogen, C 1 -C 12 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, C 1 -C 6 -alkylsulphinyl, C 1 -C 6 -alkylsulphonyl, C 1 -C 4 -halogenoalkyl, C 1 -C 4 -halogenoalkoxy, nitro, cyano or phenyl, phenoxy, phenoxy-C 1 -C 4 -alkyl, phenyl-C 1 -C 4 -alkoxy, phenylthio-C 1 -C 4 -alkyl or phenyl-C 1 -C 4 -alkylthio, each of which is optionally mono- or polysubstituted by halogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 4 -alky
  • V 2 and V 3 independently of one another each preferably represent hydrogen, halogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 4 -halogenoalkyl or C 1 -C 4 -halo-genoalkoxy.
  • W preferably represents hydrogen, halogen, C 1 -C 6 -alkyl, C 1 -C 6 -halogenoalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -halogenoalkoxy, nitro or cyano.
  • Z preferably represents halogen, C 1 -C 6 -alkyl, C 1 -C 6 -halogenoalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -halogenoalkoxy, nitro or cyano.
  • CKE preferably represents one of the groups
  • A preferably represents hydrogen or in each case optionally halogen-substituted C 1 -C 12 -alkyl, C 3 -C 8 -alkenyl, C 1 -C 10 -alkoxy-C 1 -C 8 -alkyl, poly-C 1 -C 8 -alkoxy-C 1 -C 8 -alkyl, C 1 -C 10 -alkylthio-C 1 -C 6 -alkyl, optionally halogen-, C 1 -C 6 -alkyl- or C 1 -C 6 -alkoxy-substituted C 3 -C 8 -cycloalkyl in which optionally one or two not directly adjacent ring members are replaced by oxygen and/or sulphur or represents in each case optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -halogenoalkyl-, C 1 -C 6 -alkoxy-, C 1
  • B preferably represents hydrogen, C 1 -C 16 alkyl or C 1 -C 8 -alkoxy-C 1 -C 6 -alkyl or
  • A, B and the carbon atom to which they are attached preferably represent saturated C 3 -C 10 -cycloalkyl or unsaturated C 5 -C 10 -cycloalkyl in which in each case optionally one ring member is replaced by oxygen or sulphur and which are optionally mono- or disubstituted by C 1 -C 8 -alkyl, C 3 -C 10 -cycloalkyl, C 1 -C 8 -halogenoalkyl, C 1 -C 8 -alkoxy, C 1 -C 8 -alkylthio, halogen or phenyl or
  • A, B and the carbon atom to which they are attached preferably represent C 3 -C 6 -cycloalkyl which is substituted by an alkylenedilyl group which optionally contains one or two not directly adjacent oxygen and/or sulphur atoms, or by an alkylenedioxyl group or by an alkylenedithioyl group which, together with the carbon atom to which it is attached, forms a further five- to eight-membered ring, or
  • A, B and the carbon atom to which they are attached preferably represent C 3 -C 8 -cycloalkyl or C 5 -C 8 -cycloalkenyl, in which two substituents together with the carbon atoms to which they are attached represent in each case optionally C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy- or halogen-substituted C 2 -C 6 -alkanediyl, C 2 -C 6 -alkenediyl or C 4 -C 6 -alkanedienediyl in which optionally one methylene group is replaced by oxygen or sulphur.
  • D preferably represents hydrogen, in each case optionally halogen-substituted C 1 -C 12 -alkyl, C 3 -C 8 -alkenyl, C 3 -C 8 -alkinyl, C 1 -C 10 -alkoxy-C 2 -C 8 -alkyl, poly-C 1 -C 8 -alkoxy-C 2 -C 8 -alkyl, C 1 -C 10 -alkylthio-C 2 -C 8 -alkyl, optionally halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy- or C 1 -C 4 -halogenoalkyl-substituted C 3 -C 8 -cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur or in each case optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -halogen
  • a and D together preferably represent in each case optionally substituted C 3 -C 6 -alkanediyl or C 3 -C 6 -alkenediyl in which optionally one methylene group is replaced by oxygen or sulphur,
  • a and Q 1 together preferably represent C 3 -C 6 -alkanediyl or C 4 -C 6 -alkenediyl, each of which is optionally mono- or disubstituted by identical or different substituents selected from the group consisting of halogen, hydroxyl; C 1 -C 10 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, C 3 -C 7 -cycloalkyl, each of which is optionally mono- to trisubstituted by identical or different halogens; and benzyloxy and phenyl, each of which is optionally mono- to trisubstituted by identical or different substituents selected from the group consisting of halogen, C 1 -C 6 -alkyl or C 1 -C 6 -alkoxy, and which furthermore optionally contains one of the groups below
  • Q 1 preferably represents hydrogen or C 1 -C 4 -alkyl.
  • Q 2 , Q 4 , Q 5 and Q 6 independently of one another each preferably represent hydrogen or C 1 -C 4 -alkyl
  • Q 3 preferably represents hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy-C 1 -C 2 -alkyl, C 1 -C 6 -alkylthio-C 1 -C 2 -alkyl, optionally C 1 -C 4 -alkyl- or C 1 -C 4 -alkoxy-substituted C 3 -C 8 -cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur or optionally halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy-, C 1 -C 2 -halogenoalkyl-, C 1 -C 2 -halogenoalkoxy-, cyano- or nitro-substituted phenyl, or
  • Q 3 and Q 4 together with the carbon atom to which they are attached represent an optionally C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy- or C 1 -C 4 -alkoxy or C 1 -C 2 -halogenoalkyl-substituted C 3 -C 7 -ring, in which optionally one ring member is replaced by oxygen or sulphur.
  • G preferably represents hydrogen (a) or represents one of the groups
  • (g) in particular represents (a), (b) or (c),
  • E represents a metal ion or an ammonium ion
  • L represents oxygen or sulphur
  • M represents oxygen or sulphur.
  • R 1 preferably represents in each case optionally halogen-substituted C 1 -C 20 -alkyl, C 2 -C 20 -alkenyl, C 1 -C 8 -alkoxy-C 1 -C 8 -alkyl, C 1 -C 8 -alkylthio-C 1 -C 8 -alkyl, poly-C 1 -C 8 -alkoxy-C 1 -C 8 -alkyl or optionally halogen-, C 1 -C 6 -alkyl- or C 1 -C 6 -alkoxy-substituted C 3 -C 8 -cycloalkyl in which optionally one or more (preferably not more than two) not directly adjacent ring members are replaced by oxygen and/or sulphur,
  • [0261] represents optionally halogen-, cyano-, nitro-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -halogenoalkyl-, C 1 -C 6 -halogenoalkoxy-, C 1 -C 6 -alkylthio- or C 1 -C 6 -alkylsulphonyl-substituted phenyl,
  • [0262] represents optionally halogen-, nitro-, cyano-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -halogenoalkyl- or C 1 -C 6 -halogenoalkoxy-substituted phenyl-C 1 -C 6 -alkyl,
  • [0263] represents optionally halogen- or C 1 -C 6 -alkyl-substituted 5- or 6-membered hetaryl (for example pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl or thienyl),
  • [0264] represents optionally halogen- or C 1 -C 6 -alkyl-substituted phenoxy-C 1 -C 6 -alkyl or
  • [0265] represents optionally halogen-, amino- or C 1 -C 6 -alkyl-substituted 5- or 6-membered hetaryloxy-C 1 -C 6 -alkyl (for example pyridyloxy-C 1 -C 6 -alkyl, pyrimidyloxy-C 1 -C 6 -alkyl or thiazolyloxy-C 1 -C 6 -alkyl).
  • R 2 preferably represents in each case optionally halogen-substituted C 1 -C 20 -alkyl, C 2 -C 2 O-alkenyl, C 1 -C 8 -alkoxy-C 2 -C 8 -alkyl, poly-C 1 -C 8 -alkoxy-C 2 -C 8 -alkyl,
  • [0267] represents optionally halogen-, C 1 -C 6 -alkyl- or C 1 -C 6 -alkoxy-substituted C 3 -C 8 -cycloalkyl or
  • [0268] represents in each case optionally halogen-, cyano-, nitro-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -halogenoalkyl- or C 1 -C 6 -halogenoalkoxy-substituted phenyl or benzyl.
  • R 3 preferably represents optionally halogen-substituted C 1 -C 8 -alkyl or represents in each case optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 4 -halogenoalkyl-, C 1 -C 4 -halogenoalkoxy-, cyano- or nitro-substituted phenyl or benzyl.
  • R 4 and R 5 independently of one another each preferably represent in each case optionally halogen-substituted C 1 -C 8 -alkyl, C 1 -C 8 -alkoxy, C 1 -C 8 -alkylamino, di-(C 1 -C 8 -alkyl)amino, C 1 -CS-alkylthio, C 2 -C 8 -alkenylthio, C 3 -C 7 -cycloalkylthio or represent in each case optionally halogen-, nitro-, cyano-, C 1 -C 4 -alkoxy-, C 1 -C 4 -halogenoalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -halogenoalkylthio-, C 1 -C 4 -alkyl- or C 1 -C 4 -halogenoalkyl-substituted phenyl, phenoxy or
  • R 6 and R 7 independently of one another each preferably represent hydrogen, represent in each case optionally halogen-substituted C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, C 1 -C 8 -alkoxy, C 3 -C 8 -alkenyl, C 1 -C 8 -alkoxy-C 1 -C 8 -alkyl, represent optionally halogen-, C 1 -C 8 -halogenoalkyl-, C 1 -C 8 -alkyl- or C 1 -C 8 -alkoxy-substituted phenyl, optionally halogen-, C 1 -C 8 -alkyl-, C 1 -C 8 -halogenoalkyl- or C 1 -C 8 -alkoxy-substituted benzyl or together represent an optionally C 1 -C 4 -alkyl-substituted C 3 -C 6
  • R 13 preferably represents hydrogen, represents in each case optionally halogen-substituted C 1 -C 8 -alkyl or C 1 -C 8 -alkoxy, represents optionally halogen-, C 1 -C 4 -alkyl- or C 1 -C 4 -alkoxy-substituted C 3 -C 8 -cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or represents in each case optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 4 -halogenoalkyl-, C 1 -C 4 -halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenyl-C 1 -C 4 -alkyl or phenyl-C 1 -C 4 -alkoxy.
  • R 14 preferably represents hydrogen or C 1 -C 8 -alkyl, or
  • R 13 and R 14 together preferably represent C 4 -C 6 -alkanediyl.
  • R 15 and R 16 are identical or different and each preferably represent C 1 -C 6 -alkyl, or
  • R 15 and R 16 together preferably represent a C 2 -C 4 -alkanediyl radical which is optionally substituted by C 1 -C 6 -alkyl, C 1 -C 6 -halogenoalkyl or by optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 4 -halogenoalkyl-, C 1 -C 6 -alkoxy-, C 1 -C 4 -halogenoalkoxy-, nitro- or cyano-substituted phenyl.
  • R 17 and R 18 independently of one another each preferably represent hydrogen, represent optionally halogen-substituted C 1 -C 8 -alkyl or represent optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 4 -halogenoalkyl-, C 1 -C 4 -halogenoalkoxy-, nitro- or cyano-substituted phenyl, or
  • R 17 and R 18 together with the carbon atom to which they are attached preferably represent a carbonyl group or represent optionally halogen-, C 1 -C 4 -alkyl- or C 1 -C 4 -alkoxy-substituted C 5 -C 7 -cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur.
  • R 19 and R 20 independently of one another each preferably represent C 1 -C 10 -alkyl, C 2 -C 1 o-alkenyl, C 1 -C 10 -alkoxy, C 1 -C 1 o-alkylamino, C 3 -C 10 -alkenylamino, di-(C 1 -C 10 -alkyl)amino or di-(C 3 -C 10 -alkenyl)amino.
  • halogen represents fluorine, chlorine, bromine and iodine and in particular represents fluorine, chlorine and bromine.
  • X particularly preferably represents fluorine, chlorine, bromine, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 3 -C 4 -alkenyloxy, C 1 -C 4 -halogenoalkyl, C 1 -C 4 -halogenoalkoxy, C 3 -C 4 -halogenoalkenyloxy, nitro or cyano.
  • Y particularly preferably represents one of the radicals
  • V 1 particularly preferably represents hydrogen, fluorine, chlorine, bromine, C 1 -C 6 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 2 -halogenoalkyl, C 1 -C 2 -halogenoalkoxy, nitro, cyano or phenyl, phenoxy, phenoxy-C 1 -C 2 -alkyl, phenyl-C 1 -C 2 -alkoxy, phenylthio-C 1 -C 2 -alkyl or phenyl-C 1 -C 2 -alkylthio, each of which is optionally mono- or disubstituted by fluorine, chlorine, bromine, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 2 -halogenoalkyl, C 1 -C 2 -halogenoalkoxy, nitro or cyano.
  • V 2 and V 3 independently of one another each particularly preferably represent hydrogen, fluorine, chlorine, bromine, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 2 -halogenoalkyl or C 1 -C 2 -halogenoalkoxy.
  • W particularly preferably represents hydrogen, fluorine, chlorine, bromine, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C 1 -C 4 -alkoxy or C 1 -C 4 -halogenoalkoxy.
  • Z particularly preferably represents fluorine, chlorine, bromine, C 1 -C 4 -alkyl, C 1 -C 4 -halogenoalkyl, C 1 -C 4 -alkoxy or C 1 -C 4 -halogenoalkoxy.
  • CKE particularly preferably represents one of the groups
  • B particularly preferably represents hydrogen or C 1 -C 6 -alkyl, or
  • A, B and the carbon atom to which they are attached particularly preferably represent saturated or unsaturated C 5 -C 7 -cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur and which is optionally monosubstituted by C 1 -C 6 -alkyl, C 5 -C 8 -cycloalkyl, C 1 -C 3 -halogenoalkyl, C 1 -C 6 -alkoxy, fluorine, chlorine or phenyl, or
  • A, B and the carbon atom to which they are attached particularly preferably represent C 5 -C 6 -cycloalkyl which is substituted by an alkylenediyl group which optionally contains one or two not directly adjacent oxygen or sulphur atoms or by an alkylenedioxyl group or by an alkylenedithiol group which, together with the carbon atom to which it is attached, forms a further five- or six-membered ring, or
  • A, B and the carbon atom to which they are attached particularly preferably represent C 3 -C 6 -cycloalkyl or C 5 -C 6 -cycloalkenyl in which two substituents together with the carbon atoms to which they are attached represent in each case optionally C 1 -C 5 -alkyl-, C 1 -C 5 -alkoxy-, fluorine-, chlorine- or bromine-substituted C 2 -C 4 -alkanediyl, C 2 -C 4 -alkenediyl, in which optionally one methylene group is replaced by oxygen or sulphur, or butadienediyl.
  • D particularly preferably represents hydrogen, represents in each case optionally fluorine- or chlorine-substituted C 1 -C 10 -alkyl, C 3 -C 6 -alkenyl, C 1 -C 8 -alkoxy-C 2 -C 6 -alkyl or C 1 -C 8 -alkylthio-C 2 -C 6 -alkyl, represents optionally fluorine-, chlorine-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy- or C 1 -C 2 -halogenoalkyl-substituted C 3 -C 7 -cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-1) and (I-4)) represents in each case optionally fluorine-, chlorine-, bromine-, C 1 -C 4 -alkyl-, C 1 -C 4 -
  • a and D together particularly preferably represent optionally substituted C 3 -C 5 -alkanediyl in which one methylene group may be replaced by a carbonyl group, oxygen or sulphur, possible substituents being hydroxyl, C 1 -C 6 -alkyl or C 1 -C 4 -alkoxy, or
  • a and D (in the case of the compounds of the formula (I-1)) together with the atoms to which they are attached represent one of the groups AD-I to AD-10:
  • a and Q 1 together particularly preferably represent C 3 -C 4 -alkanediyl or C 3 -C 4 -alkenediyl, each of which is optionally mono- or disubstituted by identical or different substituents selected from the group consisting of fluorine, chlorine, hydroxyl, and C 1 -C 8 -alkyl and C 1 -C 4 -alkoxy, each of which is optionally mono- to trisubstituted by fluorine, or
  • Q 1 particularly preferably represents hydrogen.
  • Q 2 particularly preferably represents hydrogen.
  • Q 4 , Q 5 and Q 6 independently of one another each particularly preferably represent hydrogen or C 1 -C 3 -alkyl.
  • Q 3 particularly preferably represents hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy-C 1 -C 2 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 2 -alkyl or optionally methyl- or methoxy-substituted C 3 -C 6 -cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or
  • Q 3 and Q 4 together with the carbon atom to which they are attached particularly preferably represent an optionally C 1 -C 4 -alkyl- or C 1 -C 4 -alkoxy-substituted saturated C 5 -C 6 ring in which optionally one ring member is replaced by oxygen or sulphur.
  • G particularly preferably represents hydrogen (a) or particularly preferably represents one of the groups
  • E represents a metal ion or an ammonium ion
  • L represents oxygen or sulphur
  • M represents oxygen or sulphur.
  • R 1 particularly preferably represents in each case optionally fluorine- or chlorine-substituted C 1 -C 16 -alkyl, C 2 -C 16 -alkenyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, C 1 -C 6 -alkylthio-C 1 -C 6 -alkyl, poly-C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl or optionally fluorine-, chlorine-, C 1 -C 5 -alkyl- or C 1 -C 5 -alkoxy-substituted C 3 -C 7 -cycloalkyl in which optionally one or two not directly adjacent ring members are replaced by oxygen and/or sulphur,
  • [0309] represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy-, C 1 -C 3 -halogenoalkyl-, C 1 -C 3 -halogenoalkoxy-, C 1 -C 4 -alkylthio- or C 1 -C 4 -alkylsulphonyl-substituted phenyl,
  • [0310] represents optionally fluorine-, chlorine-, bromine-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy-, C 1 -C 3 -halogenoalkyl- or C 1 -C 3 -halogenoalkoxy-substituted phenyl-C 1 -C 4 -alkyl,
  • [0311] represents in each case optionally fluorine-, chlorine-, bromine- or C 1 -C 4 -alkyl-substituted pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl or thienyl,
  • [0312] represents optionally fluorine-, chlorine-, bromine- or C 1 -C 4 -alkyl-substituted phenoxy-C 1 -C 3 -alkyl or represents in each case optionally fluorine-, chlorine-, bromine-, amino- or C 1 -C 4 -alkyl-substituted pyridyloxy-C 1 -C 3 -alkyl, pyrimidyloxy-C 1 -C 3 -alkyl or thiazolyloxy-C 1 -C 3 -alkyl.
  • R 2 particularly preferably represents in each case optionally fluorine-substituted C 1 -C 16 -alkyl, C 2 -C 16 -alkenyl, C 1 -C 6 -alkoxy-C 2 -C 6 -alkyl or poly-C 1 -C 6 -alkoxy-C 2 -C 6 -alkyl,
  • [0314] represents optionally fluorine-, chlorine-, C 1 -C 4 -alkyl- or C 1 -C 4 -alkoxy-substituted C 3 -C 7 -cycloalkyl or
  • [0315] represents in each case optionally fluorine-, chlorine-, bromine-, cyano-, nitro-C 1 -C 4 -alkyl-, C 1 -C 3 -alkoxy-, C 1 -C 3 -halogenoalkyl- or C 1 -C 3 -halo-genoalkoxy-substituted phenyl or benzyl,
  • R 3 particularly preferably represents optionally fluorine-substituted C 1 -C 6 -alkyl or particularly preferably represents in each case optionally fluorine-, chlorine-, bromine-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy-, C 1 -C 3 -halogenoalkyl-, C 1 -C 3 -halogenoalkoxy-, cyano- or nitro-substituted phenyl or benzyl,
  • R 4 and R 5 independently of one another each particularly preferably represent C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylamino, di-(C 1 -C 6 -alkyl)amino, C 1 -C 6 -alkylthio, C 3 -C 4 -alkenylthio, C 3 -C 6 -cycloalkylthio or represent in each case optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, C 1 -C 3 -alkoxy-, C 1 -C 3 -halogenoalkoxy-, C 1 -C 3 -alkylthio-, C 1 -C 3 -halogenoalkylthio-, C 1 -C 3 -alkyl- or C 1 -C 3 -halogenoalkyl-substituted phenyl, phenoxy or phenyl
  • R 6 and R 7 independently of one another each particularly preferably represent hydrogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -alkoxy, C 3 -C 6 -alkenyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, represent optionally fluorine-, chlorine-, bromine-, C 1 -C 3 -halogenoalkyl-, C 1 -C 4 -alkyl- or C 1 -C 4 -alkoxy-substituted phenyl, represent optionally fluorine-, chlorine-, bromine-, C 1 -C 4 -alkyl-, C 1 -C 3 -halogenoalkyl- or C 1 -C 4 -alkoxy-substituted benzyl, or together represent an optionally methyl- or ethyl-substituted C 4 -C 5
  • halogen if not stated otherwise, represents fluorine, chlorine, bromine and iodine, in particular represents fluorine, chlorine and bromine.
  • X very particularly preferably represents fluorine, chlorine, methyl, ethyl, propyl, iso-propyl, methoxy, ethoxy, propoxy, iso-propoxy, allyloxy, methallyloxy, trifluoromethyl, difluoromethoxy, trifluoromethoxy, nitro or cyano.
  • Y very particularly preferably represents one of the radicals
  • V 1 very particularly preferably represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, trifluoromethyl, trifluoromethoxy, nitro, cyano or phenyl which is optionally monosubstituted by fluorine, chlorine, methyl, methoxy, trifluoromethyl or trifluoromethoxy.
  • V 2 and V 3 independently of one another each very particularly preferably represent hydrogen, fluorine, chlorine, methyl, ethyl, n-propyl, iso-propyl, methoxy, ethoxy, trifluoromethyl or trifluoromethoxy.
  • W very particularly preferably represents hydrogen, fluorine, chlorine, methyl, ethyl, n-propyl, methoxy, ethoxy or propoxy.
  • Z very particularly preferably represents fluorine, chlorine, methyl, ethyl, n-propyl, methoxy, ethoxy or propoxy.
  • CKE very particularly preferably represents one of the groups
  • B very particularly preferably represents hydrogen or C 1 -C 4 -alkyl, or
  • A, B and the carbon atom to which they are attached very particularly preferably represent saturated C 5 -C 6 -cycloalkyl or C 5 -C 6 -cycloalkenyl in which optionally one ring member is replaced by oxygen or sulphur and which is optionally monosubstituted by methyl, ethyl, propyl, isopropyl, butyl, iso-butyl, sec-butyl, tert-butyl, trifluoromethyl, methoxy, ethoxy, propoxy, iso-propoxy, butoxy, iso-butoxy, sec-butoxy, tert-butoxy, fluorine or chlorine, or
  • A, B and the carbon atom to which they are attached very particularly preferably represent C 5 -C 6 -cycloalkyl or C 5 -C 6 -cycloalkenyl in which two substituents together with the carbon atoms to which they are attached represent C 2 -C 4 -alkanediyl or C 2 -C 4 -alkenediyl in which in each case optionally one methylene group is replaced by oxygen or sulphur, or butadienediyl.
  • D very particularly preferably represents hydrogen, represents in each case optionally fluorine- or chlorine-substituted C 1 -C 8 -alkyl, C 3 -C 4 -alkenyl, C 1 -C 6 -alkoxy-C 2 -C 4 -alkyl, C 1 -C 4 -alkylthio-C 2 -C 4 -alkyl or C 3 -C 6 -cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-1) and (I-4)) represents in each case optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoro-methoxy-substituted phenyl, furanyl, pyridyl, thienyl or
  • a and D (in the case of the compounds of the formula (I-1)) together with the atoms to which they are attached represent one of the following groups AD:
  • a and Q 1 together very particularly preferably represent C 3 -C 4 -alkanediyl or butenediyl, each of which is optionally mono- or disubstituted by fluorine, hydroxyl, methyl or methoxy, or
  • Q 1 very particularly preferably represents hydrogen.
  • Q 2 very particularly preferably represents hydrogen.
  • Q 4 , Q 5 and Q 6 independently of one another each very particularly preferably represent hydrogen, methyl or ethyl.
  • Q 3 very particularly preferably represents hydrogen, methyl, ethyl or C 3 -C 6 -cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or
  • Q 3 and Q 4 together with the carbon to which they are attached very particularly preferably represent an optionally methyl- or methoxy-substituted saturated C 5 -C 6 ring in which optionally one ring member is replaced by oxygen or sulphur.
  • G very particularly preferably represents hydrogen (a) or represents one of the groups
  • [0344] in particular represents (a), (b) or (c),
  • E represents a metal ion or an ammonium ion
  • L represents oxygen or sulphur
  • M represents oxygen or sulphur.
  • R 1 very particularly preferably represents in each case optionally fluorine- or chlorine-substituted C 1 -C 14 -alkyl, C 2 -C 14 -alkenyl, C 1 -C 4 -alkoxy-C 1 -C 6 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 6 -alkyl, poly-C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl or optionally fluorine-, chlorine-, methyl-, ethyl-, propyl-, i-propyl-, butyl-, i-butyl-, tert-butyl-, methoxy-, ethoxy-, n-propoxy- or iso-propoxy-substituted C 3 -C 6 -cycloalkyl in which optionally one or two not directly adjacent ring members are replaced by oxygen and/or sulphur,
  • [0350] represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoro-methoxy-, methylthio-, ethylthio-, methylsulphonyl- or ethylsulphonyl-substituted phenyl,
  • [0351] represents optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted benzyl,
  • [0352] represents in each case optionally fluorine-, chlorine-, bromine-, methyl- or ethyl-substituted furanyl, thienyl, pyridyl, pyrimidyl, thiazolyl or pyrazolyl,
  • [0353] represents optionally fluorine-, chlorine-, methyl- or ethyl-substituted phenoxy-C 1 -C 2 -alkyl or
  • [0354] represents in each case optionally fluorine-, chlorine-, amino-, methyl- or ethyl-substituted pyridyloxy-C 1 -C 2 -alkyl, pyrimidyloxy-C 1 -C 2 -alkyl or thiazolyloxy-C 1 -C 2 -alkyl.
  • R 2 very particularly preferably represents in each case optionally fluorine-substituted C 1 -C 16 -alkyl, C 2 -C 16 -alkenyl, C 1 -C 4 -alkoxy-C 2 -C 6 -alkyl or poly-C 1 -C 4 -alkoxy-C 2 -C 6 -alkyl,
  • [0356] represents optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, iso-propyl- or methoxy-substituted C 3 -C 6 -cycloalkyl,
  • R 3 very particularly preferably represents in each case optionally fluorine-substituted methyl, ethyl, n-propyl, isopropyl or in each case optionally fluorine-, chlorine-, bromine-, methyl-, tert-butyl-, methoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substituted phenyl or benzyl,
  • R 4 and R 5 independently of one another each very particularly preferably represent C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkylamino, di-(C 1 -C 4 -alkyl)amino, C 1 -C 4 -alkylthio or represent in each case optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, C 1 -C 2 -alkoxy-, C 1 -C 2 -fluoroalkoxy-, C 1 -C 2 -alkylthio-, C 1 -C 2 -fluoroalkylthio- or C 1 -C 3 -alkyl-substituted phenyl, phenoxy or phenylthio.
  • R 6 and R 7 independently of one another each very particularly preferably represent hydrogen, represent C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy, C 3 -C 4 -alkenyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, represent optionally fluorine-, chlorine-, bromine-, trifluoromethyl-, methyl- or methoxy-substituted phenyl, represent optionally fluorine-, chlorine-, bromine-, methyl-, trifluoromethyl- or methoxy-substituted benzyl, or together represent a C 5 -C 6 -alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
  • Saturated or unsaturated hydrocarbon radicals such as alkyl or alkenyl may in each case be straight-chain or branched as far as this is possible, including in combination with heteroatoms, such as, for example, in alkoxy.
  • optionally substituted radicals may be mono- or polysubstituted, and in the case of polysubstitutions the substituents may be identical or different.
  • Table 2 A, B and D are each as given in Table 1
  • Table 3 A, B and D are each as given in Table 1
  • Table 4 A, B and D are each as given in Table 1
  • Table 6 A, B and D are each as given in Table 1
  • Table 7 A, B and D are each as given in Table 1
  • Table 8 A, B and D are each as given in Table 1
  • Table 9 A, B and D are each as given in Table 1
  • Table 10 A, B and D are each as given in Table 1
  • Table 11 A, B and D are each as given in Table 1
  • Table 12 A, B and D are each as given in Table 1
  • Table 13 A, B and D are each as given in Table 1
  • Table 14 A, B and D are each as given in Table 1
  • Table 15 A, B and D are each as given in Table 1
  • Table 16 A, B and D are each as given in Table 1
  • Table 17 A, B and D are each as given in Table 1
  • Table 18 A, B and D are each as given in Table 1
  • Table 19 A, B and D are each as given in Table 1
  • Table 20 A, B and D are each as given in Table 1
  • Table 21 A, B and D are each as given in Table 1
  • Table 23 A and B are each as given in Table 22
  • Table 24 A and B are each as given in Table 22
  • Table 25 A and B are each as given in Table 22
  • Table 26 A and B are each as given in Table 22
  • Table 27 A and B are each as given in Table 22
  • Table 28 A and B are each as given in Table 22
  • Table 29 A and B are each as given in Table 22
  • Table 30 A and B are each as given in Table 22
  • Table 31 A and B are each as given in Table 22
  • Table 32 A and B are each as given in Table 22
  • Table 33 A and B are each as given in Table 22
  • Table 34 A and B are each as given in Table 22
  • Table 36 A and B are each as given in Table 22
  • Table 37 A and B are each as given in Table 22
  • Table 38 A and B are each as given in Table 22
  • Table 40 A and B are each as given in Table 22
  • Table 41 A and B are each as given in Table 22
  • Table 42 A and B are each as given in Table 22
  • A, B, D, W, X, Y, Z and R 8 are each as defined above
  • acylamino acid esters of the formula (II) are obtained, for example, when amino acid derivatives of the formula (XXIII)
  • A, B, R 8 and D are each as defined above
  • W, X, Y and Z are each as defined above and
  • Hal represents chlorine or bromine
  • A, B, D, W, X, Y and Z are each as defined above
  • A, B, D, W, X, Y and Z are each as defined above
  • A, B and D are each as defined above
  • W, X, Y and Z are each as defined above and
  • Hal represents chlorine or bromine
  • W, X, Y and Z are each as defined above
  • halogenating agents for example thionyl chloride, thionyl bromide, oxalyl chloride, phosgene, phosphorus trichloride, phosphorus tribromide or phosphorus pentachloride
  • a diluent for example optionally chlorinated aliphatic or aromatic hydrocarbons such as toluene or methylene chloride
  • the substituted cyclic aminocarboxylic acids of the formula (XXVIa) in which A and B form a ring are generally obtainable by the Bucherer-Bergs synthesis or by the Strecker synthesis and are in each case obtained in different isomer forms.
  • the isomers for simplicity called ⁇ below
  • the radicals R and the carboxyl group are equatorial are predominantly obtained
  • the isomers for simplicity called a below
  • A, B, D, W, X, Y, Z and R 8 are each as defined above
  • A, B and D are each as defined above
  • A, B, D, W, X, Y and Z are each as defined above
  • A, B, W, X, Y, Z and R 8 are each as defined above
  • A, B and R 8 are each as defined above
  • W, X, Y and Z are each as defined above
  • A, B and R 8 are each as defined above and
  • Hal represents chlorine or bromine.
  • W, X, Y and Z are each as defined above
  • W, X and Z are each as defined above
  • Y′ represents chlorine or bromine, preferably represents bromine
  • a solvent preferably a solvent, a base and a catalyst (preferably a palladium complex, such as, for example, tetrakis (triphenylphosphine)-palladium or
  • W, X, Y, Z and R 8 are each as defined above
  • [0555] are hydrolysed under generally known standard conditions in the presence of acids or bases, in the presence of a solvent, or
  • W, X and Z are each as defined above
  • Y is as defined above and
  • Hal represents chlorine, bromine or iodine, preferably bromine or iodine,
  • W, X and Z are each as defined above
  • W, X, Y′ and Z are each as defined above
  • R 21 represents C 1 -C 8 -alkyl or phenyl, preferably represents n-C 4 H 9 ,
  • R 8 is as defined above
  • W, X, Y, Z and R 8 are each as defined above
  • R 8 , W, X, Y′ and Z are each as defined above
  • A, B, W, X, Y, Z and R 8 are each as defined above
  • W, X, Y, R 8 and Z are each as defined above
  • A, B and W are each as defined above and
  • Hal represents halogen (in particular chlorine or bromine)
  • W, X, Y and Z are each as defined above
  • [0609] are esterified in the presence of alcohols and dehydrating agents (for example conc. sulphuric acid),
  • halogenocarbonyl ketenes of the formula (V) required as starting materials in the above processes (D), (E) and (F) are novel. They can be prepared simply by methods which are known in principle (cf., for example, Org. Prep. Proced. Int., 7, (4), 155-158, 1975 and DE 1 945 703). Thus, for example, the compounds of the formula (V)
  • W, X, Y and Z are each as defined above and
  • Hal represents chlorine or bromine
  • W, X, Y and Z are each as defined above
  • acyl halides such as, for example, thionyl chloride, phosphorus(V) chloride, phosphorus(mII) chloride, oxalyl chloride, phosgene or thionyl bromide, if appropriate in the presence of catalysts, such as, for example, dimethylformamide, methyl-steryl-formamide or triphenylphosphine and if appropriate in the presence of bases such as, for example, pyridine or triethylamine.
  • catalysts such as, for example, dimethylformamide, methyl-steryl-formamide or triphenylphosphine
  • substituted phenylmalonic acids of the formula (XXXVII) are novel. They can be prepared simply by known processes (cf., for example, Organikum, VEB Deutscher Verlag dermaschineen, Berlin 1977, p. 517 ff, EP-A-528 156, WO 96/35 664, WO 97/02 243).
  • W, X, Y and Z are each as defined above
  • W, X, Y, Z and R 8 are each as defined above
  • W, X, Y, Z and R 8 are each as defined above
  • a and D are each as defined above
  • a and D are each as defined above
  • A, D and R 8 are each as defined above
  • A, B, Q 1 , Q 2 , W, X, Y, Z and R 8 are each as defined above
  • W, X, Y, Z, A, B, Q 1 and Q 2 are each as defined above
  • [0660] are esterified (cf., for example, Organikum, 15th edition, Berlin, 1977, page 499) or alkylated (see Preparation Example).
  • A, B, Q 1 , Q 2 , W, X, Y and Z are each as defined above
  • A, B, D 1 , D 2 , W, X, Y and Z are each as defined above and
  • R 8 and R 8 ′ each represent alkyl (in particular C 1 -C 8 -alkyl)
  • A, B, Q 1 , Q 2 , W, X, Y, Z, R 8 , R 8 are each as defined above
  • A, B, Q 1 , Q 2 and R 8 are each as defined above and
  • Hal represents chlorine or bromine
  • A, B, Q 1 and Q 2 are each as defined above are acylated with a phenyl acetic ester of the formula (XXXII)
  • W, X, Y, Z and R 8 ′ are each as defined above in the presence of a diluent and in the presence of a base (cf., for example, M. S. Chambers, E. J. Thomas, D. J. Williams, J. Chem. Soc. Chem. Commun., (1987), 1228, cf. also the Preparation Examples).
  • A, B, Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y, Z and R 8 are each as defined above
  • 6-aryl-5-ketocarboxylic esters of the formula (XI) are obtained, for example, when 6-aryl-5-ketocarboxylic acids of the formula (XLII)
  • A, B, Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y and Z are each as defined above
  • A, B, Q 3 , Q 4 , QS, Q 6 , W, X, Y and Z are each as defined above
  • A, B, Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y and Z are each as defined above and
  • R 8 and R 8 are each alkyl (preferably C 1 -C 6 -alkyl),
  • A, B, Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y, Z, R 8 and R 8 are each as defined above
  • A, B, Q 3 , Q 4 , Q 5 , Q 6 and R 8 are each as defined above
  • W, X, Y, Z and R 8 ′ are each as defined above
  • W, X, Y and Z are each as defined above
  • alkoxides for example alkali metal alkoxides such as sodium methoxide or sodium ethoxide
  • a diluent for example the alcohol derived from the alkoxide
  • an acid preferably an inorganic acid such as, for example, sulphuric acid
  • W, X, Y and Z are each as defined above
  • R 21 represents alkyl, preferably C 1 -C 6 -alkyl
  • the compounds of the formula (XLVII) are known compounds of organic chemistry. Copper(II) chloride and vinylidene chloride have been known for a long time and are commercially available.
  • W, X, Y and Z are each as defined above, for example, are obtained when anilines of the formula (XLVI-a)
  • W, X and Z are each as defined above
  • Y′ represents chlorine or bromine, preferably represents bromine
  • a solvent preferably a solvent, a base and a catalyst (preferably a palladium complex, such as, for example, tetrakis (triphenylphosphine)palladium.
  • a catalyst preferably a palladium complex, such as, for example, tetrakis (triphenylphosphine)palladium.
  • anilines of the formula (XLVI-a) are known compounds or can be prepared by generally known processes.
  • the acyl halides of the formula (XIII), carboxylic anhydrides of the formula (XIV), chloroformic esters or chloroformic thioesters of the formula (XV), chloromonothioformic esters or chlorodithioformic esters of the formula (XVI), sulphonyl chlorides of the formula (XVII), phosphorus compounds of the formula (XVIIU) and metal hydroxides, metal alkoxides or amines of the formulae (XIX) and (XX) and isocyanates of the formula (XXI) and carbamoyl chlorides of the formula (XXII) furthermore required as starting materials for carrying out the processes (J), (K), (L), (M), (N), (O) and (P) according to the invention are generally known compounds of organic or inorganic chemistry.
  • the process (A) is characterized in that compounds of the formula (II) in which A, B, D, W, X, Y, Z and R 8 are each as defined above are subjected to an intramolecular condensation in the presence of a base.
  • Suitable diluents for the process (A) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone, and also alcohols, such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol.
  • hydrocarbons such as toluene and xylene
  • ethers such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether
  • polar solvents such as dimethyl s
  • phase-transfer catalysts such as, for example, triethylbenzylammonium chloride, tetrabutylammonium bromide
  • Alkali metals such as sodium and potassium can also be used.
  • alkali metal and alkaline earth metal amides and hydrides such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • reaction temperatures can be varied within a relatively wide range.
  • the reaction is carred out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C.
  • reaction components of the formula (II) and the deprotonating bases are generally employed in approximately double-equimolar amounts. However, it is also possible to use a larger excess (up to 3 mol) of one component or the other.
  • the process (B) is characterized in that compounds of the formula (III) in which A, B, W, X, Y, Z and R 8 are each as defined above are subjected to an intramolecular condensation in the presence of a diluent and in the presence of a base.
  • Suitable diluents for the process (B) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone, and also alcohols, such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol.
  • hydrocarbons such as toluene and xylene
  • ethers such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether
  • polar solvents such as dimethyl s
  • phase-transfer catalysts such as, for example, triethylbenzylammonium chloride, tetrabutylammonium bromide
  • Alkali metals such as sodium and potassium can also be used.
  • alkali metal and alkaline earth metal amides and hydrides such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • reaction temperatures can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C.
  • the process (B) according to the invention is generally carried out under atmospheric pressure.
  • reaction components of the formula (II) and the deprotonating bases are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 3 mol) of one component or the other.
  • the process (C) is characterized in that compounds of the formula (IV) in which A, B, W, X, Y, Z and R 8 are each as defined above are cyclized intramolecularly in the presence of an acid and, if appropriate, in the presence of a diluent.
  • Suitable diluents for the process (C) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore halogenated hydrocarbons such as dichloromethane, chloroform, ethylene chloride, chlorobenzene, dichlorobenzene, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethyl formamide and N-methyl-pyrrolidone. Furthermore, it is possible to employ alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, isobutanol, tert-butanol.
  • the acid used can also serve as diluent.
  • Suitable acids for the process (C) according to the invention arc all customary inorganic and organic acids, such as, for example, hydrohalic acids, sulphuric acid, alkyl, aryl and haloalkylsulphonic acids, in particular halogenated alkylcarboxylic acids, such as, for example, trifluoroacetic acid.
  • reaction temperatures can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C.
  • the process (C) according to the invention is generally carried out under atmospheric pressure.
  • reaction components of the formula (IV) and the acid are employed, for example, in equimolar amounts.
  • acid it is also possible, if appropriate, to use the acid as solvent or as catalyst.
  • Suitable diluents for the processes (D- ⁇ ) and (D- ⁇ ) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone, and also, only in the case where compounds of the formula (VI) are employed, alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol.
  • hydrocarbons such as toluene and xylene
  • ethers such as dibutyl ether, tetrahydrofuran, dioxane, glycol di
  • reaction temperatures can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between ⁇ 20° C. and 250° C., preferably between 0° C. and 150° C.
  • reaction components of the formulae (V) and (VII) or (VI) and (VII) and the deprotonating bases which are employed if appropriate are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 3 mol) of one component or the other.
  • the process (E) according to the invention is characterized in that carbonyl compounds of the formula (VIII) or enol ethers thereof of the formula (VIII-a) are reacted with ketene acid halides of the formula (V) in the presence of a diluent and, if appropriate, in the presence of an acid acceptor.
  • Suitable diluents for the process (E) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide or N-methyl-pyrrolidone.
  • hydrocarbons such as toluene and xylene
  • ethers such as dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether
  • polar solvents such as dimethyl sulphoxide, sulpholane, dimethylformamide or N-methyl-pyrrolidone.
  • Suitable acid acceptors for carrying out the process variant E) according to the invention are all customary acid acceptors.
  • tertiary amines such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicycloundecane (DBU), diazabicyclononene (DBN), Hünig base and N,N-dimethyl-aniline.
  • DABCO diazabicyclooctane
  • DBU diazabicycloundecane
  • DBN diazabicyclononene
  • Hünig base N,N-dimethyl-aniline.
  • the reaction temperatures can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 220° C.
  • reaction components of the formulae (VHI) and (V) in which A, D, W, X, Y and Z are each as defined above and Hal represents halogen, and, if appropriate, the acid acceptors, are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 5 mol) of one component or the other.
  • the process (F) according to the invention is characterized in that thioamides of the formula (IX) are reacted with ketene acid halides of the formula (V) in the presence of a diluent and, if appropriate, in the presence of an acid acceptor.
  • Suitable diluents for the process variant F) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone.
  • hydrocarbons such as toluene and xylene
  • ethers such as dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether
  • polar solvents such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone.
  • Suitable acid acceptors for carrying out the process (F) according to the invention are all customary acid acceptors.
  • tertiary amines such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicycloundecane (DBU), diazabicyclononene (DBN), Hünig base and N,N-dimethyl-aniline.
  • DABCO diazabicyclooctane
  • DBU diazabicycloundecane
  • DBN diazabicyclononene
  • Hünig base N,N-dimethyl-aniline.
  • reaction temperatures can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 20° C. and 22 0 ° C.
  • reaction components of the formulae (IX) and (V) in which A, W, X, Y and Z are each as defined above and Hal represents halogen, and, if appropriate, the acid acceptors, are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 5 mol) of one component or the other.
  • the process (G) is characterized in that compounds of the formula (X) in which A, B, Q 1 , Q 2 , W, X, Y, Z and R 8 are each as defined above are subjected to an intramolecular condensation in the presence of a base.
  • Suitable diluents for the process (G) according to the invention are all organic solvents which are inert towards the reaction participants. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylfomiamide and N-methyl-pyrrolidone. It is furthermore possible to use alcohols, such as methanol, ethanol, propanol, iso-propanol, butanol, isobutanol, tert-butanol.
  • hydrocarbons such as toluene and xylene
  • ethers such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether
  • Suitable bases (deprotonating agents) for carrying out the process (G) according to the invention are all customary proton acceptors. Preference is given to using alkali metal and alkaline earth metal oxides, hydroxides and carbonates, such as sodium hydroxide, potassium hydroxide, magnesium oxide, calcium oxide, sodium carbonate, potassium carbonate and calcium carbonate, which can also be employed in the presence of phase-transfer catalysts, such as, for example, triethylbenzylammonium chloride, tetrabutylammonium bromide, Adogen 464 (methyltrialkyl(C 8 -C 10 )ammonium chloride) or TDA 1 (tris-(methoxyethoxyethyl)-amine).
  • phase-transfer catalysts such as, for example, triethylbenzylammonium chloride, tetrabutylammonium bromide, Adogen 464 (methyltrialkyl(C 8 -C 10 )ammonium chloride)
  • Alkali metals such as sodium or potassium can also be used.
  • alkali metal and alkaline earth metal amides and hydrides such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • reaction temperatures can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between ⁇ 75° C. and 250° C., preferably between ⁇ 50° C. and 150° C.
  • reaction components of the formula (X) and the deprotonating bases are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 3 mol) of one component or the other.
  • the process (H) is characterized in that compounds of the formula (XI) in which A, B, Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y, Z and R 8 are each as defined above are subjected to an intramolecular condensation in the presence of bases.
  • Suitable diluents for the process (H) according to the invention are all organic solvents which are inert towards the reaction participants. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone. Alcohols, such as methanol, ethanol, propanol, iso-propanol, butanol, isobutanol and tert-butanol can also be used.
  • hydrocarbons such as toluene and xylene
  • ethers such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether
  • Suitable bases (deprotonating agents) for carrying out the process (H) according to the invention are all customary proton acceptors. Preference is given to using alkali metal and alkaline earth metal oxides, hydroxides and carbonates, such as sodium hydroxide, potassium hydroxide, magnesium oxide, calcium oxide, sodium carbonate, potassium carbonate and calcium carbonate, which can also be employed in the presence of phase-transfer catalysts, such as, for example, triethylbenzyl-ammonium chloride, tetrabutylammonium bromide, Adogen 464 (methyltrialkyl(C 8 -C 10 )ammonium chloride) or TDA 1 (tris-(methoxyethoxyethyl)-amine).
  • phase-transfer catalysts such as, for example, triethylbenzyl-ammonium chloride, tetrabutylammonium bromide, Adogen 464 (methyltrialkyl(C 8 -C 10 )ammonium chlor
  • Alkali metals such as sodium and potassium can also be used.
  • alkali metal and alkaline earth metal amides and hydrides such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • reaction temperatures can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C.
  • the process (H) according to the invention is generally carried out under atmospheric pressure.
  • reaction components of the formula (XII) and the deprotonating bases are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 3 mol) of one component or the other.
  • palladium(0) complexes are suitable as catalysts. Preference is given, for example, to tetrakis-(triphenyl-phosphine)palladium.
  • Suitable diluents for carrying out the process (I) according to the invention are water, organic solvents and any mixtures thereof.
  • Examples include: aliphatic, alicyclic or aromatic hydrocarbons, such as, for example, petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; halogenated hydrocarbons, such as, for example, chlorobenzene, dichlorobeiizene, methylene chloride, chloroform, carbon tetrachloride, dichloroethane, trichloroethane or tetrachloroethylene; ethers, such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-
  • reaction temperature in the process (I) according to the invention can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between 0° C. and +140° C., preferably between 50° C. and +100° C.
  • boronic acid of the formula (XII), in which Y is as defined above, and compounds of the formulae (I-1-a) to (I-8-a), in which A, B, D, Q 1 , Q 2 , Q 3 , Q 4 , Q 5 , Q 6 , W, X, Y, and Z are as defined above are employed in a molar ratio of from 1:1 to 3:1, preferably from 1:1 to 2:1.
  • 0.005 to 0.5 mol, preferably 0.01 mol to 0.1 mol of catalyst is employed per mole of the compounds of the formulae (I-1-a) to (I-8-a).
  • the base is usually employed in excess.
  • Suitable diluents for the process (J- ⁇ ) according to the invention are all solvents which are inert towards the acyl halides.
  • hydrocarbons such as benzine, benzene, toluene, xylene and tetralin
  • halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, chlorobenzene and o-dichlorobenzene
  • ketones such as acetone and methyl isopropyl ketone
  • furthermore ethers such as diethyl ether, tetrahydrofuran and dioxane
  • carboxylic esters such as ethyl acetate
  • strongly polar solvents such as dimethyl sulphoxide and sulpholane.
  • the hydrolytic stability of the acyl halide permitting, the reaction can also be carried out in the presence of water.
  • Suitable acid binders for the reaction according to the process (J- ⁇ ) according to the invention are all customary acid acceptors. Preference is given to using tertiary amines, such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicyclo-undecene (DBU), diazabicyclononene (DBN), Htinig base and N,N-dimethyl-aniline, furthermore alkaline earth metal oxides, such as magnesium oxide and calcium oxide, moreover alkali metal and alkaline earth metal carbonates, such as sodium carbonate, potassium carbonate and calcium carbonate, and also alkali metal hydroxides such as sodium hydroxide and potassium hydroxide.
  • tertiary amines such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicyclo-undecene (DBU), diazabicyclononene (DBN), H
  • reaction temperatures in the process (J-a) according to the invention can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between ⁇ 20° C. and +1 50° C., preferably between 0° C. and 100° C.
  • the starting materials of the formulae (I-1-a) to (I-8-a) and the carbonyl halide of the formula (XIU) are generally in each case employed in approximately equivalent amounts. However, it is also possible to employ a relatively large excess (up to 5 mol) of the carbonyl halide. Work-up is carried out by customary methods.
  • the process (J- ⁇ ) is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are reacted with carboxylic anhydrides of the formula (XIV), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder.
  • Preferred diluents for the process (J- ⁇ ) according to the invention are those diluents which are also preferred when acyl halides are used. Otherwise, it is also possible for a carboxylic anhydride employed in excess to act simultaneously as a diluent.
  • acid binders which are added are preferably those acid binders which are also preferred when acyl halides are used.
  • the reaction temperatures can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between ⁇ 20° C. and +150° C., preferably between 0° C. and 100° C.
  • the starting materials of the formulae (I-1-a) to (I-8-a) and the carboxylic anhydride of the formula (XIV) are generally each employed in approximately equivalent amounts. However, it is also possible to use a relatively large excess (up to 5 mol) of the carboxylic anhydride. Work-up is carried out by customary methods.
  • the adopted procedure is to remove diluent and excess carboxylic anhydride and also the carboxylic acid formed by distillation or by washing with an organic solvent or with water.
  • the process (K) is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with chloroformic esters or chloroformic thiol esters of the formula (XV), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder.
  • Suitable diluents for the reaction according to the process (K) according to the invention are all customary acid acceptors. Preference is given to using tertiary amines, such as triethylamine, pyridine, DABCO, DBU, DBA, Hünig base and N,N-dimethyl-aniline, furthermore alkaline earth metal oxides, such as magnesium oxide and calcium oxide, moreover alkali metal carbonates and alkaline earth metal carbonates, such as sodium carbonate, potassium carbonate and calcium carbonate, and also alkali metal hydroxides such as sodium hydroxide and potassium hydroxide.
  • tertiary amines such as triethylamine, pyridine, DABCO, DBU, DBA, Hünig base and N,N-dimethyl-aniline
  • alkaline earth metal oxides such as magnesium oxide and calcium oxide
  • alkali metal carbonates and alkaline earth metal carbonates such as sodium carbonate, potassium carbonate and calcium carbonate
  • Suitable diluents for the process (K) according to the invention are all solvents which are inert towards the chloroformic esters or chloroformic thiol esters.
  • hydrocarbons such as benzine, benzene, toluene, xylene and tetralin
  • halogenated hydrocarbons such as methylene chloride, chloroform, carbon tetrachloride, chlorobenzene and o-dichlorobenzene
  • ketones such as acetone and methyl isopropyl ketone
  • furthermore ethers such as diethyl ether, tetrahydrofuran and dioxane
  • carboxylic esters such as ethyl acetate
  • strongly polar solvents such as dimethyl sulphoxide and sulpholane.
  • reaction temperatures can be varied within a relatively wide range. If the reaction is carried out in the presence of a diluent and an acid binder, the reaction temperatures are generally between ⁇ 20° C. and +100° C., preferably between 0° C. and 50° C.
  • the process (K) according to the invention is generally carried out under atmospheric pressure.
  • the starting materials of the formulae (I-1-a) to (I-8-a) and the appropriate chloroformic ester or chloroformic thiol ester of the formula (XV) are generally in each case employed in approximately equivalent amounts. However, it is also possible to employ a relatively large excess (up to 2 mol) of one component or the other. Work-up is carried out by customary methods. In general, precipitated salts are removed and the reaction mixture that remains is concentrated by stripping the diluent.
  • Suitable diluents which are added if appropriate are all inert polar organic solvents, such as ethers, amides, sulphones, sulphoxides, but also halogenoalkanes.
  • the enolate salt of the compounds (I-1-a) to (I-8-a) is prepared by addition of strong deprotonating agents, such as, for example, sodium hydride or potassium tert-butoxide, it is not necessary to add further acid binders.
  • acid binders are employed, these are customary inorganic or organic bases, for example sodium hydroxide, sodium carbonate, potassium carbonate, pyridine, triethylamine.
  • reaction can be carried out at atmospheric pressure or under elevated pressure and is preferably carried out at atmospheric pressure. Work-up is carried out by customary methods.
  • the process (M) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with sulphonyl chlorides of the formula (XVII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder.
  • Suitable diluents which are added if appropriate are all inert polar organic solvents, such as ethers, amides, nitrites, sulphones, sulphoxides or halogenated hydrocarbons, such as methylene chloride.
  • the enolate salt of the compounds (I-1-a) to (I-8-a) is prepared by addition of strong deprotonating agents (such as, for example, sodium hydride or potassium tert-butoxide), it is not necessary to add further acid binders.
  • strong deprotonating agents such as, for example, sodium hydride or potassium tert-butoxide
  • acid binders are employed, these are customary inorganic or organic bases, for example sodium hydroxide, sodium carbonate, potassium carbonate, pyridine, triethylamine.
  • reaction can be carried out at atmospheric pressure or under elevated pressure and is preferably carried out at atmospheric pressure. Work-up is carried out by customary methods.
  • the process (N) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with phosphorus compounds of the formula (XVIII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder.
  • Suitable solvents which are added if appropriate are all inert polar organic solvents, such as ethers, amides, nitriles, alcohols, sulphides, sulphones, sulphoxides, etc.
  • Suitable acid binders which are added if appropriate are customary inorganic or organic bases such as hydroxides, carbonates or amines. Examples include sodium hydroxide, sodium carbonate, potassium carbonate, pyridine, triethylamine.
  • the reaction can be carried out at atmospheric pressure or under elevated pressure and is preferably carried out under atmospheric pressure. Work-up is carried out by customary methods of organic chemistry.
  • the resulting end products are preferably purified by crystallization, chromatographic purification or by so-called “incipient distillation”, i.e. removal of the volatile components under reduced pressure.
  • the process (O) is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are reacted with metal hydroxides or metal alkoxides of the formula (XIX) or amines of the formula (XX), if appropriate in the presence of a diluent.
  • Preferred diluents for the process (O) according to the invention are ethers, such as tetrahydrofuran, dioxane, diethyl ether, or else alcohols, such as methanol, ethanol, isopropanol, but also water.
  • the process (O) according to the invention is generally carried out under atmospheric pressure.
  • reaction temperatures are generally between ⁇ 20° C. and 100° C., preferably between 0° C. and 50° C.
  • the process (P) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with (P- ⁇ ) compounds of the formula (XXI), if appropriate in the presence of a diluent and if appropriate in the presence of a catalyst, or (P- ⁇ ) with compounds of the formula (XXII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder.
  • Suitable diluents which are added if appropriate are all inert organic solvents, such as ethers, amides, nitrites, sulphones, sulphoxides.
  • catalysts may be added to accelerate the reaction.
  • the catalysts which are employed are organotin compounds, such as, for example, dibutyltin dilaurate.
  • the reaction is preferably carried out at atmospheric pressure.
  • Suitable diluents which are added if appropriate are all inert polar organic solvents, such as ethers, amides, sulphones, sulphoxides or halogenated hydrocarbons.
  • the enolate salt of the compounds (I-1-a) to (I-8-a) is prepared by addition of strong deprotonating agents (such as, for example, sodium hydride or potassium tert-butoxide), it is not necessary to add further acid binders.
  • strong deprotonating agents such as, for example, sodium hydride or potassium tert-butoxide
  • acid binders are employed, these are customary inorganic or organic bases, for example sodium hydroxide, sodium carbonate, potassium carbonate, triethylamine or pyridine.
  • reaction can be carried out at atmospheric pressure or under elevated pressure and is preferably carried out at atmospheric pressure. Work-up is carried out by customary methods.
  • the active compounds are suitable for controlling animal pests, preferably arthropods and nematodes, in particular insects and arachnids, which are encountered in agriculture, in forestry, in the protection of stored products and of materials, and in the hygiene sector. They are active against normally sensitive and resistant species and against all or some stages of development.
  • animal pests preferably arthropods and nematodes, in particular insects and arachnids, which are encountered in agriculture, in forestry, in the protection of stored products and of materials, and in the hygiene sector. They are active against normally sensitive and resistant species and against all or some stages of development.
  • the abovementioned pests include:
  • Thysanura for example, Lepisma saccharina.
  • Thysanoptera for example, Frankliniella occidentalis, Hercinothrips femoralis, Thrips palmi and Thrips tabaci.
  • Acarina for example, Acarus siro, Argas spp., Ornithodoros spp., Dermanyssus gallinae, Eriophyes ribis, Phyllocoptruta oleivora, Boophilus spp., Rhipicephalus spp., Amblyonrma spp., Hyalonmma spp., Ixodes spp., Psoroptes spp., Chorioptes spp., Sarcoptes spp., Tarsonemus spp., Bryobia praetiosa, Panonychus spp. and Tetranychus spp.
  • the active compounds according to the invention have high insecticidal and acaridical activity after foliar and soil application.
  • the active compounds according to the invention can further be used as defoliants, desiccants, haulm killers and, especially, as weed killers.
  • weeds in the broadest sense there are to be understood all plants which grow in locations where they are undesired. Whether the substances according to the invention act as total or selective herbicides depends essentially on the amount used.
  • the dosages of the active compounds according to the invention required for controlling weeds are between 0.001 and 10 kg/ha, preferably between 0.005 and 5 kg/ha.
  • the active compounds according to the invention can be used, for example, in connection with the following plants:
  • Echinochloa Setaria, Panicum, Digitaria, Phleum, Poa, Festuca, Eleusine, Brachiaria, Lolium, Bromus, Avena, Cyperus, Sorghum, Agropyron, Cycnodon, Monochoria, Fimbristylis, Sagittaria, Eleocharis, Scirpus, Paspalum, Ischaemum, Sphenoclea, Dactyloctenium, Agrostis, Alopecurus, Apera.
  • Oryza Zea, Triticum, Hordeum, Avena, Secale, Sorghum, Panicum, Sachharum, Ananas, Asparagus, Allium.
  • the compounds are suitable for total weed control, for example on industrial terrain and rail tracks and on paths and areas with or without tree growth.
  • the compounds can be employed for controlling weeds in perennial crops, for example forests, ornamental tree plantings, orchards, vineyards, citrus groves, nut orchards, banana plantations, coffee plantations, tea plantations, rubber plantations, oil palm plantations, cocoa plantations, soft fruit plantings and hop fields, on lawns and turf and pastures and for selective weed control in annual crops.
  • the active compounds according to the invention are highly suitable for selective control of monocotyledonous weeds in dicotyledonous crops, by the pre-emergence and by the post-emergence method. In cotton or sugar beet, for example, they can be employed with very good results for controlling harmful grass.
  • the active compounds can be converted to the customary formulations, such as solutions, emulsions, wettable powders, suspensions, powders, dusts, pastes, soluble powders, granules, suspension-emulsion concentrates, natural and synthetic materials impregnated with active compound and microencapsulations in polymeric substances.
  • formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is, liquid solvents, and/or solid carriers, optionally with the use of surfactants, that is emulsifiers and/or dispersants, and/or foam-formers.
  • extenders that is, liquid solvents, and/or solid carriers
  • surfactants that is emulsifiers and/or dispersants, and/or foam-formers.
  • suitable liquid solvents are: aromatics such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons such as cyclohexane or paraffins, for example petroleum fractions, mineral and vegetable oils, alcohols such as butanol or glycol and also their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide and dimethyl sulphoxide, and also water.
  • aromatics such as xylene, toluene or alkylnaphthalenes
  • chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride
  • aliphatic hydrocarbons
  • ammomnum salts and ground natural minerals such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals, such as highly disperse silica, alumina and silicates; as solid carriers for granules there are suitable: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, and also synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks; as emulsifiers and/or foam-formers there are suitable: for example nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphon
  • Tackifiers such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, as well as natural phospholipids such as cephalins and lecithins, and synthetic phospholipids, can be used in the formulations.
  • Other additives can be mineral and vegetable oils.
  • colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs, such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • inorganic pigments for example iron oxide, titanium oxide and Prussian Blue
  • organic dyestuffs such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs
  • trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • the formulations generally comprise between 0.1 and 95% by weight of active compound, preferably between 0.5 and 90% and, in addition, preferably extenders and/or surfactants.
  • the active compound according to the invention can be present in its commercially available formulations and in the use forms, prepared from these formulations, as a mixture with other active compounds, such as insecticides, attractants, sterilizing agents, acaricides, nematicides, flugicides, growth-regulating substances or herbicides.
  • active compounds such as insecticides, attractants, sterilizing agents, acaricides, nematicides, flugicides, growth-regulating substances or herbicides.
  • the insecticides include, for example, phosphoric acid esters, carbarnates, carboxylates, chlorinated hydrocarbons, phenylureas and substances produced by microorganisms, inter alia.
  • kasugamycin copper preparations, such as: copper hydroxide, copper naphthenate, copper oxychloride, copper sulphate, copper oxide, oxine-copper and Bordeaux mixture,
  • pefurazoate penconazole, pencycuron, phosdiphen, phthalide, pimaricin, piperalin, polycarbamate, polyoxin, probenazole, prochloraz, procymidone, propamocarb, propiconazole, propineb, pyrazophos, pyrifenox, pyrimethanil, pyroquilon,
  • bronopol dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, fuirancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations.
  • abamectin, AC 303 630 acephate, acrinathrin, alanycarb, aldicarb, alphamethrin, amitraz, avermectin, AZ 60541, azadirachtin, azinphos A, azinphos M, azocyclotin,
  • Bacillus thuringiensis bendiocarb, benfuracarb, bensultap, betacyfluthrin, bifenthrin, BPMC, brofenprox, bromophos A, bufencarb, buprofezin, butocarboxim, butylpyridaben,
  • fenamiphos fenazaquin, fenbutatin oxide, fenitrothion, fenobucarb, fenothiocarb, fenoxycarb, fenpropathrin, fenpyrad, fenpyroximate, fenthion, fenvalerate, fipronil, fluazinam, flucycloxuron, flucythrinate, flufenoxuron, flufenprox, fluvalinate, fonophos, formothion, fosthiazate, fubfenprox, furathiocarb,
  • parathion A parathion M, permethrin, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimicarb, pirimiphos M, pirimiphos A, profenofos, promecarb, propaphos, propoxur, prothiofos, prothoate, pymetrozine, pyrachlophos, pyridaphenthion, pyresmethrin, pyrethrum, pyridaben, pyrimidifen, pyriproxyfen,
  • vamidothion XMC, xylylcarb, YI 5301/5302, zetamethrin.
  • anilides such as, for example, diflufenican and propanil; arylcarboxylic acids such as, for example, dichloropicolinic acid, dicamba and picloram; aryloxyalkanoic acids such as, for example, 2,4-D, 2,4-DB, 2,4-DP, fluroxypyr, MCPA, MCPP and triclopyr; aryloxy-phenoxy-alkanoic esters such as, for example, diclofop-methyl, fenoxaprop-ethyl, fluazifop-butyl, haloxyfop-methyl and quizalofop-ethyl; azinones such as, for example, chloridazon and norflurazon; carbamates such as, for example, chlorpropham, desmedipham, phenmedipham and propham; chloroacetanilides such as, for example, alachlor, acetochlor, butachlor, metazachlor, me
  • the active compound according to the invention can furthermore be present in its commercially available formulations and in the use forms, prepared from these formulations, as a mixture with synergistic agents.
  • Synergistic agents are compounds which increase the action of the active compounds, without it being necessary for the synergistic agent added to be active itself.
  • the active compound content of the use forms prepared from the commercially available formulations can vary within wide limits.
  • the active compound concentration of the use forms can be from 0.0000001 to 95% by weight of active compound, preferably between 0.0001 and 1% by weight.
  • the active compound When used against hygiene pests and pests of stored products, the active compound is distinguished by an excellent residual action on wood and clay as well as a good stability to alkali on limed substrates.
  • the active compounds according to the invention act not only against plant, hygiene and stored product pests, but also in the veterinary medicine sector against animal parasites (ectoparasites), such as hard ticks, soft ticks, mange mites, leaf mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, feather lice and fleas.
  • animal parasites ectoparasites
  • ectoparasites such as hard ticks, soft ticks, mange mites, leaf mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, feather lice and fleas.
  • parasites include:
  • Nematocerina and Brachycerina for example, Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomy
  • the active compounds of the formula (I) according to the invention are also suitable for controlling arthropods which infest agricultural productive livestock, such as, for example, cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese and bees, other pets, such as, for example, dogs, cats, caged birds and aquarium fish, and also so-called test animals, such as, for example, hamsters, guinea pigs, rats and mice.
  • arthropods cases of death and reduction in productivity (for meat, milk, wool, hides, eggs, honey etc.) should be diminished, so that more economic and easier animal husbandry is possible by use of the active compounds according to the invention.
  • the active compounds according to the invention are used in the veterinary sector in a known manner by enteral administration in the form of, for example, tablets, capsules, potions, drenches, granules, pastes, boluses, the feed-through process and suppositories, by parenteral administration, such as, for example, by injection (intramuscular, subcutaneous, intravenous, intraperitoneal and the like), implants by nasal administration, by dermal use in the form, for example, of dipping or bathing, spraying, pouring on and spotting on, washing and powdering, and also with the aid of molded articles containing the active compound, such as collars, ear marks, tail marks, limb bands, halters, marking devices and the like.
  • enteral administration in the form of, for example, tablets, capsules, potions, drenches, granules, pastes, boluses, the feed-through process and suppositories
  • parenteral administration such as, for example, by injection (
  • the active compounds of the formula (1) can be used as formulations (for example powders, emulsions, free-flowing compositions), which comprise the active compounds in an amount of 1 to 80% by weight, directly or after 100 to 10 000-fold dilution, or they can be used as a chemical bath.
  • insects may be mentioned as examples and as preferred—but without a limitation:
  • Hymenopterons such as
  • Kaloterrnes flavicollis Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermnes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis, Coptoterrnes formosanus.
  • Industrial materials in the present connection are to be understood as meaning non-living materials, such as, preferably, plastics, adhesives, sizes, papers and cards, leather, wood and processed wood products and coating compositions.
  • Wood and processed wood products are materials to be protected, especially preferably, from insect infestation.
  • Wood and wood processed wood products which can be protected by the agents according to the invention or mixtures comprising these are to be understood as meaning, for example: building timber, wooden beams, railway sleepers, bridge components, boat jetties, wooden vehicles, boxes, pallets, containers, telegraph poles, wood panelling, wooden windows and doors, plywood, chipboard, joinery or wooden products which are used quite generally in house-building or in building joinery.
  • the active compounds can be used as such, in the form of concentrates or in generally customary formulations, such as powders, granules, solutions, suspensions, emulsions or pastes.
  • the formulations mentioned can be prepared in a manner known per se, for example by mixing the active compounds with at least one solvent or diluent, emulsifier, dispersing agent and/or binder or fixing agent, a water repellent, if appropriate siccatives and UV stabilizers and if appropriate dyestuffs and pigrnents, and also other processing auxiliaries.
  • the insecticidal compositions or concentrates used for the preservation of wood and wood-derived timber products comprise the active compound according to the invention in a concentration of 0.0001 to 95% by weight, in particular 0.001 to 60% by weight.
  • compositions or concentrates employed depends on the nature and occurrence of the insects and on the medium. The optimum amount employed can be determined for the use in each case by a series of tests. In general, however, it is sufficient to employ 0.0001 to 20% by weight, preferably 0.001 to 10% by weight, of the active compound, based on the material to be preserved.
  • Solvents and/or diluents which are used are an organic chemical solvent or solvent mixture and/or an oily or oil-like organic chemical solvent or solvent mixture of low volatility and/or a polar organic chemical solvent or solvent mixture and/or water, and if appropriate an emulsifier and/or wetting agent.
  • Organic chemical solvents which are preferably used are oily or oil-like solvents having an evaporation number above 35 and a flashpoint above 30° C., preferably above 45° C.
  • Substances which are used as such oily or oil-like water-insoluble solvents of low volatility are appropriate mineral oils or aromatic fractions thereof, or solvent mixtures containing mineral oils, preferably white spirit, petroleum and/or alkylbenzene.
  • Mineral oils having a boiling range from 170 to 220° C., white spirit having a boiling range from 170 to 220° C., spindle oil having a boiling range from 250 to 350° C., petroleum and aromatics having a boiling range from 160 to 280° C., terpentine oil and the like, are advantageously employed.
  • liquid aliphatic hydrocarbons having a boiling range from 180 to 210° C. or high-boiling mixtures of aromatic and aliphatic hydrocarbons having a boiling range from 180 to 220° C. and/or spindle oil and/or monochloronaphthalene, preferably ⁇ -monochloronaphthalene, are used.
  • organic oily or oil-like solvents of low volatility which have an evaporation number above 35 and a flashpoint above 30° C., preferably above 45° C., can be replaced in part by organic chemical solvents of high or medium volatility, providing that the solvent mixture likewise has an evaporation number above 35 and a flashpoint above 30° C., preferably above 45° C., and that the insecticide/fungicide mixture is soluble or emulsifiable in this solvent mixture.
  • organic chemical solvent or solvent mixture is replaced by an aliphatic polar organic chemical solvent or solvent mixture.
  • Aliphatic organic chemical solvents containing hydroxyl and/or ester and/or ether groups such as, for example, glycol ethers, esters or the like, are preferably used.
  • Organic chemical binders which are used in the context of the present invention are the synthetic resins and/or binding drying oils which are known per se, are water-dilutable and/or are soluble or dispersible or emulsifiable in the organic chemical solvents employed, in particular binders consisting of or comprising an acrylate resin, a vinyl resin, for example polyvinyl acetate, polyester resin, polycondensation or polyaddition resin, polyurethane resin, alkyd resin or modified alkyd resin, phenolic resin, hydrocarbon resin, such as indene-cumarone resin, silicone resin, drying vegetable oils and/or drying oils and/or physically drying binders based on a natural and/or synthetic resin.
  • binders consisting of or comprising an acrylate resin, a vinyl resin, for example polyvinyl acetate, polyester resin, polycondensation or polyaddition resin, polyurethane resin, alkyd resin or modified alkyd resin, phenolic resin, hydrocarbon resin, such
  • the synthetic resin used as the binder can be employed in the form of an emulsion, dispersion or solution.
  • Bitumen or bituminous substances can also be used as binders in an amount of up to 10% by weight.
  • Dyestuffs, pigments, water-repelling agents, odour correctants and inhibitors or anticorrosive agents and the like which are known per se can additionally be employed.
  • composition or concentrate comprises, as the organic chemical binder, at least one alkyd resin or modified alkyd resin and/or one drying vegetable oil.
  • Alkyd resins having an oil content of more than 45% by weight, preferably 50 to 68% by weight, are preferably used according to the invention.
  • binder mentioned can be replaced by a fixing agent (mixture) or a plasticizer (mixture). These additives are intended to prevent evaporation of the active compounds and crystallization or precipitation. They preferably replace 0.01 to 30% of the binder (based on 100% of the binder employed).
  • the plasticizers originate from the chemical classes of phthalic acid esters, such as dibutyl, dioctyl or benzyl butyl phthalate, phosphoric acid esters, such as tributyl phosphate, adipic acid esters, such as di-(2-ethylhexyl) adipate, stearates, such as butyl stearate or amyl stearate, oleates, such as butyl oleate, glycerol ethers or higher molecular weight glycol ethers, glycerol esters and p-toluenesulphonic acid esters.
  • phthalic acid esters such as dibutyl, dioctyl or benzyl butyl phthalate
  • phosphoric acid esters such as tributyl phosphate
  • adipic acid esters such as di-(2-ethylhexyl) adipate
  • Fixing agents are based chemically on polyvinyl alkyl ethers, such as, for example, polyvinyl methyl ether or ketones, such as benzophenone or ethylenebenzophenone.
  • Possible solvents or diluents are, in particular, also water, if appropriate as a mixture with one or more of the abovementioned organic chemical solvents or diluents, emulsifiers and dispersing agents.
  • the ready-to-use compositions can also comprise other insecticides, if appropriate, and also one or more fungicides, if appropriate.
  • Possible additional mixing partners are, preferably, the insecticides and fungicides mentioned in WO 94/29 268.
  • the compounds mentioned in this document are an explicit constituent of the present application.
  • insecticides such as chlorpyriphos, phoxim, silafluofin, alphamethrin, cyfluthrin, cypermethrin, deltamethrin, permetlrin, imidacloprid, NI-25, flufenoxuron, hexaflumuron and triflumuron
  • fungicides such as epoxyconazole, hexaconazole, azaconazole, propiconazole, tebuconazole, cyproconazole, metconazole, imazalil, dichlorfluanid, tolylfluanid, 3-iodo-2-propinyl-butyl carbamate, N-octyl-isothiazolin-3-one and 4,5-dichloro-N-octylisothiazolin-3-one.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel arylphenyl-substituted cyclic ketoenols of the formula (I)
Figure US20030096806A1-20030522-C00001
in which
X represents halogen, alkyl, alkoxy, alkenyloxy, alkylthio, alkylsulphinyl, alkylsulphonyl, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro, cyano or in each case optionally substituted phenyl, phenoxy, phenylthio, phenylalkoxy or phenylalkylthio,
Y represents in each case optionally substituted cycloalkyl, aryl or hetaryl,
W represents hydrogen, halogen, alkyl, alkoxy, alkenyloxy, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro or cyano,
Z represents halogen, alkyl, alkoxy, alkenyloxy, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro or cyano,
CKE represents one of the groups
Figure US20030096806A1-20030522-C00002
in which
A, B, D, G and Q1, S, Q6 are each as defined in the description,
to a plurality of processes for their preparation and to their use as pesticides and herbicides.

Description

  • The present invention relates to novel arylphenyl-substituted cyclic ketoenols, to a plurality of processes for their preparation and to their use as pesticides and herbicides. [0001]
  • Pharmaceutical properties of 3-acyl-pyrrolidine-2,4-diones have already been described (S. Suzuki et al. Chem. Pharm. Bull. 15 1120 (1967)). Furthermore, N-phenylpyrrolidine-2,4-diones have been synthesized by R. Schmierer and H. Mildenberger (Liebigs Ann. Chem. 1985, 1095). A biological activity of these compounds has not been described. [0002]
  • EP-A-0 262 399 and GB-A-2 266 888 disclose compounds of a similar structure (3-aryl-pyrrolidine-2,4-diones) of which, however, no herbicidal, insecticidal or acaricidal activity has become known. Unsubstituted bicyclic 3-aryl-pyrrolidine-2,4-dione derivatives (EP-A-355 599 and EP-415 211) and substituted monocyclic 3-aryl-pyrrolidine-2,4-dione derivatives (EP-A-377 893 and EP-442 077) having herbicidal, insecticidal or acaricidal activity are known. [0003]
  • Also known are polycyclic 3-arylpyrrolidine-2,4-dione derivatives (EP-442 073) and 1H-arylpyrrolidine-dione derivatives (EP-456 063, EP-521 334, EP-596 298, EP-613 884, EP-613 885, WO 94/01 997, WO 95/26 954, WO 95/20 572, EP-A-0 668 267, WO 96/25 395, WO 96/35 664, WO 97/01 535, WO 97/02 243 and WO 97/36 868, DE 19 716 591). [0004]
  • It is known that certain substituted Δ[0005] 3-dihydrofuran-2-one derivatives have herbicidal properties (cf. DE-A-4 014 420). The synthesis of the tetronic acid derivatives used as starting materials (such as, for example, 3-(2-methyl-phenyl)-4-hydroxy-5-(4-fluorophenyl)-Δ3-dihydrofuran-2-one) is likewise described in DE-A-4 014 420. Compounds of a similar structure are known from the publication Campbell et al., J. Chem. Soc., Perkin Trans. 1, 1985, (8) 1567-76, without any insecticidal and/or acaricidal activity being mentioned. Furthermore, 3-aryl-Δ3-dihydrofuranone derivatives having herbicidal, acaricidal and insecticidal properties are known from EP-A-528 156, EP-A-0 647 637, WO 95/26 345, WO 96/20 196, WO 96/25 395, WO 96/35 664, WO 97/01 535, WO 97/02 243 and WO 97/36 868, DE 19 716 591. 3-Aryl-Δ3-dihydrothiophene-one derivatives are likewise known (WO 95/26 345, 96/25 395, WO 97/01 535, WO 97/02 243, WO 97/36 868, DE 19 716 591).
  • Also known from the literature are certain 3H-pyrazol-3-one derivatives, such as, for example, 1,2-diethyl-1,2-dihydro-5-hydroxy-4-phenyl-3H-pyrazol-3-one or [5-oxo-1,2-diphenyl-4-(p-sulphophenyl)-3-pyrazolin-3-yl]-oxy, disodium salt, or p-(3-hydroxy-5-oxo-1,2-diphenyl-3-pyrazolin-4-yl)-benzenesulphonic acid (cf. J. Heterocycl. Chem., 25(5), 1301-1305, 1988 or J. Heterocycl. Chem., 25(5), 1307-1310, 1988 or Zh. Obshch. Khim., 34(7), 2397-2402, 1964). However, a biological activity of these compounds is not described. [0006]
  • Furthermore, it is known that the trisodium salt of 4,4′,4″-(5-hydroxy-3-oxo-1H-pyrazol-1,2,4 (3H)-triyl)-tris-benzenesulphonic acid has pharmacological properties (cf. Farmnakol. Toksikol. (Moscow), 38(2), 180-186, 1976). However, it is not known to be used in crop protection. [0007]
  • Moreover, EP-508 126 and WO 92/16 510, WO 96/21 652 describe 4-arylpyrazolidin-3,5-dione derivatives having herbicidal, acaricidal and insecticidal properties. Additionally, 4-arylpyrazolidines have become known of which fungicidal properties have been described (WO 96/36 229, WO 96/36 615, WO 96/36 616, WO 96/36 633). [0008]
  • Certain phenyl-pyrone derivatives which are unsubstituted in the phenyl ring have already become known (cf. A. M. Chirazi, T. Kappe and E. Ziegler, Arch. Pharm. 309, 558 (1976) and K. -H. Boltze and K. Heidenbluth, Chem. Ber. 91, 2849), a possible use of these compounds as pesticides not being mentioned. Phenyl-pyrone derivatives which are substituted in the phenyl ring and have herbicidal, acaricidal and insecticidal properties are described in EP-A-588 137, WO 96/25 395, WO 96/35 664, WO 97/01 535, WO 97/02 243, WO 97/16 436, WO 97/19 941 and WO 97/36 868, DE 19 716 591. [0009]
  • Certain 5-phenyl-1,3-thiazine derivatives which are unsubstituted in the phenyl ring have already become known (cf. E. Ziegler and E. Steiner, Monatsh. 95, 147 (1964), R. Ketcham, T. Kappe and E. Ziegler, J. Heterocycl. Chem. 10, 223 (1973)), a possible use of these compounds as pesticides not being mentioned. 5-Phenyl-1,3-thiazine derivatives which are substituted in the phenyl ring and have herbicidal, acaricidal and insecticidal activity are described in WO 94/14 785, WO 96/02 539, WO 96/35 664, WO 97/01 535, WO 97/02 243, WO 97/02 243, WO 97/36 868. [0010]
  • It is known that certain substituted 2-arylcyclopentanediones have herbicidal and acaricidal properties (cf., for example, U.S. Pat. Nos. 4,283,348; 4,338,122; 4,436,666; 4,526,723; 4,551,547; 4,632,698; WO 96/01 798; WO 96/03 366 and also WO 97/14 667). Moreover, compounds of a similar structure are known: 3-hydroxy-5,5-dimethyl-2-phenylcyclopent-2-ene-1-one from the publication Micklefield et al., Tetrahedron, (1992), 7519-26 and the natural product involutine (−)-cis-5-(3,4-dihydroxyphenyl)-3,4-dihydroxy-2-(4-hydroxyphenyl)-cyclopent-2-ene-one from the publication Edwards et al., J. Chem. Soc. S, (1967), 405-9. An insecticidal or acaricidal activity is not described. Moreover, 2-(2,4,6-trimethylphenyl)-1,3-indanedione is known from the publication J. Economic Entomology, 66, (1973), 584 and the Offenlegungsschrift DE-2 361 084, with herbicidal and acaricidal activities being mentioned. [0011]
  • It is known that certain substituted 2-arylcyclohexanediones have herbicidal and acaricidal properties (cf., for example, U.S. Pat. Nos. 4,175,135, 4,209,432, 4,256,657, 4,256,658, 4,256,659, 4,257,858, 4,283,348, 4,303,669, 4,351,666, 4,409,153, 4,436,666, 4,526,723, 4,613,617, 4,659,372, DE-2 813 341, and also Wheeler, T. N., J. Org. Chem. 44, 4906 (1979)). [0012]
  • However, the activity and the activity spectrum of these compounds are, in particular at low application rates and concentrations, not always entirely satisfactory. Furthermore, the compatibility of these compounds with plants is not always satisfactory. [0013]
  • This invention, accordingly, provides novel compounds of the formula (I) [0014]
    Figure US20030096806A1-20030522-C00003
  • in which [0015]
  • X represents halogen, alkyl, alkoxy, alkenyloxy, alkylthio, alkylsulphinyl, alkylsulphonyl, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro, cyano or in each case optionally substituted phenyl, phenoxy, phenylthio, phenylalkoxy or phenylalkylthio, [0016]
  • Y represents in each case optionally substituted cycloalkyl, aryl or hetaryl, [0017]
  • W represents hydrogen, halogen, alkyl, alkoxy, alkenyloxy, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro or cyano, [0018]
  • Z represents halogen, alkyl, alkoxy, alkenyloxy, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro or cyano, [0019]
  • CKE represents one of the groups [0020]
    Figure US20030096806A1-20030522-C00004
  • in which [0021]
  • A represents hydrogen, in each case optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, saturated or unsaturated, optionally substituted cycloalkyl in which optionally at least one ring atom is replaced by a heteroatom, or in each case optionally halogen-, alkyl-, halogenoalkyl-, alkoxy, halogenoalkoxy-, cyano- or nitro-substituted aryl, arylalkyl or hetaryl, [0022]
  • B represents hydrogen, alkyl or alkoxyalkyl, or [0023]
  • A and B together with the carbon atom to which they are attached represent a saturated or unsaturated unsubstituted or substituted ring which optionally contains at least one heteroatom, [0024]
  • D represents hydrogen or an optionally substituted radical selected from the series consisting of alkyl, alkenyl, alkinyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, saturated or unsaturated cycloalkyl in which one or more ring members are optionally replaced by heteroatoms, arylalkyl, aryl, hetarylalkyl or hetaryl or [0025]
  • A and D together with the atoms to which they are attached represent a saturated or unsaturated ring which is unsubstituted or substituted in the A,D moiety and which optionally contains at least one (in the case where CKE=(4) further) heteroatom, or [0026]
  • A and Q[0027] 1 together represent alkanediyl or alkenediyl, each of which is optionally substituted by in each case optionally substituted alkyl, hydroxyl, alkoxy, alkylthio, cycloalkyl, benzyloxy or aryl, or
  • Q[0028] 1 represents hydrogen or alkyl,
  • Q[0029] 2, Q4, Q5 and Q6 independently of one another each represent hydrogen or alkyl,
  • Q[0030] 3 represents hydrogen, alkyl, alkoxyalkyl, alkylthioalkyl, optionally substituted cycloalkyl (in which optionally one methylene group is replaced by oxygen or sulphur) or optionally substituted phenyl, or
  • Q[0031] 3 and Q4 together with the carbon atom to which they are attached represent a saturated or unsaturated unsubstituted or substituted ring which optionally contains a heteroatom,
  • G represents hydrogen (a) or represents one of the groups [0032]
    Figure US20030096806A1-20030522-C00005
  • in which [0033]
  • E represents a metal ion or an ammonium ion, [0034]
  • L represents oxygen or sulphur, [0035]
  • M represents oxygen or sulphur, [0036]
  • R[0037] 1 represents in each case optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, alkylthioalkyl, polyalkoxyalkyl or optionally halogen-, alkyl- or alkoxy-substituted cycloalkyl, which may be interrupted by at least one heteroatom, in each case optionally substituted phenyl, phenylalkyl, hetaryl, phenoxyalkyl or hetaryloxyalkyl,
  • R[0038] 2 represents in each case optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl or represents in each case optionally substituted cycloalkyl, phenyl or benzyl,
  • R[0039] 3, R4 and R5 independently of one another each represent in each case optionally halogen-substituted alkyl alkoxy, alkylamino, dialkylamino, alkylthio, alkenylthio, cycloalkylthio and represent in each case optionally substituted phenyl, benzyl, phenoxy or phenylthio,
  • R[0040] 6 and R7 independently of one another each represent hydrogen, in each case optionally halogen-substituted alkyl, cycloalkyl, alkenyl, alkoxy, alkoxyalkyl, represent optionally substituted phenyl, represent optionally substituted benzyl, or together with the nitrogen atom to which they are attached represent a cycle which is optionally interrupted by oxygen or sulphur.
  • Depending, inter alia, on the nature of the substituents, the compounds of the formula (I) can be present as geometrical and/or optical isomers or mixtures of isomers in varying compositions, which can be separated, if desired, in a customary manner. The present invention provides both the pure isomers and the isomer mixtures, their preparation and use and also compositions comprising them. In the following, for simplicity, however, compounds of the formula (I) are always referred to, although both pure compounds and, if appropriate, mixtures having different proportions of isomeric compounds are intended. [0041]
  • Including the meanings (1) to (8) of the group CKE, the following principal structures (I-1) to (I-8) result: [0042]
    Figure US20030096806A1-20030522-C00006
  • in which [0043]
  • A, B, D, G, Q[0044] 1, Q2, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined above.
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-1-a) to (I-1-g), result if CKE represents the group (1), [0045]
    Figure US20030096806A1-20030522-C00007
  • in which [0046]
  • A, B, D, E, L, M, W, X, Y, Z, R[0047] 1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-2-a) to (I-2-g), result if CKE represents the group (2), [0048]
    Figure US20030096806A1-20030522-C00008
  • in which [0049]
  • A, B, E, L, M, W, X, Y, Z, R[0050] 1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-3-a) to (I-3-g), result if CKE represents the group (3), [0051]
    Figure US20030096806A1-20030522-C00009
  • in which [0052]
  • A, B, E, L, M, W, X, Y, Z, R[0053] 1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-4-a) to (I-4-g), result if CKE represents the group (4), [0054]
    Figure US20030096806A1-20030522-C00010
  • in which [0055]
  • A, D, E, L, M, W, X, Y, Z, R[0056] 1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Depending on the position of the substituent G, the compounds of the formula (I-5) can be present in the two isomeric forms of the formulae (I-5-A) and (I-5-B), [0057]
    Figure US20030096806A1-20030522-C00011
  • which is meant to be indicated by the dashed line in the formula (I-5). [0058]
  • The compounds of the formulae (I-5-A) and (I-5-B) can be present both as mixtures and in the form of their pure isomers. Mixtures of the compounds of the formulae (I-5-A) and (I-5-B) can be separated, if desired, in a manner known per se by physical methods, for example by chromatographic methods. [0059]
  • For reasons of clarity, hereinbelow in each case only one of the possible isomers is given. This does not exclude that the compounds may, if appropriate, be present in the form of the isomer mixtures or in the respective other isomeric form. [0060]
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-5-a) to (I-5-g) result if CKE represents the group (5), [0061]
    Figure US20030096806A1-20030522-C00012
  • in which [0062]
  • A, D, E, L, M, W, X, Y, Z, R[0063] 1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-6-a) to (I-6-g), result if CKE represents the group (6), [0064]
    Figure US20030096806A1-20030522-C00013
  • in which [0065]
  • A, E, L, M, W, X, Y, Z, R[0066] 1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Depending on the position of the substituent G, the compounds of the formula (I-7) can be present in the two isomeric forms of the formulae (I-7-A) and (I-7-B): [0067]
    Figure US20030096806A1-20030522-C00014
  • which is meant to be indicated by the dashed line in the formula (I). [0068]
  • The compounds of the formulae (I-7-A) and (I-7-B) can be present both as mixtures and in the form of their pure isomers. Mixtures of the compounds of the formulae (I-7-A) and (I-7-B) can be separated, if desired, by physical methods, for example by chromatographic methods. [0069]
  • For reasons of clarity, hereinbelow in each case only one of the possible isomers is given. This does not exclude that the compounds may, if appropriate, be present in the form of the isomer mixtures or in the respective other isomeric form. [0070]
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-7-a) to (I-7-g) result: [0071]
    Figure US20030096806A1-20030522-C00015
  • in which [0072]
  • A, B, Q[0073] 1, Q2, E, L, M, W, X, Y, Z, R1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Depending on the position of the substituent G, the compounds of the formula (I-8) can be present in the two isomeric forms of the formulae (I-8-A) and (I-8-B) [0074]
    Figure US20030096806A1-20030522-C00016
  • which is meant to be indicated by the dashed line in the formula (I). [0075]
  • The compounds of the formulae (I-8-A) and (I-8-B) can be present both as mixtures and in the form of their pure isomers. Mixtures of the compounds of the formulae (I-8-A) and (I-8-B) can be separated, if desired, by physical methods, for example by chromatographic methods. [0076]
  • For reasons of clarity, hereinbelow in each case only one of the possible isomers is given. This takes into account that the relevant compound may, if appropriate, be present as an isomer mixture or in the respective other isomeric form. [0077]
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-8-a) to (I-8-g) result: [0078]
    Figure US20030096806A1-20030522-C00017
  • in which [0079]
  • A, B, E, L, M, Q[0080] 3, Q4, Q5, Q6, W, X, Y, Z, R1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Furthermore, it has been found that the novel compounds of the formula (I) are obtained by the processes described below: [0081]
  • (A) Substituted 3-phenylpyrrolidine-2,4-diones or their enols of the formula (I-1-a) [0082]
    Figure US20030096806A1-20030522-C00018
  • in which [0083]
  • A, B, D, W, X, Y and Z are each as defined above [0084]
  • are obtained when [0085]
  • N-acylamino acid esters of the formula (II) [0086]
    Figure US20030096806A1-20030522-C00019
  • in which [0087]
  • A, B, D, W, X, Y and Z are each as defined above [0088]
  • and [0089]
  • R[0090] 8 represents alkyl (preferably C1-C6-alkyl)
  • are condensed intramolecularly in the presence of a diluent and in the presence of a base. [0091]
  • (B) Moreover, it has been found that substituted 3-phenyl-4-hydroxy-Δ[0092] 3-dihydrofuranone derivatives of the formula (I-2-a)
    Figure US20030096806A1-20030522-C00020
  • in which [0093]
  • A, B, W, X, Y and Z are each as defined above [0094]
  • are obtained when [0095]
  • carboxylic esters of the formula (III) [0096]
    Figure US20030096806A1-20030522-C00021
  • in which [0097]
  • A, B, W, X, Y, Z and R[0098] 8 are each as defined above
  • are condensed intramolecularly in the presence of a diluent and in the presence of a base. [0099]
  • (C) Furthermore, it has been found that substituted 3-phenyl-4-hydroxy-Δ[0100] 3-dihydrothiophenone derivatives of the formula (I-3-a)
    Figure US20030096806A1-20030522-C00022
  • in which [0101]
  • A, B, W, X, Y and Z are each as defined above [0102]
  • are obtained when [0103]
  • β-ketocarboxylic esters of the formula (IV) [0104]
    Figure US20030096806A1-20030522-C00023
  • in which [0105]
  • A, B, W, X, Y, Z and R[0106] 8 are each as defined above and
  • W[0107] 1 represents hydrogen, halogen, alkyl (preferably C1-C6-alkyl) or alkoxy (preferably C1-C8-alkoxy)
  • are cyclized intramolecularly, if appropriate in the presence of a diluent and in the presence of an acid. [0108]
  • (D) Furtherrnore, substituted 3-hydroxyl-4-phenyl-5-oxo-pyrazolines of the formula (I-4-a) [0109]
    Figure US20030096806A1-20030522-C00024
  • in which [0110]
  • A, D, W, X, Y and Z are each as defined above [0111]
  • are obtained when [0112]
  • (a) halogenocarbonyl ketenes of the formula (V) [0113]
    Figure US20030096806A1-20030522-C00025
  • in which [0114]
  • W, X, Y and Z are each as defined above [0115]
  • and [0116]
  • Hal represents halogen (in particular chlorine or bromine) [0117]
  • or [0118]
  • (β) malonic acid derivatives of the formula (VI) [0119]
    Figure US20030096806A1-20030522-C00026
  • in which [0120]
  • R[0121] 8, W, X, Y and Z are each as defined above
  • are reacted with hydrazines of the formula (VII) [0122]
  • A—NH—NH-D  (VII)
  • in which [0123]
  • A and D are each as defined above [0124]
  • if appropriate in the presence of a diluent and if appropriate in the presence of a base. [0125]
  • (E) Furthermore, it has been found that the novel substituted 3-phenylpyrone derivatives of the formula (I-5-a) [0126]
    Figure US20030096806A1-20030522-C00027
  • in which [0127]
  • A, D, W, X, Y and Z are each as defined above [0128]
  • are obtained when [0129]
  • carbonyl compounds of the formula (VIII) [0130]
    Figure US20030096806A1-20030522-C00028
  • in which [0131]
  • A and D are each as defined above [0132]
  • or their silyl enol ethers of the formula (Vila) [0133]
    Figure US20030096806A1-20030522-C00029
  • in which [0134]
  • A, D and R[0135] 8 are each as defined above
  • are reacted with ketene acid halides of the formula (V) [0136]
    Figure US20030096806A1-20030522-C00030
  • in which [0137]
  • W, X, Y and Z are each as defined above and [0138]
  • Hal represents halogen (preferably represents chlorine or bromine), [0139]
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor. [0140]
  • Furthermore, it has been found [0141]
  • (F) that the novel substituted phenyl-1,3-thiazine derivatives of the formula (I-6-a) [0142]
    Figure US20030096806A1-20030522-C00031
  • in which [0143]
  • A, W, X, Y and Z are each as defined above [0144]
  • are obtained when thioamides of the formula (IX) [0145]
    Figure US20030096806A1-20030522-C00032
  • in which [0146]
  • A is as defined above [0147]
  • are reacted with ketene acid halides of the formula (V) [0148]
    Figure US20030096806A1-20030522-C00033
  • in which [0149]
  • Hal, W, X, Y and Z are each as defined above, [0150]
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor. [0151]
  • Furthermore, it has been found [0152]
  • (G) that compounds of the formula (I-7-a) [0153]
    Figure US20030096806A1-20030522-C00034
  • in which [0154]
  • A, B, Q[0155] 1, Q2, W, X, Y and Z are each as defined above
  • are obtained when [0156]
  • ketocarboxylic esters of the formula (X) [0157]
    Figure US20030096806A1-20030522-C00035
  • in which [0158]
  • A, B, Q[0159] 1, Q2, W, X, Y and Z are each as defined above and
  • R[0160] 8 represents alkyl (in particular C1-C8-alkyl)
  • are cyclized intramolecularly, if appropriate in the presence of a diluent and in the presence of a base. [0161]
  • Moreover, it has been found [0162]
  • (H) that compounds of the formula (I-8-a) [0163]
    Figure US20030096806A1-20030522-C00036
  • in which [0164]
  • A, B, Q[0165] 3, Q4, Q5, Q6, W, X, Y and Z are each as defined above
  • are obtained when [0166]
  • 6-aryl-5-keto-hexanoic esters of the formula (XI) [0167]
    Figure US20030096806A1-20030522-C00037
  • in which [0168]
  • A, B, Q[0169] 3, Q4, Q5, Q6, W, X, Y and Z are each as defined above
  • and [0170]
  • R[0171] 8 represents alkyl (preferably C1-C6-alkyl)
  • are condensed intramolecularly in the presence of a diluent and in the presence of a base; [0172]
  • or [0173]
  • (I) that compounds of the formulae (I-1-a) to (I-8-a) shown above in which A, B, D, Q[0174] 1, Q2, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined above are obtained when compounds of the formula (I-1′-a) to (I-8′-a),
    Figure US20030096806A1-20030522-C00038
  • in which [0175]
  • A, B, D, Q[0176] 1, Q2, Q3, Q4, Q5, Q6, W, X and Z are each as defined above and
  • Y′ represents chlorine, bromine or iodine, preferably represents bromine, [0177]
  • are reacted with boronic acids of the formula (XII) [0178]
    Figure US20030096806A1-20030522-C00039
  • in which [0179]
  • Y is as defined above [0180]
  • in the presence of a solvent, a base and a catalyst, suitable catalysts being, in particular, palladium complexes. [0181]
  • Moreover, it has been found [0182]
  • (J) that the compounds of the formulae (I-1-b) to (I-8-b) shown above in which A, B, D, Q[0183] 1, Q2, Q3, Q4, Q5, Q6, R1, W, X, Y and Z are each as defined above are obtained when compounds of the formulae (I-1-a) to (I-8-a) shown above in which A, B, D, Q1, Q2, Q3, Q4, Q5, Q6, X, Y and Z are each as defined above are in each case
  • (a) reacted with acyl halides of the formula (XIII) [0184]
    Figure US20030096806A1-20030522-C00040
  • in which [0185]
  • R[0186] 1 is as defined above and
  • Hal represents halogen (in particular chlorine or bromine) [0187]
  • or [0188]
  • (β) reacted with carboxylic anhydrides of the formula (XIV) [0189]
  • R1—CO—O—CO—R1  (XIV)
  • in which [0190]
  • R[0191] 1 is as defined above,
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder; [0192]
  • (K) that the compounds of the formulae (I-1-c) to (I-8-c) shown above in which A, B, D, Q[0193] 1, Q2, Q3, Q4, Q5, Q6, R2, M, W, X, Y and Z are each as defined above and L represents oxygen are obtained when compounds of the formulae (I-1-a) to (I-8-a) shown above in which A, B, D, Q1, Q2, Q3, Q4, QS, Q6, W, X, Y and Z are each as defined above are in each case reacted with chloroformic esters or chloroformic thioesters of the formula (XV)
  • R2—M—CO—Cl  (XV)
  • in which [0194]
  • R[0195] 2 and M are each as defined above,
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder; [0196]
  • (L) that compounds of the formulae (I-1-c) to (I-8-c) shown above in which A, B, D, Q[0197] 1, Q2, Q3, Q4, Q5, Q6, R2, M, W, X, Y and Z are each as defined above and L represents sulphur are obtained when compounds of the formulae (I-1-a) to (I-8-a) shown above in which A, B, D, Q1, Q2, Q3, Q4, Q5, Q6, W, X, y and Z are each as defined above are in each case
  • reacted with chloromonothioformic esters or chlorodithioformic esters of the formula (XVI) [0198]
    Figure US20030096806A1-20030522-C00041
  • in which [0199]
  • M and R[0200] 2 are each as defined above
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder [0201]
  • and [0202]
  • (M) that compounds of the formulae (I-1-d) to (I-8-d) shown above in which A, B, D, Q[0203] 1, Q2, Q3, Q4, Q5, Q6, R3, W, X, Y and Z are each as defined above are obtained when compounds of the formulae (I-1-a) to (I-8-a) shown above in which A, B, D, Q1, Q2, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined above are in each case
  • reacted with sulphonyl chlorides of the formula (XVII) [0204]
  • R3—SO2—Cl  (XVII)
  • in which [0205]
  • R[0206] 3 is as defined above,
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder, [0207]
  • (N) that compounds of the formulae (I-1-e) to (I-8-e) shown above in which A, B, D, L, Q[0208] 1, Q2, Q3, Q4, Q5, Q6, R4, R5, W, X, Y and Z are each as defined above are obtained when compounds of the formulae (I-1-a) to (I-8-a) shown above in which A, B, D, Q1, Q2, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined above are in each case
  • reacted with phosphorus compounds of the formula (XVIII) [0209]
    Figure US20030096806A1-20030522-C00042
  • in which [0210]
  • L, R[0211] 4 and R5 are each as defined above and
  • Hal represents halogen (in particular chlorine or bromine), [0212]
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder, [0213]
  • (L) that compounds of the formulae (I-1-f) to (I-8-f) shown above in which A, B, D, E, Q[0214] 1, Q2, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined above are obtained when compounds of the formulae (I-1-a) to (I-8-a) in which A, B, D, Q1, Q2, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined above are in each case
  • reacted with metal compounds or amines of the formulae (XIX) or (XX) [0215]
  • Me(OR10)t  (XIX)
    Figure US20030096806A1-20030522-C00043
  • in which [0216]
  • Me represents a mono- or divalent metal (preferably an alkali metal or alkaline earth metal, such as lithium, sodium, potassium, magnesium or calcium), [0217]
  • t represents the number 1 or 2 and [0218]
  • R[0219] 11, R11, R1 2 independently of one another each represent hydrogen or alkyl (preferably C1-C8-alkyl),
  • if appropriate in the presence of a diluent, [0220]
  • (P) that compounds of the formulae (I-1-g) to (I-8-g) shown above in which A, B, D, L, Q[0221] 1, Q2, Q3, Q4, Q5, Q6, R6, R7, W, X, Y and Z are each as defined above are obtained when compounds of the formulae (I-1-a) to (I-8-a) shown above in which A, B, D, Q1, Q2, Q3, Q4, Q5, Q6, X, Y and Z are each as defined above are in each case
  • (α) reacted with isocyanates or isothiocyanates of the formula (XXI) [0222]
  • R6—N═C═L  (XXI)
  • in which [0223]
  • R[0224] 6 and L are each as defined above
  • if appropriate in the presence of a diluent and if appropriate in the presence of a catalyst, or [0225]
  • (β) reacted with carbamoyl chlorides or thiocarbamoyl chlorides of the formula (XXII) [0226]
    Figure US20030096806A1-20030522-C00044
  • in which [0227]
  • L, R[0228] 6 and R7 are each as defined above
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder. [0229]
  • Furthermore, it has been found that the novel compounds of the formula (I) have very good activity as pesticides, preferably as insecticides, acaricides and herbicides. [0230]
  • The formula (I) provides a general definition of the compounds according to the invention. Preferred substituents or ranges of the radicals listed in the formulae mentioned hereinabove and hereinbelow are illustrated below: [0231]
  • X preferably represents halogen, C[0232] 1-C6-alkyl, C1-C6-halogenoalkyl, C1-C6-alkoxy, C3-C6-alkenyloxy, C1-C6-alkylthio, C1-C6-alkylsulphinyl, C1-C6-alkylsulphonyl, C1-C6-halogenoalkoxy, C3-C6-halogenoalkenyloxy, nitro, cyano or in each case optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenoxy, phenylthio, benzyloxy or benzylthio.
  • Y preferably represents one of the radicals [0233]
    Figure US20030096806A1-20030522-C00045
  • V[0234] 1 preferably represents hydrogen, halogen, C1-C12-alkyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-alkylsulphinyl, C1-C6-alkylsulphonyl, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, nitro, cyano or phenyl, phenoxy, phenoxy-C1-C4-alkyl, phenyl-C1-C4-alkoxy, phenylthio-C1-C4-alkyl or phenyl-C1-C4-alkylthio, each of which is optionally mono- or polysubstituted by halogen, C1-C6-alkyl, C1-C6-alkoxy, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, nitro or cyano.
  • V[0235] 2 and V3 independently of one another each preferably represent hydrogen, halogen, C1-C6-alkyl, C1-C6-alkoxy, C1-C4-halogenoalkyl or C1-C4-halo-genoalkoxy.
  • W preferably represents hydrogen, halogen, C[0236] 1-C6-alkyl, C1-C6-halogenoalkyl, C1-C6-alkoxy, C1-C6-halogenoalkoxy, nitro or cyano.
  • Z preferably represents halogen, C[0237] 1-C6-alkyl, C1-C6-halogenoalkyl, C1-C6-alkoxy, C1-C6-halogenoalkoxy, nitro or cyano.
  • CKE preferably represents one of the groups [0238]
    Figure US20030096806A1-20030522-C00046
  • A preferably represents hydrogen or in each case optionally halogen-substituted C[0239] 1-C12-alkyl, C3-C8-alkenyl, C1-C10-alkoxy-C1-C8-alkyl, poly-C1-C8-alkoxy-C1-C8-alkyl, C1-C10-alkylthio-C1-C6-alkyl, optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl in which optionally one or two not directly adjacent ring members are replaced by oxygen and/or sulphur or represents in each case optionally halogen-, C1-C6-alkyl-, C1-C6-halogenoalkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkoxy-, cyano- or nitro-substituted C6- or C10-aryl (phenyl or naphthyl), hetaryl having 5 to 6 ring atoms (for example furanyl, pyridyl, imidazolyl, triazolyl, pyrazolyl, pyrimidyl, thiazolyl or thienyl) or C 6- or C10-aryl-C1-C6-alkyl (phenyl-C1-C6-alkyl or naphthyl-C1-C6-alkyl).
  • B preferably represents hydrogen, C[0240] 1-C16alkyl or C1-C8-alkoxy-C1-C6-alkyl or
  • A, B and the carbon atom to which they are attached preferably represent saturated C[0241] 3-C10-cycloalkyl or unsaturated C5-C10-cycloalkyl in which in each case optionally one ring member is replaced by oxygen or sulphur and which are optionally mono- or disubstituted by C1-C8-alkyl, C3-C10-cycloalkyl, C1-C8-halogenoalkyl, C1-C8-alkoxy, C1-C8-alkylthio, halogen or phenyl or
  • A, B and the carbon atom to which they are attached preferably represent C[0242] 3-C6-cycloalkyl which is substituted by an alkylenedilyl group which optionally contains one or two not directly adjacent oxygen and/or sulphur atoms, or by an alkylenedioxyl group or by an alkylenedithioyl group which, together with the carbon atom to which it is attached, forms a further five- to eight-membered ring, or
  • A, B and the carbon atom to which they are attached preferably represent C[0243] 3-C8-cycloalkyl or C5-C8-cycloalkenyl, in which two substituents together with the carbon atoms to which they are attached represent in each case optionally C1-C6-alkyl-, C1-C6-alkoxy- or halogen-substituted C2-C6-alkanediyl, C2-C6-alkenediyl or C4-C6-alkanedienediyl in which optionally one methylene group is replaced by oxygen or sulphur.
  • D preferably represents hydrogen, in each case optionally halogen-substituted C[0244] 1-C12-alkyl, C3-C8-alkenyl, C3-C8-alkinyl, C1-C10-alkoxy-C2-C8-alkyl, poly-C1-C8-alkoxy-C2-C8-alkyl, C1-C10-alkylthio-C2-C8-alkyl, optionally halogen-, C1-C4-alkyl-, C1-C4-alkoxy- or C1-C4-halogenoalkyl-substituted C3-C8-cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur or in each case optionally halogen-, C1-C6-alkyl-, C1-C6-halogenoalkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkoxy-, cyano- or nitro-substituted phenyl, hetaryl having 5 or 6 ring atoms (for example furanyl, imidazolyl, pyridyl, thiazolyl, pyrazolyl, pyrimidyl, pyrrolyl, thienyl or triazolyl), phenyl-C1-C6-alkyl or hetaryl-C1-C6-alkyl having 5 or 6 ring atoms (for example furanyl, imidazolyl, pyridyl, thiazolyl, pyrazolyl, pyrimidyl, pyrrolyl, thienyl or triazolyl), or
  • A and D together preferably represent in each case optionally substituted C[0245] 3-C6-alkanediyl or C3-C6-alkenediyl in which optionally one methylene group is replaced by oxygen or sulphur,
  • possible substituents in each case being: [0246]
  • halogen, hydroxyl, mercapto or in each case optionally halogen-substituted C[0247] 1-C1 o-alkyl, C1-C6-alkoxy, C1-C6-alkylthio, C3-C7-cycloalkyl, phenyl or benzyloxy, or a further C3-C6-alkanediyl grouping, C3-C6-alkenediyl grouping or a butadienyl grouping which is optionally substituted by C1-C6-alkyl or in which optionally two adjacent substituents together with the carbon atoms to which they are attached form a further saturated or unsaturated cycle having 5 or 6 ring atoms (in the case of the compound of the formula (I-1), A and D, together with the atoms to which they are attached, then represent, for example, the groups AD-1 to AD-10 mentioned further below) which cycle may contain oxygen or sulphur, or which may optionally contain one of the groups below
    Figure US20030096806A1-20030522-C00047
  • A and Q[0248] 1 together preferably represent C3-C6-alkanediyl or C4-C6-alkenediyl, each of which is optionally mono- or disubstituted by identical or different substituents selected from the group consisting of halogen, hydroxyl; C1-C10-alkyl, C1-C6-alkoxy, C1-C6-alkylthio, C3-C7-cycloalkyl, each of which is optionally mono- to trisubstituted by identical or different halogens; and benzyloxy and phenyl, each of which is optionally mono- to trisubstituted by identical or different substituents selected from the group consisting of halogen, C1-C6-alkyl or C1-C6-alkoxy, and which furthermore optionally contains one of the groups below
    Figure US20030096806A1-20030522-C00048
  • or is bridged by a C[0249] 1-C2-alkanediyl group or by an oxygen atom, or
  • Q[0250] 1 preferably represents hydrogen or C1-C4-alkyl.
  • Q[0251] 2, Q4, Q5 and Q6 independently of one another each preferably represent hydrogen or C1-C4-alkyl,
  • Q[0252] 3 preferably represents hydrogen, C1-C6-alkyl, C1-C6-alkoxy-C1-C2-alkyl, C1-C6-alkylthio-C1-C2-alkyl, optionally C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C8-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur or optionally halogen-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C2-halogenoalkyl-, C1-C2-halogenoalkoxy-, cyano- or nitro-substituted phenyl, or
  • Q[0253] 3 and Q4 together with the carbon atom to which they are attached represent an optionally C1-C4-alkyl-, C1-C4-alkoxy- or C1-C4-alkoxy or C1-C2-halogenoalkyl-substituted C3-C7-ring, in which optionally one ring member is replaced by oxygen or sulphur.
  • G preferably represents hydrogen (a) or represents one of the groups [0254]
    Figure US20030096806A1-20030522-C00049
  • (g), in particular represents (a), (b) or (c), [0255]
  • in which [0256]
  • E represents a metal ion or an ammonium ion, [0257]
  • L represents oxygen or sulphur and [0258]
  • M represents oxygen or sulphur. [0259]
  • R[0260] 1 preferably represents in each case optionally halogen-substituted C1-C20-alkyl, C2-C20-alkenyl, C1-C8-alkoxy-C1-C8-alkyl, C1-C8-alkylthio-C1-C8-alkyl, poly-C1-C8-alkoxy-C1-C8-alkyl or optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl in which optionally one or more (preferably not more than two) not directly adjacent ring members are replaced by oxygen and/or sulphur,
  • represents optionally halogen-, cyano-, nitro-, C[0261] 1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl-, C1-C6-halogenoalkoxy-, C1-C6-alkylthio- or C1-C6-alkylsulphonyl-substituted phenyl,
  • represents optionally halogen-, nitro-, cyano-, C[0262] 1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl- or C1-C6-halogenoalkoxy-substituted phenyl-C1-C6-alkyl,
  • represents optionally halogen- or C[0263] 1-C6-alkyl-substituted 5- or 6-membered hetaryl (for example pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl or thienyl),
  • represents optionally halogen- or C[0264] 1-C6-alkyl-substituted phenoxy-C1-C6-alkyl or
  • represents optionally halogen-, amino- or C[0265] 1-C6-alkyl-substituted 5- or 6-membered hetaryloxy-C1-C6-alkyl (for example pyridyloxy-C1-C6-alkyl, pyrimidyloxy-C1-C6-alkyl or thiazolyloxy-C1-C6-alkyl).
  • R[0266] 2 preferably represents in each case optionally halogen-substituted C1-C20-alkyl, C2-C2O-alkenyl, C1-C8-alkoxy-C2-C8-alkyl, poly-C1-C8-alkoxy-C2-C8-alkyl,
  • represents optionally halogen-, C[0267] 1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl or
  • represents in each case optionally halogen-, cyano-, nitro-, C[0268] 1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl- or C1-C6-halogenoalkoxy-substituted phenyl or benzyl.
  • R[0269] 3 preferably represents optionally halogen-substituted C1-C8-alkyl or represents in each case optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, cyano- or nitro-substituted phenyl or benzyl.
  • R[0270] 4 and R5 independently of one another each preferably represent in each case optionally halogen-substituted C1-C8-alkyl, C1-C8-alkoxy, C1-C8-alkylamino, di-(C1-C8-alkyl)amino, C1-CS-alkylthio, C2-C8-alkenylthio, C3-C7-cycloalkylthio or represent in each case optionally halogen-, nitro-, cyano-, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, C1-C4-alkylthio-, C1-C4-halogenoalkylthio-, C1-C4-alkyl- or C1-C4-halogenoalkyl-substituted phenyl, phenoxy or phenylthio.
  • R[0271] 6 and R7 independently of one another each preferably represent hydrogen, represent in each case optionally halogen-substituted C1-C8-alkyl, C3-C8-cycloalkyl, C1-C8-alkoxy, C3-C8-alkenyl, C1-C8-alkoxy-C1-C8-alkyl, represent optionally halogen-, C1-C8-halogenoalkyl-, C1-C8-alkyl- or C1-C8-alkoxy-substituted phenyl, optionally halogen-, C1-C8-alkyl-, C1-C8-halogenoalkyl- or C1-C8-alkoxy-substituted benzyl or together represent an optionally C1-C4-alkyl-substituted C3-C6-alkylene radical in which optionally one carbon atom is replaced by oxygen or sulphur.
  • R[0272] 13 preferably represents hydrogen, represents in each case optionally halogen-substituted C1-C8-alkyl or C1-C8-alkoxy, represents optionally halogen-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C8-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or represents in each case optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenyl-C1-C4-alkyl or phenyl-C1-C4-alkoxy.
  • R[0273] 14 preferably represents hydrogen or C1-C8-alkyl, or
  • R[0274] 13 and R14 together preferably represent C4-C6-alkanediyl.
  • R[0275] 15 and R16 are identical or different and each preferably represent C1-C6-alkyl, or
  • R[0276] 15 and R16 together preferably represent a C2-C4-alkanediyl radical which is optionally substituted by C1-C6-alkyl, C1-C6-halogenoalkyl or by optionally halogen-, C1-C6-alkyl-, C1-C4-halogenoalkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl.
  • R[0277] 17 and R18 independently of one another each preferably represent hydrogen, represent optionally halogen-substituted C1-C8-alkyl or represent optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl, or
  • R[0278] 17 and R18 together with the carbon atom to which they are attached preferably represent a carbonyl group or represent optionally halogen-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C5-C7-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur.
  • R[0279] 19 and R20 independently of one another each preferably represent C1-C10-alkyl, C2-C1 o-alkenyl, C1-C10-alkoxy, C1-C1 o-alkylamino, C3-C10-alkenylamino, di-(C1-C10-alkyl)amino or di-(C3-C10-alkenyl)amino.
  • In the preferred radical definitions, halogen represents fluorine, chlorine, bromine and iodine and in particular represents fluorine, chlorine and bromine. [0280]
  • X particularly preferably represents fluorine, chlorine, bromine, C[0281] 1-C4-alkyl, C1-C4-alkoxy, C3-C4-alkenyloxy, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, C3-C4-halogenoalkenyloxy, nitro or cyano.
  • Y particularly preferably represents one of the radicals [0282]
    Figure US20030096806A1-20030522-C00050
  • V[0283] 1 particularly preferably represents hydrogen, fluorine, chlorine, bromine, C1-C6-alkyl, C1-C4-alkoxy, C1-C2-halogenoalkyl, C1-C2-halogenoalkoxy, nitro, cyano or phenyl, phenoxy, phenoxy-C1-C2-alkyl, phenyl-C1-C2-alkoxy, phenylthio-C1-C2-alkyl or phenyl-C1-C2-alkylthio, each of which is optionally mono- or disubstituted by fluorine, chlorine, bromine, C1-C4-alkyl, C1-C4-alkoxy, C1-C2-halogenoalkyl, C1-C2-halogenoalkoxy, nitro or cyano.
  • V[0284] 2 and V3 independently of one another each particularly preferably represent hydrogen, fluorine, chlorine, bromine, C1-C4-alkyl, C1-C4-alkoxy, C1-C2-halogenoalkyl or C1-C2-halogenoalkoxy.
  • W particularly preferably represents hydrogen, fluorine, chlorine, bromine, C[0285] 1-C4-alkyl, C1-C4-halogenoalkyl, C1-C4-alkoxy or C1-C4-halogenoalkoxy.
  • Z particularly preferably represents fluorine, chlorine, bromine, C[0286] 1-C4-alkyl, C1-C4-halogenoalkyl, C1-C4-alkoxy or C1-C4-halogenoalkoxy.
  • CKE particularly preferably represents one of the groups [0287]
    Figure US20030096806A1-20030522-C00051
  • A particularly preferably represents hydrogen, in each case optionally fluorine- or chlorine-substituted C[0288] 1-C10-alkyl, C1-C8-alkoxy-C1-C6-alkyl, optionally fluorine-, chlorine-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C7-cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-5), (I-7) and (I-8)) in each case optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-halogenoalkyl-, C1-C4-alkoxy- or C1-C4-halogenoalkoxy-substituted phenyl, furanyl, pyridyl, imidazolyl, triazolyl, pyrazolyl, pyrimidyl, thiazolyl, thienyl or phenyl-C1-C4-alkyl.
  • B particularly preferably represents hydrogen or C[0289] 1-C6-alkyl, or
  • A, B and the carbon atom to which they are attached particularly preferably represent saturated or unsaturated C[0290] 5-C7-cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur and which is optionally monosubstituted by C1-C6-alkyl, C5-C8-cycloalkyl, C1-C3-halogenoalkyl, C1-C6-alkoxy, fluorine, chlorine or phenyl, or
  • A, B and the carbon atom to which they are attached particularly preferably represent C[0291] 5-C6-cycloalkyl which is substituted by an alkylenediyl group which optionally contains one or two not directly adjacent oxygen or sulphur atoms or by an alkylenedioxyl group or by an alkylenedithiol group which, together with the carbon atom to which it is attached, forms a further five- or six-membered ring, or
  • A, B and the carbon atom to which they are attached particularly preferably represent C[0292] 3-C6-cycloalkyl or C5-C6-cycloalkenyl in which two substituents together with the carbon atoms to which they are attached represent in each case optionally C1-C5-alkyl-, C1-C5-alkoxy-, fluorine-, chlorine- or bromine-substituted C2-C4-alkanediyl, C2-C4-alkenediyl, in which optionally one methylene group is replaced by oxygen or sulphur, or butadienediyl.
  • D particularly preferably represents hydrogen, represents in each case optionally fluorine- or chlorine-substituted C[0293] 1-C10-alkyl, C3-C6-alkenyl, C1-C8-alkoxy-C2-C6-alkyl or C1-C8-alkylthio-C2-C6-alkyl, represents optionally fluorine-, chlorine-, C1-C4-alkyl-, C1-C4-alkoxy- or C1-C2-halogenoalkyl-substituted C3-C7-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-1) and (I-4)) represents in each case optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-halogenoalkyl-, C1-C4-alkoxy- or C1-C4-halogenoalkoxy-substituted phenyl, furanyl, imidazolyl, pyridyl, thiazolyl, pyrazolyl, pyrimidyl, pyrrolyl, thienyl, triazolyl or phenyl-C1-C4-alkyl, or
  • A and D together particularly preferably represent optionally substituted C[0294] 3-C5-alkanediyl in which one methylene group may be replaced by a carbonyl group, oxygen or sulphur, possible substituents being hydroxyl, C1-C6-alkyl or C1-C4-alkoxy, or
  • A and D (in the case of the compounds of the formula (I-1)) together with the atoms to which they are attached represent one of the groups AD-I to AD-10: [0295]
    Figure US20030096806A1-20030522-C00052
  • A and Q[0296] 1 together particularly preferably represent C3-C4-alkanediyl or C3-C4-alkenediyl, each of which is optionally mono- or disubstituted by identical or different substituents selected from the group consisting of fluorine, chlorine, hydroxyl, and C1-C8-alkyl and C1-C4-alkoxy, each of which is optionally mono- to trisubstituted by fluorine, or
  • Q[0297] 1 particularly preferably represents hydrogen.
  • Q[0298] 2 particularly preferably represents hydrogen.
  • Q[0299] 4, Q5 and Q6 independently of one another each particularly preferably represent hydrogen or C1-C3-alkyl.
  • Q[0300] 3 particularly preferably represents hydrogen, C1-C4-alkyl, C1-C4-alkoxy-C1-C2-alkyl, C1-C4-alkylthio-C1-C2-alkyl or optionally methyl- or methoxy-substituted C3-C6-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or
  • Q[0301] 3 and Q4 together with the carbon atom to which they are attached particularly preferably represent an optionally C1-C4-alkyl- or C1-C4-alkoxy-substituted saturated C5-C6 ring in which optionally one ring member is replaced by oxygen or sulphur.
  • G particularly preferably represents hydrogen (a) or particularly preferably represents one of the groups [0302]
    Figure US20030096806A1-20030522-C00053
  • (g), in particular represents (a), (b) or (c), [0303]
  • in which [0304]
  • E represents a metal ion or an ammonium ion, [0305]
  • L represents oxygen or sulphur and [0306]
  • M represents oxygen or sulphur. [0307]
  • R[0308] 1 particularly preferably represents in each case optionally fluorine- or chlorine-substituted C1-C16-alkyl, C2-C16-alkenyl, C1-C6-alkoxy-C1-C6-alkyl, C1-C6-alkylthio-C1-C6-alkyl, poly-C1-C6-alkoxy-C1-C6-alkyl or optionally fluorine-, chlorine-, C1-C5-alkyl- or C1-C5-alkoxy-substituted C3-C7-cycloalkyl in which optionally one or two not directly adjacent ring members are replaced by oxygen and/or sulphur,
  • represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C[0309] 1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl-, C1-C3-halogenoalkoxy-, C1-C4-alkylthio- or C1-C4-alkylsulphonyl-substituted phenyl,
  • represents optionally fluorine-, chlorine-, bromine-, C[0310] 1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl- or C1-C3-halogenoalkoxy-substituted phenyl-C1-C4-alkyl,
  • represents in each case optionally fluorine-, chlorine-, bromine- or C[0311] 1-C4-alkyl-substituted pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl or thienyl,
  • represents optionally fluorine-, chlorine-, bromine- or C[0312] 1-C4-alkyl-substituted phenoxy-C1-C3-alkyl or represents in each case optionally fluorine-, chlorine-, bromine-, amino- or C1-C4-alkyl-substituted pyridyloxy-C1-C3-alkyl, pyrimidyloxy-C1-C3-alkyl or thiazolyloxy-C1-C3-alkyl.
  • R[0313] 2 particularly preferably represents in each case optionally fluorine-substituted C1-C16-alkyl, C2-C16-alkenyl, C1-C6-alkoxy-C2-C6-alkyl or poly-C1-C6-alkoxy-C2-C6-alkyl,
  • represents optionally fluorine-, chlorine-, C[0314] 1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C7-cycloalkyl or
  • represents in each case optionally fluorine-, chlorine-, bromine-, cyano-, nitro-C[0315] 1-C4-alkyl-, C1-C3-alkoxy-, C1-C3-halogenoalkyl- or C1-C3-halo-genoalkoxy-substituted phenyl or benzyl,
  • R[0316] 3 particularly preferably represents optionally fluorine-substituted C1-C6-alkyl or particularly preferably represents in each case optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl-, C1-C3-halogenoalkoxy-, cyano- or nitro-substituted phenyl or benzyl,
  • R[0317] 4 and R5 independently of one another each particularly preferably represent C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylamino, di-(C1-C6-alkyl)amino, C1-C6-alkylthio, C3-C4-alkenylthio, C3-C6-cycloalkylthio or represent in each case optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, C1-C3-alkoxy-, C1-C3-halogenoalkoxy-, C1-C3-alkylthio-, C1-C3-halogenoalkylthio-, C1-C3-alkyl- or C1-C3-halogenoalkyl-substituted phenyl, phenoxy or phenylthio, and
  • R[0318] 6 and R7 independently of one another each particularly preferably represent hydrogen, C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C3-C6-alkenyl, C1-C6-alkoxy-C1-C6-alkyl, represent optionally fluorine-, chlorine-, bromine-, C1-C3-halogenoalkyl-, C1-C4-alkyl- or C1-C4-alkoxy-substituted phenyl, represent optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C3-halogenoalkyl- or C1-C4-alkoxy-substituted benzyl, or together represent an optionally methyl- or ethyl-substituted C4-C5-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
  • In the particularly preferred radical definitions, halogen, if not stated otherwise, represents fluorine, chlorine, bromine and iodine, in particular represents fluorine, chlorine and bromine. [0319]
  • X very particularly preferably represents fluorine, chlorine, methyl, ethyl, propyl, iso-propyl, methoxy, ethoxy, propoxy, iso-propoxy, allyloxy, methallyloxy, trifluoromethyl, difluoromethoxy, trifluoromethoxy, nitro or cyano. [0320]
  • Y very particularly preferably represents one of the radicals [0321]
    Figure US20030096806A1-20030522-C00054
  • in particular represents [0322]
  • V[0323] 1 very particularly preferably represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, trifluoromethyl, trifluoromethoxy, nitro, cyano or phenyl which is optionally monosubstituted by fluorine, chlorine, methyl, methoxy, trifluoromethyl or trifluoromethoxy.
  • V[0324] 2 and V3 independently of one another each very particularly preferably represent hydrogen, fluorine, chlorine, methyl, ethyl, n-propyl, iso-propyl, methoxy, ethoxy, trifluoromethyl or trifluoromethoxy.
  • W very particularly preferably represents hydrogen, fluorine, chlorine, methyl, ethyl, n-propyl, methoxy, ethoxy or propoxy. [0325]
  • Z very particularly preferably represents fluorine, chlorine, methyl, ethyl, n-propyl, methoxy, ethoxy or propoxy. [0326]
  • CKE very particularly preferably represents one of the groups [0327]
    Figure US20030096806A1-20030522-C00055
  • A very particularly preferably represents hydrogen, in each case optionally fluorine-substituted C[0328] 1-C8-alkyl or C1-C6-alkoxy-C1-C4-alkyl, optionally fluorine-, methyl-, ethyl- or methoxy-substituted C3-C6-cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-5), (I-7) and (I-8)) represents in each case optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substituted phenyl or benzyl.
  • B very particularly preferably represents hydrogen or C[0329] 1-C4-alkyl, or
  • A, B and the carbon atom to which they are attached very particularly preferably represent saturated C[0330] 5-C6-cycloalkyl or C5-C6-cycloalkenyl in which optionally one ring member is replaced by oxygen or sulphur and which is optionally monosubstituted by methyl, ethyl, propyl, isopropyl, butyl, iso-butyl, sec-butyl, tert-butyl, trifluoromethyl, methoxy, ethoxy, propoxy, iso-propoxy, butoxy, iso-butoxy, sec-butoxy, tert-butoxy, fluorine or chlorine, or
  • A, B and the carbon atom to which they are attached very particularly preferably represent C[0331] 5-C6-cycloalkyl or C5-C6-cycloalkenyl in which two substituents together with the carbon atoms to which they are attached represent C2-C4-alkanediyl or C2-C4-alkenediyl in which in each case optionally one methylene group is replaced by oxygen or sulphur, or butadienediyl.
  • D very particularly preferably represents hydrogen, represents in each case optionally fluorine- or chlorine-substituted C[0332] 1-C8-alkyl, C3-C4-alkenyl, C1-C6-alkoxy-C2-C4-alkyl, C1-C4-alkylthio-C2-C4-alkyl or C3-C6-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-1) and (I-4)) represents in each case optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoro-methoxy-substituted phenyl, furanyl, pyridyl, thienyl or benzyl,
  • or [0333]
  • A and D together very particularly preferably represent optionally substituted C[0334] 3-C4-alkanediyl in which optionally one carbon atom is replaced by sulphur and which is optionally substituted by hydroxyl, methyl, ethyl, methoxy or ethoxy,
  • or [0335]
  • A and D (in the case of the compounds of the formula (I-1)) together with the atoms to which they are attached represent one of the following groups AD: [0336]
    Figure US20030096806A1-20030522-C00056
  • A and Q[0337] 1 together very particularly preferably represent C3-C4-alkanediyl or butenediyl, each of which is optionally mono- or disubstituted by fluorine, hydroxyl, methyl or methoxy, or
  • Q[0338] 1 very particularly preferably represents hydrogen.
  • Q[0339] 2 very particularly preferably represents hydrogen.
  • Q[0340] 4, Q5 and Q6 independently of one another each very particularly preferably represent hydrogen, methyl or ethyl.
  • Q[0341] 3 very particularly preferably represents hydrogen, methyl, ethyl or C3-C6-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or
  • Q[0342] 3 and Q4 together with the carbon to which they are attached very particularly preferably represent an optionally methyl- or methoxy-substituted saturated C5-C6 ring in which optionally one ring member is replaced by oxygen or sulphur.
  • G very particularly preferably represents hydrogen (a) or represents one of the groups [0343]
    Figure US20030096806A1-20030522-C00057
  • in particular represents (a), (b) or (c), [0344]
  • in which [0345]
  • E represents a metal ion or an ammonium ion, [0346]
  • L represents oxygen or sulphur and [0347]
  • M represents oxygen or sulphur. [0348]
  • R[0349] 1 very particularly preferably represents in each case optionally fluorine- or chlorine-substituted C1-C14-alkyl, C2-C14-alkenyl, C1-C4-alkoxy-C1-C6-alkyl, C1-C4-alkylthio-C1-C6-alkyl, poly-C1-C4-alkoxy-C1-C4-alkyl or optionally fluorine-, chlorine-, methyl-, ethyl-, propyl-, i-propyl-, butyl-, i-butyl-, tert-butyl-, methoxy-, ethoxy-, n-propoxy- or iso-propoxy-substituted C3-C6-cycloalkyl in which optionally one or two not directly adjacent ring members are replaced by oxygen and/or sulphur,
  • represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoro-methoxy-, methylthio-, ethylthio-, methylsulphonyl- or ethylsulphonyl-substituted phenyl, [0350]
  • represents optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted benzyl, [0351]
  • represents in each case optionally fluorine-, chlorine-, bromine-, methyl- or ethyl-substituted furanyl, thienyl, pyridyl, pyrimidyl, thiazolyl or pyrazolyl, [0352]
  • represents optionally fluorine-, chlorine-, methyl- or ethyl-substituted phenoxy-C[0353] 1-C2-alkyl or
  • represents in each case optionally fluorine-, chlorine-, amino-, methyl- or ethyl-substituted pyridyloxy-C[0354] 1-C2-alkyl, pyrimidyloxy-C1-C2-alkyl or thiazolyloxy-C1-C2-alkyl.
  • R[0355] 2 very particularly preferably represents in each case optionally fluorine-substituted C1-C16-alkyl, C2-C16-alkenyl, C1-C4-alkoxy-C2-C6-alkyl or poly-C1-C4-alkoxy-C2-C6-alkyl,
  • represents optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, iso-propyl- or methoxy-substituted C[0356] 3-C6-cycloalkyl,
  • or represents in each case optionally fluorine-, chlorine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted phenyl or benzyl. [0357]
  • R[0358] 3 very particularly preferably represents in each case optionally fluorine-substituted methyl, ethyl, n-propyl, isopropyl or in each case optionally fluorine-, chlorine-, bromine-, methyl-, tert-butyl-, methoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substituted phenyl or benzyl,
  • R[0359] 4 and R5 independently of one another each very particularly preferably represent C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylamino, di-(C1-C4-alkyl)amino, C1-C4-alkylthio or represent in each case optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, C1-C2-alkoxy-, C1-C2-fluoroalkoxy-, C1-C2-alkylthio-, C1-C2-fluoroalkylthio- or C1-C3-alkyl-substituted phenyl, phenoxy or phenylthio.
  • R[0360] 6 and R7 independently of one another each very particularly preferably represent hydrogen, represent C1-C4-alkyl, C3-C6-cycloalkyl, C1-C4-alkoxy, C3-C4-alkenyl, C1-C4-alkoxy-C1-C4-alkyl, represent optionally fluorine-, chlorine-, bromine-, trifluoromethyl-, methyl- or methoxy-substituted phenyl, represent optionally fluorine-, chlorine-, bromine-, methyl-, trifluoromethyl- or methoxy-substituted benzyl, or together represent a C5-C6-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
  • The abovementioned general or preferred radical definitions or illustrations can be combined with each other as desired, i.e. including combinations between the respective ranges and preferred ranges. They apply both to the end products and, correspondingly, to the precursors and intermediates. [0361]
  • Preference according to the invention is given to the compounds of the formula (I) which contain a combination of the meanings listed above as being preferred (preferable). [0362]
  • Particular preference according to the invention is given to the compounds of the formula (I) which contain a combination of the meanings listed above as being particularly preferred. [0363]
  • Very particular preference according to the invention is given to the compounds of the formula (I) which contain a combination of the meanings listed above as being very particularly preferred. [0364]
  • Saturated or unsaturated hydrocarbon radicals such as alkyl or alkenyl may in each case be straight-chain or branched as far as this is possible, including in combination with heteroatoms, such as, for example, in alkoxy. [0365]
  • Unless stated otherwise, optionally substituted radicals may be mono- or polysubstituted, and in the case of polysubstitutions the substituents may be identical or different. [0366]
  • Besides the compounds mentioned in the Preparation Examples, the following compounds of the formula (I-1-a) may be specifically mentioned: [0367]
    TABLE 1
    Figure US20030096806A1-20030522-C00058
    W = H, X = CH3, Z = CH3, V1 = H, V2 = H.
    A B D
    CH3 H H
    C2H5 H H
    C3H7 H H
    i-C3H7 H H
    C4H9 H H
    i-C4H9 H H
    s-C4H9 H H
    t-C4H9 H H
    CH3 CH3 H
    C2H5 CH3 H
    C3H7 CH3 H
    i-C3H7 CH3 H
    C4H9 CH3 H
    i-C4H9 CH3 H
    s-C4H9 CH3 H
    t-C4H9 CH3 H
    C2H5 C2H5 H
    C3H7 C3H7 H
    Figure US20030096806A1-20030522-C00059
         		CH3 H
    Figure US20030096806A1-20030522-C00060
         		CH3 H
    Figure US20030096806A1-20030522-C00061
         		CH3 H
    —(CH2)2— H
    —(CH2)4— H
    —(CH2)5— H
    —(CH2)6— H
    —(CH2)7— H
    —(CH2)2—O—(CH2)2— H
    —CH2—O—(CH2)3— H
    —(CH2)2—S—(CH2)2— H
    —CH2—CHCH3—(CH2)3— H
    —(CH2)2—CHCH3—(CH2)2— H
    —(CH2)2—CHC2H5—(CH2)2— H
    —(CH2)2—CHC3H7—(CH2)2— H
    —(CH2)2—CHi-C3H7—(CH2)2— H
    —(CH2)2—CHOCH3—(CH2)2— H
    —(CH2)2—CHOC2H5—(CH2)2— H
    —(CH2)2—CHOC3H7—(CH2)2— H
    —(CH2)2—CHi-C3H7—(CH2)2— H
    —(CH2)2—C(CH3)2—(CH2)2— H
    —CH2—(CHCH3)2—(CH2)2— H
    Figure US20030096806A1-20030522-C00062
         		H
    Figure US20030096806A1-20030522-C00063
         		H
    Figure US20030096806A1-20030522-C00064
         		H
    Figure US20030096806A1-20030522-C00065
         		H
    Figure US20030096806A1-20030522-C00066
         		H
    A D B
    —(CH2)3— H
    —(CH2)4— H
    —CH2—CHCH3—CH2— H
    —CH2—CH2—CHCH3 H
    —CH2—CHCH3—CHCH3— H
    —CH2—S—CH2— H
    —CH2—S—(CH2)2— H
    —(CH2)2—S—CH2— H
    Figure US20030096806A1-20030522-C00067
         		H
    H CH3 H
    H C2H5 H
    H C3H7 H
    H i-C3H7 H
    H
    Figure US20030096806A1-20030522-C00068
         		H
    H
    Figure US20030096806A1-20030522-C00069
         		H
    H
    Figure US20030096806A1-20030522-C00070
         		H
    CH3 CH3 H
    CH3 C2H5 H
    CH3 C3H7 H
    CH3 i-C3H7 H
    CH3
    Figure US20030096806A1-20030522-C00071
         		H
    CH3
    Figure US20030096806A1-20030522-C00072
         		H
    CH3
    Figure US20030096806A1-20030522-C00073
         		H
    C2H5 CH3 H
    C2H5 C2H5 H
  • Table 2: A, B and D are each as given in Table 1 [0368]
  • W═H, X=CH[0369] 3; Z=Cl; V1═H; V2═H.
  • Table 3: A, B and D are each as given in Table 1 [0370]
  • W═H, X=Cl; Z=CH[0371] 3; V1═H; V2═H.
  • Table 4: A, B and D are each as given in Table 1 [0372]
  • W═H, X=CH[0373] 3; Z=CH3; V1=4-Cl; V2═H.
  • Table 5: A, B and D are each as given in Table 1 [0374]
  • W═H, X=CH[0375] 3; Z=Cl; V1=4-Cl; V2═H.
  • Table 6: A, B and D are each as given in Table 1 [0376]
  • W═H, X=Cl; Z=CH[0377] 3; V1=4-Cl; V2═H.
  • Table 7: A, B and D are each as given in Table 1 [0378]
  • W═H, X=CH[0379] 3; Z=CH3; V1=3-Cl; V2═H.
  • Table 8: A, B and D are each as given in Table 1 [0380]
  • W═H, X=CH[0381] 3; Z=Cl; V1=3-Cl; V2═H.
  • Table 9: A, B and D are each as given in Table 1 [0382]
  • W═H, X=Cl; Z=CH[0383] 3; V1=3-Cl; V2═H.
  • Table 10: A, B and D are each as given in Table 1 [0384]
  • W═H, X=CH[0385] 3; Z=CH3; V1=2-Cl; V2=4-Cl.
  • Table 11: A, B and D are each as given in Table 1 [0386]
  • W═H, X=CH[0387] 3; Z=Cl; V1=2-Cl; V2=4-Cl.
  • Table 12: A, B and D are each as given in Table 1 [0388]
  • W═H, X=Cl; Z=CH[0389] 3; V1=2-Cl; V2 4-Cl.
  • Table 13: A, B and D are each as given in Table 1 [0390]
  • W═H, X=CH[0391] 3; Z=CH3; V1=4-CF3; V2═H.
  • Table 14: A, B and D are each as given in Table 1 [0392]
  • W═H, X=CH[0393] 3; Z=Cl; V1=4-CF3; V2H.
  • Table 15: A, B and D are each as given in Table 1 [0394]
  • W═H, X=Cl; Z=CH[0395] 3; V1=4-CF3; V2H.
  • Table 16: A, B and D are each as given in Table 1 [0396]
  • W═H, X=CH[0397] 3; Z=CH3; Vi=4-CH3; V2═H.
  • Table 17: A, B and D are each as given in Table 1 [0398]
  • W═H, X=CH[0399] 3; Z=Cl; V1=4-CH3; V2═H.
  • Table 18: A, B and D are each as given in Table 1 [0400]
  • W═H, X=Cl; Z=CH[0401] 3; V1=4-CH3; V2═H.
  • Table 19: A, B and D are each as given in Table 1 [0402]
  • W═H, X=CH[0403] 3; Z=CH3; V1=4-OCH3; V2═H.
  • Table 20: A, B and D are each as given in Table 1 [0404]
  • W═H, X=CH[0405] 3; Z=Cl; V1=4-OCH3; V2═H.
  • Table 21: A, B and D are each as given in Table 1 [0406]
  • W═H, X=Cl; Z=CH[0407] 3; V1=4-OCH3; V2═H.
  • Besides the compounds mentioned in the Preparation Examples, the following compounds of the formula (I-2-a) may be specifically mentioned: [0408]
    TABLE 22
    Figure US20030096806A1-20030522-C00074
    W = H, X = CH3, Z = CH3, V1 = H, V2 = H.
    A B
    CH3 H
    C2H5 H
    C3H7 H
    i-C3H7 H
    C4H9 H
    i-C4H9 H
    s-C4H9 H
    t-C4H9 H
    CH3 CH3
    C2H5 CH3
    C3H7 CH3
    i-C3H7 CH3
    C4H9 CH3
    i-C4H9 CH3
    s-C4H9 CH3
    t-C4H9 CH3
    C2H5 C2H5
    C3H7 C3H7
    Figure US20030096806A1-20030522-C00075
         		CH3
    Figure US20030096806A1-20030522-C00076
         		CH3
    Figure US20030096806A1-20030522-C00077
         		CH3
    —(CH2)2—
    —(CH2)4—
    —(CH2)5—
    —(CH2)6—
    —(CH2)7—
    —(CH2)2—O—(CH2)2—
    —CH2—O—(CH2)3—
    —(CH2)2—S—(CH2)2—
    —CH2—CHCH3—(CH2)3—
    —(CH2)2—CHCH3—(CH2)2—
    (CH2)2—CHC2H5—(CH2)2—
    —(CH2)2—CHC3H7—(CH2)2—
    —(CH2)2—CHi-C3H7—(CH2)2—
    —(CH2)2—CHOCH3—(CH2)2—
    —(CH2)2—CHOC2H5—(CH2)2—
    —(CH2)2—CHOC3H7—(CH2)2—
    —(CH2)2—CHi-C3H7—(CH2)2—
    —(CH2)2—C(CH3)2—(CH2)2—
    —CH2—(CHCH3)2—(CH2)2—
    Figure US20030096806A1-20030522-C00078
    Figure US20030096806A1-20030522-C00079
    Figure US20030096806A1-20030522-C00080
    Figure US20030096806A1-20030522-C00081
    Figure US20030096806A1-20030522-C00082
  • Table 23: A and B are each as given in Table 22 [0409]
  • W═H, X=CH[0410] 3; Z=Cl; V1═H; V2═H.
  • Table 24: A and B are each as given in Table 22 [0411]
  • W═H, X=Cl; Z=CH[0412] 3; V1═H; V2═H.
  • Table 25: A and B are each as given in Table 22 [0413]
  • W═H, X=CH[0414] 3; Z=CH3; V1=4-Cl; V2H.
  • Table 26: A and B are each as given in Table 22 [0415]
  • W═H, X CH[0416] 3; Z=Cl; V1=4-Cl; V2═H.
  • Table 27: A and B are each as given in Table 22 [0417]
  • W═H, X=Cl; Z=CH[0418] 3; V1=4-Cl; V2═H.
  • Table 28: A and B are each as given in Table 22 [0419]
  • W═H, X=CH[0420] 3; Z=CH3; V1=3-Cl; V2═H.
  • Table 29: A and B are each as given in Table 22 [0421]
  • W═H, X=CH[0422] 3; Z=Cl; V1=3-Cl; V2═H.
  • Table 30: A and B are each as given in Table 22 [0423]
  • W═H, X=Cl; Z=CH[0424] 3; V1=3-Cl; V2═H.
  • Table 31: A and B are each as given in Table 22 [0425]
  • W═H, X=CH[0426] 3; Z=CH3; V1=4-CF3; V2═H.
  • Table 32: A and B are each as given in Table 22 [0427]
  • W═H. X=CH[0428] 3; Z=Cl; V1=4-CF3; V2═H.
  • Table 33: A and B are each as given in Table 22 [0429]
  • W═H, X=Cl; Z=CH[0430] 3; V1=4-CF3; V2═H.
  • Table 34: A and B are each as given in Table 22 [0431]
  • W═H, X=CH[0432] 3; Z=CH3; V1=2-Cl; V2=4-Cl.
  • Table 35: A and B are each as given in Table 22 [0433]
  • W═H, X=CH[0434] 3; Z=Cl; Vi=2-Cl; V2=4-Cl.
  • Table 36: A and B are each as given in Table 22 [0435]
  • W═H, X=Cl; Z=CH[0436] 3; V1=2-Cl; V1=4-Cl.
  • Table 37: A and B are each as given in Table 22 [0437]
  • W═H, X=CH[0438] 3; Z=CH3; V1=4-CH3; V2═H.
  • Table 38: A and B are each as given in Table 22 [0439]
  • W═H, X=CH[0440] 3; Z═C; V=4-CH3; V2H.
  • Table 39: A and B are each as given in Table 22 [0441]
  • W═H, X=Cl; Z=CH[0442] 3; V1=4-CH3; V2═H.
  • Table 40: A and B are each as given in Table 22 [0443]
  • W═H, X=CH[0444] 3; Z=CH3; V1=4-OCH3; V2═H.
  • Table 41: A and B are each as given in Table 22 [0445]
  • W═H, X=CH[0446] 3; Z=Cl; V1=4-OCH3; V2H.
  • Table 42: A and B are each as given in Table 22 [0447]
  • W═H, X=Cl; Z=CH[0448] 3; V1=4-OCH3; V2═H.
  • Using, in accordance with process (A), ethyl N-[(2,5-dimethyl-4-phenyl)-phenyl-acetyl]-1-amino-cyclohexane-carboxylate as starting material, the course of the process according to the invention can be represented by the following equation: [0449]
    Figure US20030096806A1-20030522-C00083
  • Using, in accordance with process (B), ethyl (B) O-[(2-chloro-5-methoxy-4-(4-chloro)-phenyl)-phenylacetyl]-2-hydroxyisobutyrate, the course of the process according to the invention can be represented by the following equation: [0450]
    Figure US20030096806A1-20030522-C00084
  • Using, in accordance with process (C), ethyl 2-[(2,5-dimethyl-4-phenyl)-phenyl]4-(4-methoxy)-benzylmercapto-4-methyl-3-oxo-valerate, the course of the process according to the invention can be represented by the following equation: [0451]
    Figure US20030096806A1-20030522-C00085
  • Using, for example in accordance with process (D-ax), chlorocarbonyl 3-[(3-chloro-6-methyl-4-(4-methyl)-phenyl)-phenyl] ketene and 1,2-diazacyclopentane as starting materials, the course of the process according to the invention can be represented by the following equation: [0452]
    Figure US20030096806A1-20030522-C00086
  • Using, for example in accordance with process (D-β), diethyl 3-[2,5-dimethyl-4-(3-chloro-phenyl)]-phenylmalonate and 1,2-diazacyclopentane as starting materials, the course of the process according to the invention can be represented by the following equation: [0453]
    Figure US20030096806A1-20030522-C00087
  • Using, for example in accordance with process (E), chlorocarbonyl 2-[(2-ethyl-6-methyl-(4-trifluoromethoxy-phenyl))-phenyl] ketene and acetone as starting materials, the course of the process according to the invention can be represented by the following equation: [0454]
    Figure US20030096806A1-20030522-C00088
  • Using, for example in accordance with process (F), chlorocarbonyl 2-[(2-chloro-5-methyl-4-phenyl)-phenyl] ketene and thiobenzamide as starting materials, the course of the process according to the invention can be represented by the following equation: [0455]
    Figure US20030096806A1-20030522-C00089
  • Using, in accordance with process (G), ethyl 5-[(2-chloro-5-methyl-4-phenyl)-phenyl]-2,3-tetramethylene-4-oxo-valerate, the course of the process according to the invention can be represented by the following equation; [0456]
    Figure US20030096806A1-20030522-C00090
  • Using, in accordance with process (H), ethyl 5-[(2,5-dichloro-4-phenyl)-phenyl]-2,2-dimethyl-5-oxo-hexanoate, the course of the process according to the invention can be represented by the following equation: [0457]
    Figure US20030096806A1-20030522-C00091
  • Using, in accordance with process (I), 3-[(2,5-dimethyl-4-bromo)-phenyl]-4,4-(penta-methylene)-pyrrolidine-2,4-dione and 4-chlorophenylboronic acid as starting materials, the course of the reaction can be represented by the following scheme: [0458]
    Figure US20030096806A1-20030522-C00092
  • Using, in accordance with process (Ja), 3-[(2-chloro-5-methyl-4-(3-chloro-phenyl))-phenyl]-5,5-dimethylpyrrolidine-2,4-dione and pivaloyl chloride as starting materials, the course of the process according to the invention can be represented by the following equation: [0459]
    Figure US20030096806A1-20030522-C00093
  • Using, in accordance with process (J), (variant B), 3-[(2,5-dichloro-4-(4-methoxy-phenyl))-phenyl]-4-hydroxy-5-phenyl-Δ[0460] 3-dihydrofuran-2-one and acetic anhydride as starting materials, the course of the process according to the invention can be represented by the following equation:
    Figure US20030096806A1-20030522-C00094
  • Using, in accordance with process (K), 8-[(2-chloro-5-methyl-4-phenyl)-phenyl]-1,6-diaza-bicyclo-(4.3.0[0461] 1.6)-nonane-7,9-dione and ethoxyethyl chloroformate as starting materials, the course of the process according to the invention can be represented by the following equation:
    Figure US20030096806A1-20030522-C00095
  • Using, in accordance with process (L), 3-[(2-chloro-5-methyl-4-(4-fluoro-phenyl))-phenyl]-4-hydroxy-5-methyl-6-(3-pyridyl)-pyrone and methyl chloromonothio-formate as starting materials, the course of the reaction can be represented as follows: [0462]
    Figure US20030096806A1-20030522-C00096
  • Using, in accordance with process (M), 2-[(2,5-dimethyl-4-(4-methyl-phenyl))-phenyl]-5,5-pentamethylene-pyrrolidine-2,4-dione and methanesulphonyl chloride as starting materials, the course of the reaction can be represented by the following equation: [0463]
    Figure US20030096806A1-20030522-C00097
  • Using, in accordance with process (N), 2-[(3-chloro-6-methyl-4-phenyl)-phenyl]-4-hydroxy-5,5-dimethyl-Δ[0464] 3-dihydrofuran-2-one and 2,2,2-trifluoroethyl methanethio-phosphonyl chloride as starting materials, the course of the reaction can be represented by the following equation:
    Figure US20030096806A1-20030522-C00098
  • Using, in accordance with process (O), 3-[(2,5-dimethyl-4-(4-trifluoromethyl-phenyl))-phenyl]-5-cyclopropyl-5-methyl-pyrrolidine-2,4-dione and NaOH as components, the course of the process according to the invention can be represented by the following equation: [0465]
    Figure US20030096806A1-20030522-C00099
  • Using, in accordance with process (P), variant cx, 3-[(3-chloro-6-methyl-4-(3-trifluoromethyl-phenyl))-phenyl]-4-hydroxy-5-tetramethylene-Δ[0466] 3-dihydro-fiuran-2-one and ethyl isocyanate as starting materials, the course of the reaction can be represented by the following equation:
    Figure US20030096806A1-20030522-C00100
  • Using, in accordance with process (P), variant β, 3-[(2-chloro-5-methyl-4-phenyl)-phenyl]-5-methyl-pyrrolidine-2,4-dione and dimethylcarbamoyl chloride as starting materials, the course of the reaction can be represented by the following scheme: [0467]
    Figure US20030096806A1-20030522-C00101
  • The compounds of the formula (11) [0468]
    Figure US20030096806A1-20030522-C00102
  • in which [0469]
  • A, B, D, W, X, Y, Z and R[0470] 8 are each as defined above
  • which are required as starting materials in the process (a) according to the invention are novel. [0471]
  • The acylamino acid esters of the formula (II) are obtained, for example, when amino acid derivatives of the formula (XXIII) [0472]
    Figure US20030096806A1-20030522-C00103
  • in which [0473]
  • A, B, R[0474] 8 and D are each as defined above
  • are acylated with substituted phenylacetyl halides of the formula (XXIV) [0475]
    Figure US20030096806A1-20030522-C00104
  • in which [0476]
  • W, X, Y and Z are each as defined above and [0477]
  • Hal represents chlorine or bromine [0478]
  • (Chem. Reviews 52, 237-416 (1953); Bhattacharya, Indian J. Chem. 6, 341-5, 1968) [0479]
  • or when acylamino acids of the formula (XXV) [0480]
    Figure US20030096806A1-20030522-C00105
  • in which [0481]
  • A, B, D, W, X, Y and Z are each as defined above [0482]
  • are esterified (Chem. Ind. (London) 1568 (1968)). [0483]
  • The compounds of the formula (XXV) [0484]
    Figure US20030096806A1-20030522-C00106
  • in which [0485]
  • A, B, D, W, X, Y and Z are each as defined above [0486]
  • are novel. [0487]
  • The compounds of the formula (XXV) are obtained when amino acids of the formula (XXVI) [0488]
    Figure US20030096806A1-20030522-C00107
  • in which [0489]
  • A, B and D are each as defined above [0490]
  • are acylated with substituted phenylacetyl halides of the formula (XXIV) [0491]
    Figure US20030096806A1-20030522-C00108
  • in which [0492]
  • W, X, Y and Z are each as defined above and [0493]
  • Hal represents chlorine or bromine, [0494]
  • for example according to Schotten-Baumann (Organikum, VEB Deutscher Verlag der Wissenschaften, Berlin 1977, p. 505). [0495]
  • The compounds of the formula (XXIV) are novel. They can be prepared by processses which are known in principle (see, for example, H. Henecka, Houben-Weyl, Methoden der Organischen Chemie, Vol. 8, p. 467-469 (1952)). [0496]
  • The compounds of the formula (XXIV) are obtained, for example, by reacting substituted phenylacetic acids of the formula (XXVII) [0497]
    Figure US20030096806A1-20030522-C00109
  • in which [0498]
  • W, X, Y and Z are each as defined above [0499]
  • with halogenating agents (for example thionyl chloride, thionyl bromide, oxalyl chloride, phosgene, phosphorus trichloride, phosphorus tribromide or phosphorus pentachloride), if appropriate in the presence of a diluent (for example optionally chlorinated aliphatic or aromatic hydrocarbons such as toluene or methylene chloride), at temperatures from −20° C. to 150° C., preferably from −10° C. to 100° C. [0500]
  • Some of the compounds of the formulae (XXIII) and (XXVI) are known, and/or they can be prepared by known processes (see, for example, Compagnon, Miocque Ann. Chim. (Paris) [14] 5, p. 11[0501] −22, 23-27 (1970)).
  • The substituted cyclic aminocarboxylic acids of the formula (XXVIa) in which A and B form a ring are generally obtainable by the Bucherer-Bergs synthesis or by the Strecker synthesis and are in each case obtained in different isomer forms. Thus, under the conditions of the Bucherer-Bergs synthesis, the isomers (for simplicity called β below), in which the radicals R and the carboxyl group are equatorial are predominantly obtained, while under the conditions of the Strecker synthesis the isomers (for simplicity called a below) in which the amino group and the radicals R are equatorial are predominantly obtained. [0502]
    Figure US20030096806A1-20030522-C00110
  • (L. Munday, J. Chem. Soc. 4372 (1961); J. T. Eward, C. Jitrangeri, Can. J. Chem. 53, 3339 (1975). [0503]
  • Furthermore, the starting materials of the formula (U) [0504]
    Figure US20030096806A1-20030522-C00111
  • in which [0505]
  • A, B, D, W, X, Y, Z and R[0506] 8 are each as defined above
  • used in the above process (A) can be prepared when aminonitriles of the formula (XXVIII) [0507]
    Figure US20030096806A1-20030522-C00112
  • in which [0508]
  • A, B and D are each as defined above [0509]
  • are reacted with substituted phenylacetyl halides of the formula (XXIV) [0510]
    Figure US20030096806A1-20030522-C00113
  • in which [0511]
  • W, X, Y, Z and Hal are each as defined above [0512]
  • to give compounds of the formula (XXIX) [0513]
    Figure US20030096806A1-20030522-C00114
  • in which [0514]
  • A, B, D, W, X, Y and Z are each as defined above [0515]
  • and these are subsequently subjected to acidic alcoholysis. [0516]
  • The compounds of the formula (XXIX) are likewise novel [0517]
  • The compounds of the formula (III) [0518]
    Figure US20030096806A1-20030522-C00115
  • in which [0519]
  • A, B, W, X, Y, Z and R[0520] 8 are each as defined above
  • required as starting materials in the process (B) according to the invention are novel. [0521]
  • They can be prepared by methods known in principle. [0522]
  • Thus, the compounds of the formula (1E), for example, are obtained when [0523]
  • 2-hydroxycarboxylic esters of the formula (XXX) [0524]
    Figure US20030096806A1-20030522-C00116
  • in which [0525]
  • A, B and R[0526] 8 are each as defined above
  • are acylated with substituted phenylacetyl halides of the formula (XXIV) [0527]
    Figure US20030096806A1-20030522-C00117
  • in which [0528]
  • W, X, Y, Z and Hal are each as defined above [0529]
  • (Chem. Reviews 52, 237-416 (1953)) and applications cited in the introduction. [0530]
  • Furthermore, compounds of the formula (III) are obtained when substituted phenylacetic acids of the formula (XXVII) [0531]
    Figure US20030096806A1-20030522-C00118
  • in which [0532]
  • W, X, Y and Z are each as defined above [0533]
  • are alkylated with a-halogenocarboxylic esters of the formula (XXXI) [0534]
    Figure US20030096806A1-20030522-C00119
  • in which [0535]
  • A, B and R[0536] 8 are each as defined above and
  • Hal represents chlorine or bromine. [0537]
  • The compounds of the formula (XXVII) are novel. [0538]
  • The compounds of the formula (XXXI) are commercially available. [0539]
  • The compounds of the formula (XXVII) [0540]
    Figure US20030096806A1-20030522-C00120
  • in which [0541]
  • W, X, Y and Z are each as defined above [0542]
  • are obtained, for example, [0543]
  • α) when compounds of the formula (XXVII-a) [0544]
    Figure US20030096806A1-20030522-C00121
  • in which [0545]
  • W, X and Z are each as defined above [0546]
  • Y′ represents chlorine or bromine, preferably represents bromine, [0547]
  • are reacted with boronic acids of the formula (XII) [0548]
    Figure US20030096806A1-20030522-C00122
  • in which [0549]
  • Y is as defined above [0550]
  • in the presence of a solvent, a base and a catalyst (preferably a palladium complex, such as, for example, tetrakis (triphenylphosphine)-palladium or [0551]
  • β) when phenylacetic esters of the formula (XXXII) [0552]
    Figure US20030096806A1-20030522-C00123
  • in which [0553]
  • W, X, Y, Z and R[0554] 8 are each as defined above
  • are hydrolysed under generally known standard conditions in the presence of acids or bases, in the presence of a solvent, or [0555]
  • γ) when phenylacetic acids of the formula (XXVII-b) [0556]
    Figure US20030096806A1-20030522-C00124
  • in which [0557]
  • W, X and Z are each as defined above [0558]
  • are reacted with halogen compounds of the formula (XXXIII), [0559]
  • Y-Hal  (XXXIII)
  • in which [0560]
  • Y is as defined above and [0561]
  • Hal represents chlorine, bromine or iodine, preferably bromine or iodine, [0562]
  • in the presence of a solvent, a base and a catalyst (preferably one of the abovementioned palladium complexes). [0563]
  • Some of the compounds of the formulae (XII) and (XXXIII) are known, some of them are commercially available, or they can be prepared by processes known in principle. Some of the phenylacetic acids of the formula (XXVII-a) are known from WO 96/35 664 and WO 97/02 243, or they can be prepared by the processes described therein. [0564]
  • The compounds of the formula (XXVII-b) and (XXXII) are novel. [0565]
  • The compounds of the formula (XXVII-b) [0566]
    Figure US20030096806A1-20030522-C00125
  • in which [0567]
  • W, X and Z are each as defined above [0568]
  • are obtained, for example, when phenylacetic acids of the formula (XXVII-a) [0569]
    Figure US20030096806A1-20030522-C00126
  • in which [0570]
  • W, X, Y′ and Z are each as defined above [0571]
  • are reacted with lithium compounds of the formula (XXXIV) [0572]
  • Li—R21  (XXXIV)
  • in which [0573]
  • R[0574] 21 represents C1-C8-alkyl or phenyl, preferably represents n-C4H9,
  • and boronic esters of the formula (XXXV) [0575]
  • B(OR8)3  (XXXV)
  • in which [0576]
  • R[0577] 8 is as defined above
  • in the presence of a diluent. [0578]
  • The compounds of the formulae (XXXIV) and (XXXV) are commercially available compounds. [0579]
  • The compounds of the formula (XXXII) [0580]
    Figure US20030096806A1-20030522-C00127
  • in which [0581]
  • W, X, Y, Z and R[0582] 8 are each as defined above
  • are obtained, for example, [0583]
  • when phenylacetic esters of the formula (XXX-a) [0584]
    Figure US20030096806A1-20030522-C00128
  • in which [0585]
  • R[0586] 8, W, X, Y′ and Z are each as defined above
  • are reacted with boronic acids of the formula (XII) [0587]
    Figure US20030096806A1-20030522-C00129
  • in which [0588]
  • Y is as defined above [0589]
  • in the presence of a solvent, a base and a catalyst (preferably one of the abovementioned palladium complexes). [0590]
  • Some of the phenylacetic esters of the formula (XXXII-a) are known from the applications WO 96/35 664 and WO 97/02 243, or they can be prepared by the processes described therein. [0591]
  • The compounds of the formula (IV) [0592]
    Figure US20030096806A1-20030522-C00130
  • in which [0593]
  • A, B, W, X, Y, Z and R[0594] 8 are each as defined above
  • required as starting materials in the above process (C) are novel. [0595]
  • They can be prepared by methods known in principle. [0596]
  • The compounds of the formula (IV) are obtained, for example, when [0597]
  • substituted phenylacetic esters of the formula (XXXI) [0598]
    Figure US20030096806A1-20030522-C00131
  • in which [0599]
  • W, X, Y, R[0600] 8 and Z are each as defined above
  • are acylated with 2-benzylthio-carbonyl halides of the formula (XXXVI) [0601]
    Figure US20030096806A1-20030522-C00132
  • in which [0602]
  • A, B and W are each as defined above and [0603]
  • Hal represents halogen (in particular chlorine or bromine) [0604]
  • in the presence of strong bases (see, for example, M. S. Chambers, E. J. Thomas, D. J. Williams, J. Chem. Soc. Chem. Commun., (1987), 1228). [0605]
  • The compounds of the formula (XXXII) are novel. Compounds of the formula (XXXII) are obtained, for example, when compounds of the formula (XXVII) [0606]
    Figure US20030096806A1-20030522-C00133
  • in which [0607]
  • W, X, Y and Z are each as defined above [0608]
  • are esterified in the presence of alcohols and dehydrating agents (for example conc. sulphuric acid), [0609]
  • or when alcohols are acylated with compounds of the formula (XXIV) [0610]
    Figure US20030096806A1-20030522-C00134
  • in which [0611]
  • W, X, Y, Z and Hal are each as defined above [0612]
  • (Chem. Reviews 52, 237-416 (1953)). [0613]
  • Some of the benzylthio-carbonyl halides of the formula (XXXVI) are known, and/or they can be prepared by known processes (J. Antibiotics (1983), 26, 1589). [0614]
  • The halogenocarbonyl ketenes of the formula (V) required as starting materials in the above processes (D), (E) and (F) are novel. They can be prepared simply by methods which are known in principle (cf., for example, Org. Prep. Proced. Int., 7, (4), 155-158, 1975 and DE 1 945 703). Thus, for example, the compounds of the formula (V) [0615]
    Figure US20030096806A1-20030522-C00135
  • in which [0616]
  • W, X, Y and Z are each as defined above and [0617]
  • Hal represents chlorine or bromine [0618]
  • are obtained when [0619]
  • substituted phenylmalonic acids of the formula (XXXVII) [0620]
    Figure US20030096806A1-20030522-C00136
  • in which [0621]
  • W, X, Y and Z are each as defined above [0622]
  • are reacted with acyl halides, such as, for example, thionyl chloride, phosphorus(V) chloride, phosphorus(mII) chloride, oxalyl chloride, phosgene or thionyl bromide, if appropriate in the presence of catalysts, such as, for example, dimethylformamide, methyl-steryl-formamide or triphenylphosphine and if appropriate in the presence of bases such as, for example, pyridine or triethylamine. [0623]
  • The substituted phenylmalonic acids of the formula (XXXVII) are novel. They can be prepared simply by known processes (cf., for example, Organikum, VEB Deutscher Verlag der Wissenschaften, Berlin 1977, p. 517 ff, EP-A-528 156, WO 96/35 664, WO 97/02 243). [0624]
  • Thus, phenylmalonic acids of the formula (XXXVII) [0625]
    Figure US20030096806A1-20030522-C00137
  • in which [0626]
  • W, X, Y and Z are each as defined above [0627]
  • are obtained when phenylmalonic esters of the formula (VI) [0628]
    Figure US20030096806A1-20030522-C00138
  • in which [0629]
  • W, X, Y, Z and R[0630] 8 are each as defined above
  • are initially hydrolysed in the presence of a base and in a solvent and subsequently carefully acidified (EP-528 156, WO 96/35 664, WO 97/02 243). [0631]
  • The malonic esters of the formula (VI) [0632]
    Figure US20030096806A1-20030522-C00139
  • in which [0633]
  • W, X, Y, Z and R[0634] 8 are each as defined above
  • are novel. [0635]
  • They can be prepared by generally known methods of organic chemistry (cf., for example, Tetrahedron Lett. 27, 2763 (1986) and Organikum, VEB Deutscher Verlag der Wissenschaften, Berlin 1977, p. 587 ff.). [0636]
  • Some of the hydrazines of the formula (VII) [0637]
  • A—NH—NH-D  (VII),
  • in which [0638]
  • A and D are each as defined above [0639]
  • required as starting materials for the process (D) according to the invention are known, and/or they can be prepared by methods known from the literature (cf., for example, Liebigs Ann. Chem. 585, 6 (1954); Reaktionen der organischen Synthese, C. Ferri, p. 212, 513; Georg Thieme Verlag Stuttgart, 1978; Liebigs Ann. Chem. 443, 242 (1925); Chem. Ber. 98, 2551 (1965), EP-508 126). [0640]
  • The carbonyl compounds of the formula (VIII) (VIII) [0641]
    Figure US20030096806A1-20030522-C00140
  • in which [0642]
  • A and D are each as defined above [0643]
  • or their silyl enol ethers of the formula (Vila) [0644]
    Figure US20030096806A1-20030522-C00141
  • in which [0645]
  • A, D and R[0646] 8 are each as defined above
  • required as starting materials for the process (E) according to the invention are commercially available, generally known compounds or compounds which are obtainable by known processes. [0647]
  • The preparation of the ketene acid chlorides of the formula (V), required as starting materials for carrying out the process (F) according to the invention has already been described above. The thioamides of the formula (IX) [0648]
    Figure US20030096806A1-20030522-C00142
  • in which [0649]
  • A is as defined above [0650]
  • required for carrying out the process (F) according to the invention are compounds which are generally known in organic chemistry. [0651]
  • The compounds of the formula (X) [0652]
    Figure US20030096806A1-20030522-C00143
  • in which [0653]
  • A, B, Q[0654] 1, Q2, W, X, Y, Z and R8 are each as defined above
  • required as starting materials in the above process (G) are novel. [0655]
  • They can be prepared by methods known in principle. [0656]
  • The 5-aryl-4-ketocarboxylic esters of the formula (X) are obtained, for example, when 5-aryl-4-ketocarboxylic acids of the formula (XXXVIII) [0657]
    Figure US20030096806A1-20030522-C00144
  • in which [0658]
  • W, X, Y, Z, A, B, Q[0659] 1 and Q2 are each as defined above
  • are esterified (cf., for example, Organikum, 15th edition, Berlin, 1977, page 499) or alkylated (see Preparation Example). [0660]
  • The 5-aryl-4-ketocarboxylic acids of the formula (XXXVIII) [0661]
    Figure US20030096806A1-20030522-C00145
  • in which [0662]
  • A, B, Q[0663] 1, Q2, W, X, Y and Z are each as defined above
  • are novel but can be prepared by methods known in principle (see Preparation Example). [0664]
  • The 5-aryl-4-ketocarboxylic acids of the formula (XXXVffl) are obtained, for example, when 2-phenyl-3-oxo-adipic esters of the formula (XXXIX) [0665]
    Figure US20030096806A1-20030522-C00146
  • in which [0666]
  • A, B, D[0667] 1, D2, W, X, Y and Z are each as defined above and
  • R[0668] 8 and R8′ each represent alkyl (in particular C1-C8-alkyl)
  • are decarboxylated, if appropriate in the presence of a diluent and if appropriate in the presence of a base or acid (cf., for example, Organikum, 15th edition, Berlin, 1977, pages 519 to 521). [0669]
  • The compounds of the formula (XXXIX) [0670]
    Figure US20030096806A1-20030522-C00147
  • in which [0671]
  • A, B, Q[0672] 1, Q2, W, X, Y, Z, R8, R8 are each as defined above
  • are novel. [0673]
  • The compounds of the formula (XXXIX) are obtained, for example, [0674]
  • when dicarboxylic monoester chlorides of the formula (XL), [0675]
    Figure US20030096806A1-20030522-C00148
  • in which [0676]
  • A, B, Q[0677] 1, Q2 and R8 are each as defined above and
  • Hal represents chlorine or bromine [0678]
  • or carboxylic anhydrides of the formula (XLI) [0679]
    Figure US20030096806A1-20030522-C00149
  • in which [0680]
  • A, B, Q[0681] 1 and Q2 are each as defined above are acylated with a phenyl acetic ester of the formula (XXXII)
    Figure US20030096806A1-20030522-C00150
  • in which [0682]
  • W, X, Y, Z and R[0683] 8′ are each as defined above in the presence of a diluent and in the presence of a base (cf., for example, M. S. Chambers, E. J. Thomas, D. J. Williams, J. Chem. Soc. Chem. Commun., (1987), 1228, cf. also the Preparation Examples).
  • Some of the compounds of the formulae (XL) and (XLI) are known compounds of organic chemistry or are commercially available, and/or they can be prepared in a simple manner by methods known in principle. [0684]
  • The compounds of the formula (XI) [0685]
    Figure US20030096806A1-20030522-C00151
  • in which [0686]
  • A, B, Q[0687] 3, Q4, Q5, Q6, W, X, Y, Z and R8 are each as defined above
  • required as starting materials in the above process (H) are novel. [0688]
  • They can be prepared by methods known in principle. [0689]
  • The 6-aryl-5-ketocarboxylic esters of the formula (XI) are obtained, for example, when 6-aryl-5-ketocarboxylic acids of the formula (XLII) [0690]
    Figure US20030096806A1-20030522-C00152
  • in which [0691]
  • A, B, Q[0692] 3, Q4, Q5, Q6, W, X, Y and Z are each as defined above
  • are esterified (cf., for example, Organikum, 15th edition, Berlin, 1977, page 499). [0693]
  • The 6-aryl-5-ketocarboxylic acids of the formula (XLII) [0694]
    Figure US20030096806A1-20030522-C00153
  • in which [0695]
  • A, B, Q[0696] 3, Q4, QS, Q6, W, X, Y and Z are each as defined above
  • are novel. They can be prepared by methods known in principle, for example by hydrolysing and decarboxylating [0697]
  • substituted 2-phenyl-3-oxo-heptanedioic esters of the formula (XL1H) [0698]
    Figure US20030096806A1-20030522-C00154
  • in which [0699]
  • A, B, Q[0700] 3, Q4, Q5, Q6, W, X, Y and Z are each as defined above and
  • R[0701] 8 and R8 are each alkyl (preferably C1-C6-alkyl),
  • if appropriate in the presence of a diluent and if appropriate in the presence of a base or acid (cf., for example, Organikum, 15th edition, Berlin, 1977, page 519 to 521). [0702]
  • The compounds of the formula (XLII) [0703]
    Figure US20030096806A1-20030522-C00155
  • in which [0704]
  • A, B, Q[0705] 3, Q4, Q5, Q6, W, X, Y, Z, R8 and R8 are each as defined above
  • are novel. They can be obtained [0706]
  • when dicarboxylic anhydrides of the formula (XLIV), [0707]
    Figure US20030096806A1-20030522-C00156
  • in which [0708]
  • A, B, Q[0709] 3, Q4, Q5, Q6 and R8 are each as defined above
  • are condensed with a substituted phenylacetic ester of the formula (XXXII) [0710]
    Figure US20030096806A1-20030522-C00157
  • in which [0711]
  • W, X, Y, Z and R[0712] 8′ are each as defined above
  • in the presence of a diluent and in the presence of a base. [0713]
  • Some of the compounds of the formula (XLIV) are known, and/or they can be prepared by known processes. [0714]
  • The compounds of the formula (XXXII) have already been described under the precursors for the process (B). Furthermore, compounds of the formula (XXXII) are obtained by reacting substituted 1,1,1-trichloro-2-phenylethanes of the formula (XLV) [0715]
    Figure US20030096806A1-20030522-C00158
  • in which [0716]
  • W, X, Y and Z are each as defined above [0717]
  • initially with alkoxides (for example alkali metal alkoxides such as sodium methoxide or sodium ethoxide) in the presence of a diluent (for example the alcohol derived from the alkoxide) at temperatures between 0° C. and 150° C., preferably between 20° C. and 120° C., and subsequently with an acid (preferably an inorganic acid such as, for example, sulphuric acid) at temperatures between −20° C. and 150° C., preferably between 0° C. and 100° C. (cf. DE 3 314 249). [0718]
  • Some of the compounds of the formula (XLV) are novel, they can be prepared by processes known in principle. [0719]
  • The compounds of the formula (XLV) are obtained, for example, when anilines of the formula (XLVI) [0720]
    Figure US20030096806A1-20030522-C00159
  • in which [0721]
  • W, X, Y and Z are each as defined above [0722]
  • are reacted with vinylidene chloride (CH[0723] 2═CCl2) in the presence of an alkyl nitrite of the formula (XLVII)
  • R21—ONO  (XLVII)
  • in which [0724]
  • R[0725] 21 represents alkyl, preferably C1-C6-alkyl,
  • in the presence of copper(II) chloride and, if appropriate, in the presence of a diluent (for example an aliphatic nitrile such as acetonitrile), at a temperature of from −20° C. to 80° C., preferably from 0° C. to 60° C. [0726]
  • The compounds of the formula (XLVII) are known compounds of organic chemistry. Copper(II) chloride and vinylidene chloride have been known for a long time and are commercially available. [0727]
  • Some of the anilines of the formula (XLVI) are novel. The anilines of the formula (XLVI) [0728]
    Figure US20030096806A1-20030522-C00160
  • in which [0729]
  • W, X, Y and Z are each as defined above, for example, are obtained when anilines of the formula (XLVI-a) [0730]
    Figure US20030096806A1-20030522-C00161
  • in which [0731]
  • W, X and Z are each as defined above [0732]
  • Y′ represents chlorine or bromine, preferably represents bromine, [0733]
  • are reacted with boronic acids of the formula (XII) [0734]
    Figure US20030096806A1-20030522-C00162
  • in which [0735]
  • Y is as defined above [0736]
  • in the presence of a solvent, a base and a catalyst (preferably a palladium complex, such as, for example, tetrakis (triphenylphosphine)palladium. [0737]
  • The anilines of the formula (XLVI-a) are known compounds or can be prepared by generally known processes. [0738]
  • Some of the compounds of the formulae (I-1′-a) to (I-8′-a) in which A, B, D, Q[0739] 1, Q2, Q3, Q4, Q5, Q6, X and Z are each as defined above and Y′ represents chlorine and bromine, preferably represents bromine, and which are required as starting materials in the above process (I) are known (WO 96/35 664, WO 97/02 243) or they can be prepared by the processes described therein or by processes (A) to (H).
  • Some of the boronic acids of the formula (XII) [0740]
    Figure US20030096806A1-20030522-C00163
  • in which [0741]
  • Y is as defined above [0742]
  • are commercially available, or they can be prepared in a simple manner by generally known processes. [0743]
  • The acyl halides of the formula (XIII), carboxylic anhydrides of the formula (XIV), chloroformic esters or chloroformic thioesters of the formula (XV), chloromonothioformic esters or chlorodithioformic esters of the formula (XVI), sulphonyl chlorides of the formula (XVII), phosphorus compounds of the formula (XVIIU) and metal hydroxides, metal alkoxides or amines of the formulae (XIX) and (XX) and isocyanates of the formula (XXI) and carbamoyl chlorides of the formula (XXII) furthermore required as starting materials for carrying out the processes (J), (K), (L), (M), (N), (O) and (P) according to the invention are generally known compounds of organic or inorganic chemistry. [0744]
  • Moreover, the compounds of the formulae (VII), (VUI), (IX), (XIII) to (XXIII), (XXVI), (XXVM), (XXX), (XXXVI), (XL), (XLI) and (XLIV) are known from the patent applications cited at the outset, and/or they can be prepared by the methods given therein. [0745]
  • The process (A) is characterized in that compounds of the formula (II) in which A, B, D, W, X, Y, Z and R[0746] 8 are each as defined above are subjected to an intramolecular condensation in the presence of a base.
  • Suitable diluents for the process (A) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone, and also alcohols, such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol. [0747]
  • Suitable bases (deprotonating agents) for carrying out the process (A) according to the invention are all customary proton acceptors. Preference is given to using alkali metal and alkaline earth metal oxides, hydroxides and carbonates, such as sodium hydroxide, potassium hydroxide, magnesium oxide, calcium oxide, sodium carbonate, potassium carbonate and calcium carbonate, which can also be employed in the presence of phase-transfer catalysts, such as, for example, triethylbenzylammonium chloride, tetrabutylammonium bromide, Adogen 464 (=methyltrialkyl(C[0748] 8-C10)amnmonium chloride) or TDA 1 (=tris-(methoxyethoxyethyl)-amine). Alkali metals such as sodium and potassium can also be used. Furthermore, alkali metal and alkaline earth metal amides and hydrides, such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • When carrying out the process (A) according to the invention, the reaction temperatures can be varied within a relatively wide range. In general, the reaction is carred out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C. [0749]
  • The process (A) according to the invention is generally carried out under atmospheric pressure. [0750]
  • When carrying out process (A) according to the invention, the reaction components of the formula (II) and the deprotonating bases are generally employed in approximately double-equimolar amounts. However, it is also possible to use a larger excess (up to 3 mol) of one component or the other. [0751]
  • The process (B) is characterized in that compounds of the formula (III) in which A, B, W, X, Y, Z and R[0752] 8 are each as defined above are subjected to an intramolecular condensation in the presence of a diluent and in the presence of a base.
  • Suitable diluents for the process (B) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone, and also alcohols, such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol. [0753]
  • Suitable bases (deprotonating agents) for carrying out the process (B) according to the invention are all customary proton acceptors. Preference is given to using alkali metal and alkaline earth metal oxides, hydroxides and carbonates, such as sodium hydroxide, potassium hydroxide, magnesium oxide, calcium oxide, sodium carbonate, potassium carbonate and calcium carbonate, which can also be employed in the presence of phase-transfer catalysts, such as, for example, triethylbenzylammonium chloride, tetrabutylammonium bromide, Adogen 464 (=methyltrialkyl(C[0754] 8-C10)ammonium chloride) or TDA 1 (=tris-(methoxyethoxyethyl)-amine). Alkali metals such as sodium and potassium can also be used. Furthermore, alkali metal and alkaline earth metal amides and hydrides, such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • When carrying out the process (B) according to the invention, the reaction temperatures can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C. [0755]
  • The process (B) according to the invention is generally carried out under atmospheric pressure. [0756]
  • When carrying out the process (B) according to the invention, the reaction components of the formula (II) and the deprotonating bases are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 3 mol) of one component or the other. [0757]
  • The process (C) is characterized in that compounds of the formula (IV) in which A, B, W, X, Y, Z and R[0758] 8 are each as defined above are cyclized intramolecularly in the presence of an acid and, if appropriate, in the presence of a diluent.
  • Suitable diluents for the process (C) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore halogenated hydrocarbons such as dichloromethane, chloroform, ethylene chloride, chlorobenzene, dichlorobenzene, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethyl formamide and N-methyl-pyrrolidone. Furthermore, it is possible to employ alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, isobutanol, tert-butanol. [0759]
  • If appropriate, the acid used can also serve as diluent. [0760]
  • Suitable acids for the process (C) according to the invention arc all customary inorganic and organic acids, such as, for example, hydrohalic acids, sulphuric acid, alkyl, aryl and haloalkylsulphonic acids, in particular halogenated alkylcarboxylic acids, such as, for example, trifluoroacetic acid. [0761]
  • When carrying out the process (C) according to the invention, the reaction temperatures can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C. [0762]
  • The process (C) according to the invention is generally carried out under atmospheric pressure. [0763]
  • When carrying out the process (C) according to the invention, the reaction components of the formula (IV) and the acid are employed, for example, in equimolar amounts. However, it is also possible, if appropriate, to use the acid as solvent or as catalyst. [0764]
  • The processes (D-α) and (D-β) are characterized in that compounds of the formula (V) or (VI) in which W, X, Y, Z, R[0765] 8 and Hal are each as defined above are reacted with compounds of the formula (VII) in which A and D are each as defined above, if appropriate in the presence of a base and if appropriate in the presence of a diluent.
  • Suitable diluents for the processes (D-α) and (D-β) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone, and also, only in the case where compounds of the formula (VI) are employed, alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol. [0766]
  • When compounds of the formula (V) are employed, suitable bases are inorganic bases, in particular alkali metal or alkaline earth metal carbonates such as sodium carbonate, potassium carbonate or calcium carbonate, and also organic bases, such as, for example, pyridine or triethylamine, and when compounds of the formula (VI) are employed, alkali metal and alkaline earth metal oxides, hydroxides and carbonates, such as sodium hydroxide, potassium hydroxide, magnesium hydroxide, calcium oxide, sodium carbonate, potassium carbonate and calcium carbonate, which can also be employed in the presence of phase-transfer catalysts, such as, for example, triethylbenzylammonium chloride, tetrabutylammonium bromide, Adogen 464 (=methyltrialkyl(C[0767] 8-C10)-ammonium chloride) or TDA 1 (=tris-(methoxyethoxyethyl)-amine), furthermore alkali metals, such as sodium or potassium, alkali metal amides and hydnrdes and alkaline earth metal amides and hydrides, such as sodium amide, sodium hydride and calcium hydride, and additionally alkali metal alkoxides, such as sodium methoxide and potassium tert-butoxide.
  • When carrying out the processes (D-α) and (D-β) according to the invention, the reaction temperatures can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between −20° C. and 250° C., preferably between 0° C. and 150° C. [0768]
  • The processes (D-α) and (D-β) according to the invention are generally carried out under atmospheric pressure. [0769]
  • When carrying out the processes (D-α) and (D-β) according to the invention, the reaction components of the formulae (V) and (VII) or (VI) and (VII) and the deprotonating bases which are employed if appropriate are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 3 mol) of one component or the other. [0770]
  • The process (E) according to the invention is characterized in that carbonyl compounds of the formula (VIII) or enol ethers thereof of the formula (VIII-a) are reacted with ketene acid halides of the formula (V) in the presence of a diluent and, if appropriate, in the presence of an acid acceptor. [0771]
  • Suitable diluents for the process (E) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide or N-methyl-pyrrolidone. [0772]
  • Suitable acid acceptors for carrying out the process variant E) according to the invention are all customary acid acceptors. [0773]
  • Preference is given to using tertiary amines, such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicycloundecane (DBU), diazabicyclononene (DBN), Hünig base and N,N-dimethyl-aniline. [0774]
  • When carrying out the process variant E) according to the invention, the reaction temperatures can be varied within a relatively wide range. Advantageously, the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 220° C. [0775]
  • The process (E) according to the invention is advantageously carried out under atmospheric pressure. [0776]
  • When carrying out the process (E) according to the invention, the reaction components of the formulae (VHI) and (V) in which A, D, W, X, Y and Z are each as defined above and Hal represents halogen, and, if appropriate, the acid acceptors, are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 5 mol) of one component or the other. [0777]
  • The process (F) according to the invention is characterized in that thioamides of the formula (IX) are reacted with ketene acid halides of the formula (V) in the presence of a diluent and, if appropriate, in the presence of an acid acceptor. [0778]
  • Suitable diluents for the process variant F) according to the invention are all inert organic solvents. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone. [0779]
  • Suitable acid acceptors for carrying out the process (F) according to the invention are all customary acid acceptors. [0780]
  • Preference is given to using tertiary amines, such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicycloundecane (DBU), diazabicyclononene (DBN), Hünig base and N,N-dimethyl-aniline. [0781]
  • When carrying out the process (F) according to the invention, the reaction temperatures can be varied within a relatively wide range. Advantageously, the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 20° C. and 22[0782] 0° C.
  • The process (F) according to the invention is advantageously carried out under atmospheric pressure. [0783]
  • When carrying out the process (F) according to the invention, the reaction components of the formulae (IX) and (V) in which A, W, X, Y and Z are each as defined above and Hal represents halogen, and, if appropriate, the acid acceptors, are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 5 mol) of one component or the other. The process (G) is characterized in that compounds of the formula (X) in which A, B, Q[0784] 1, Q2, W, X, Y, Z and R8 are each as defined above are subjected to an intramolecular condensation in the presence of a base.
  • Suitable diluents for the process (G) according to the invention are all organic solvents which are inert towards the reaction participants. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylfomiamide and N-methyl-pyrrolidone. It is furthermore possible to use alcohols, such as methanol, ethanol, propanol, iso-propanol, butanol, isobutanol, tert-butanol. [0785]
  • Suitable bases (deprotonating agents) for carrying out the process (G) according to the invention are all customary proton acceptors. Preference is given to using alkali metal and alkaline earth metal oxides, hydroxides and carbonates, such as sodium hydroxide, potassium hydroxide, magnesium oxide, calcium oxide, sodium carbonate, potassium carbonate and calcium carbonate, which can also be employed in the presence of phase-transfer catalysts, such as, for example, triethylbenzylammonium chloride, tetrabutylammonium bromide, Adogen 464 (methyltrialkyl(C[0786] 8-C10)ammonium chloride) or TDA 1 (tris-(methoxyethoxyethyl)-amine). Alkali metals such as sodium or potassium can also be used. Furthermore, alkali metal and alkaline earth metal amides and hydrides, such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • When carrying out the process (G) according to the invention, the reaction temperatures can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between −75° C. and 250° C., preferably between −50° C. and 150° C. [0787]
  • The process (G) according to the invention is generally carried out under atmospheric pressure. [0788]
  • When carrying out the process (G) according to the invention, the reaction components of the formula (X) and the deprotonating bases are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 3 mol) of one component or the other. [0789]
  • The process (H) is characterized in that compounds of the formula (XI) in which A, B, Q[0790] 3, Q4, Q5, Q6, W, X, Y, Z and R8 are each as defined above are subjected to an intramolecular condensation in the presence of bases.
  • Suitable diluents for the process (H) according to the invention are all organic solvents which are inert towards the reaction participants. Preference is given to using hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, moreover polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone. Alcohols, such as methanol, ethanol, propanol, iso-propanol, butanol, isobutanol and tert-butanol can also be used. [0791]
  • Suitable bases (deprotonating agents) for carrying out the process (H) according to the invention are all customary proton acceptors. Preference is given to using alkali metal and alkaline earth metal oxides, hydroxides and carbonates, such as sodium hydroxide, potassium hydroxide, magnesium oxide, calcium oxide, sodium carbonate, potassium carbonate and calcium carbonate, which can also be employed in the presence of phase-transfer catalysts, such as, for example, triethylbenzyl-ammonium chloride, tetrabutylammonium bromide, Adogen 464 (methyltrialkyl(C[0792] 8-C10)ammonium chloride) or TDA 1 (tris-(methoxyethoxyethyl)-amine). Alkali metals such as sodium and potassium can also be used. Furthermore, alkali metal and alkaline earth metal amides and hydrides, such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • When carrying out the process (H) according to the invention, the reaction temperatures can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C. [0793]
  • The process (H) according to the invention is generally carried out under atmospheric pressure. [0794]
  • When carrying out the process (H) according to the invention, the reaction components of the formula (XII) and the deprotonating bases are generally employed in approximately equimolar amounts. However, it is also possible to use a relatively large excess (up to 3 mol) of one component or the other. [0795]
  • For carrying out the process (I) according to the invention, palladium(0) complexes are suitable as catalysts. Preference is given, for example, to tetrakis-(triphenyl-phosphine)palladium. [0796]
  • Suitable acid acceptors for carrying out the process (I) according to the invention are inorganic or organic bases. These preferably include alkaline earth metal or alkali metal hydroxides, acetates, carbonates or bicarbonates, such as, for example, sodium hydroxide, potassium hydroxide, barium hydroxide or amrnmonium hydroxide, sodium acetate, potassium acetate, calcium acetate or ammonium acetate, sodium carbonate, potassium carbonate or ammonium carbonate, sodium bicarbonate or potassium bicarbonate, alkali metal fluorides, such as, for example, caesium fluoride, and also tertiary amines, such as trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, N,N-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicycloundecene (DBU). Suitable diluents for carrying out the process (I) according to the invention are water, organic solvents and any mixtures thereof. Examples include: aliphatic, alicyclic or aromatic hydrocarbons, such as, for example, petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; halogenated hydrocarbons, such as, for example, chlorobenzene, dichlorobeiizene, methylene chloride, chloroform, carbon tetrachloride, dichloroethane, trichloroethane or tetrachloroethylene; ethers, such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane, diethylene glycol dimethyl ether or anisole; alcohols, such as methanol, ethanol, n- or i-propanol, n-, iso-, sec- or tert-butanol, ethanediol, propane-1,2-diol, ethoxyethanol, methoxyethanol, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether; water. [0797]
  • The reaction temperature in the process (I) according to the invention can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between 0° C. and +140° C., preferably between 50° C. and +100° C. [0798]
  • When carrying out the process (I) according to the invention, boronic acid of the formula (XII), in which Y is as defined above, and compounds of the formulae (I-1-a) to (I-8-a), in which A, B, D, Q[0799] 1, Q2, Q3, Q4, Q5, Q6, W, X, Y, and Z are as defined above, are employed in a molar ratio of from 1:1 to 3:1, preferably from 1:1 to 2:1. In general, 0.005 to 0.5 mol, preferably 0.01 mol to 0.1 mol of catalyst is employed per mole of the compounds of the formulae (I-1-a) to (I-8-a). The base is usually employed in excess.
  • The process (J-α) is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with carbonyl halides of the formula (XIII), if appropriate in the presence of a diluent and if appropriate in the prescence of an acid binder. [0800]
  • Suitable diluents for the process (J-α) according to the invention are all solvents which are inert towards the acyl halides. Preference is given to using hydrocarbons, such as benzine, benzene, toluene, xylene and tetralin, furthermore halogenated hydrocarbons, such as methylene chloride, chloroform, carbon tetrachloride, chlorobenzene and o-dichlorobenzene, moreover ketones, such as acetone and methyl isopropyl ketone, furthermore ethers, such as diethyl ether, tetrahydrofuran and dioxane, additionally carboxylic esters, such as ethyl acetate, and also strongly polar solvents, such as dimethyl sulphoxide and sulpholane. The hydrolytic stability of the acyl halide permitting, the reaction can also be carried out in the presence of water. [0801]
  • Suitable acid binders for the reaction according to the process (J-α) according to the invention are all customary acid acceptors. Preference is given to using tertiary amines, such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicyclo-undecene (DBU), diazabicyclononene (DBN), Htinig base and N,N-dimethyl-aniline, furthermore alkaline earth metal oxides, such as magnesium oxide and calcium oxide, moreover alkali metal and alkaline earth metal carbonates, such as sodium carbonate, potassium carbonate and calcium carbonate, and also alkali metal hydroxides such as sodium hydroxide and potassium hydroxide. [0802]
  • The reaction temperatures in the process (J-a) according to the invention can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between −20° C. and +1 50° C., preferably between 0° C. and 100° C. [0803]
  • When carrying out the process (J-α) according to the invention, the starting materials of the formulae (I-1-a) to (I-8-a) and the carbonyl halide of the formula (XIU) are generally in each case employed in approximately equivalent amounts. However, it is also possible to employ a relatively large excess (up to 5 mol) of the carbonyl halide. Work-up is carried out by customary methods. [0804]
  • The process (J-β) is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are reacted with carboxylic anhydrides of the formula (XIV), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder. [0805]
  • Preferred diluents for the process (J-β) according to the invention are those diluents which are also preferred when acyl halides are used. Otherwise, it is also possible for a carboxylic anhydride employed in excess to act simultaneously as a diluent. [0806]
  • In the process (J-13), acid binders which are added, if appropriate, are preferably those acid binders which are also preferred when acyl halides are used. [0807]
  • In the process (J-β) according to the invention, the reaction temperatures can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between −20° C. and +150° C., preferably between 0° C. and 100° C. [0808]
  • When carrying out the process (J-β) according to the invention, the starting materials of the formulae (I-1-a) to (I-8-a) and the carboxylic anhydride of the formula (XIV) are generally each employed in approximately equivalent amounts. However, it is also possible to use a relatively large excess (up to 5 mol) of the carboxylic anhydride. Work-up is carried out by customary methods. [0809]
  • In general, the adopted procedure is to remove diluent and excess carboxylic anhydride and also the carboxylic acid formed by distillation or by washing with an organic solvent or with water. [0810]
  • The process (K) is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with chloroformic esters or chloroformic thiol esters of the formula (XV), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder. [0811]
  • Suitable diluents for the reaction according to the process (K) according to the invention are all customary acid acceptors. Preference is given to using tertiary amines, such as triethylamine, pyridine, DABCO, DBU, DBA, Hünig base and N,N-dimethyl-aniline, furthermore alkaline earth metal oxides, such as magnesium oxide and calcium oxide, moreover alkali metal carbonates and alkaline earth metal carbonates, such as sodium carbonate, potassium carbonate and calcium carbonate, and also alkali metal hydroxides such as sodium hydroxide and potassium hydroxide. [0812]
  • Suitable diluents for the process (K) according to the invention are all solvents which are inert towards the chloroformic esters or chloroformic thiol esters. Preference is given to using hydrocarbons, such as benzine, benzene, toluene, xylene and tetralin, furthermore halogenated hydrocarbons, such as methylene chloride, chloroform, carbon tetrachloride, chlorobenzene and o-dichlorobenzene, moreover ketones, such as acetone and methyl isopropyl ketone, furthermore ethers, such as diethyl ether, tetrahydrofuran and dioxane, additionally carboxylic esters, such as ethyl acetate, and also strongly polar solvents, such as dimethyl sulphoxide and sulpholane. [0813]
  • When carrying out the process (K) according to the invention the reaction temperatures can be varied within a relatively wide range. If the reaction is carried out in the presence of a diluent and an acid binder, the reaction temperatures are generally between −20° C. and +100° C., preferably between 0° C. and 50° C. [0814]
  • The process (K) according to the invention is generally carried out under atmospheric pressure. [0815]
  • When carrying out the process (K) according to the invention, the starting materials of the formulae (I-1-a) to (I-8-a) and the appropriate chloroformic ester or chloroformic thiol ester of the formula (XV) are generally in each case employed in approximately equivalent amounts. However, it is also possible to employ a relatively large excess (up to 2 mol) of one component or the other. Work-up is carried out by customary methods. In general, precipitated salts are removed and the reaction mixture that remains is concentrated by stripping the diluent. [0816]
  • The process (L) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with compounds of the formula (XVI) in the presence of a diluent and, if appropriate, in the presence of an acid binder. [0817]
  • In the preparation process (L), approximately 1 mol of chloromonothioformic ester or chlorodithioformic ester of the formula (XVI) is reacted per mole of starting material of the formulae (I-1-a) to (I-8-a), at from 0 to 120° C., preferably from 20 to 60° C. [0818]
  • Suitable diluents which are added if appropriate are all inert polar organic solvents, such as ethers, amides, sulphones, sulphoxides, but also halogenoalkanes. [0819]
  • Preference is given to using dimethyl sulphoxide, tetrahydrofuran, dimethylformamide or methylene chloride. [0820]
  • If, in a preferred embodiment, the enolate salt of the compounds (I-1-a) to (I-8-a) is prepared by addition of strong deprotonating agents, such as, for example, sodium hydride or potassium tert-butoxide, it is not necessary to add further acid binders. [0821]
  • If acid binders are employed, these are customary inorganic or organic bases, for example sodium hydroxide, sodium carbonate, potassium carbonate, pyridine, triethylamine. [0822]
  • The reaction can be carried out at atmospheric pressure or under elevated pressure and is preferably carried out at atmospheric pressure. Work-up is carried out by customary methods. [0823]
  • The process (M) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with sulphonyl chlorides of the formula (XVII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder. [0824]
  • In the preparation process (M), approximately 1 mol of sulphonyl chloride of the formula (XVII) is reacted per mole of starting material of the formula (I-1-a) to (I-8-a), at from −20 to 150° C., preferably at from 20 to 70° C. um. [0825]
  • Suitable diluents which are added if appropriate are all inert polar organic solvents, such as ethers, amides, nitrites, sulphones, sulphoxides or halogenated hydrocarbons, such as methylene chloride. [0826]
  • Preference is given to using dimethyl sulphoxide, tetrahydrofuran, dimethylformamide, methylene chloride. [0827]
  • If, in a preferred embodiment, the enolate salt of the compounds (I-1-a) to (I-8-a) is prepared by addition of strong deprotonating agents (such as, for example, sodium hydride or potassium tert-butoxide), it is not necessary to add further acid binders. [0828]
  • If acid binders are employed, these are customary inorganic or organic bases, for example sodium hydroxide, sodium carbonate, potassium carbonate, pyridine, triethylamine. [0829]
  • The reaction can be carried out at atmospheric pressure or under elevated pressure and is preferably carried out at atmospheric pressure. Work-up is carried out by customary methods. [0830]
  • The process (N) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with phosphorus compounds of the formula (XVIII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder. [0831]
  • In the preparation process (N), 1 to 2, preferably 1 to 1.3, mol of the phosphorus compound of the formula (XVIII) are reacted per mole of the compounds (I-1-a) to (I-8-a) at temperatures between 40° C. and 150° C., preferably between −10 and 110° C., to give compounds of the formulae (I-1-e) to (I-8-e). [0832]
  • Suitable solvents which are added if appropriate are all inert polar organic solvents, such as ethers, amides, nitriles, alcohols, sulphides, sulphones, sulphoxides, etc. [0833]
  • Preference is given to using acetonitrile, dimethyl sulphoxide, tetrahydrofuran, dimethylformamide, methylene chloride. [0834]
  • Suitable acid binders which are added if appropriate are customary inorganic or organic bases such as hydroxides, carbonates or amines. Examples include sodium hydroxide, sodium carbonate, potassium carbonate, pyridine, triethylamine. [0835]
  • The reaction can be carried out at atmospheric pressure or under elevated pressure and is preferably carried out under atmospheric pressure. Work-up is carried out by customary methods of organic chemistry. The resulting end products are preferably purified by crystallization, chromatographic purification or by so-called “incipient distillation”, i.e. removal of the volatile components under reduced pressure. [0836]
  • The process (O) is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are reacted with metal hydroxides or metal alkoxides of the formula (XIX) or amines of the formula (XX), if appropriate in the presence of a diluent. [0837]
  • Preferred diluents for the process (O) according to the invention are ethers, such as tetrahydrofuran, dioxane, diethyl ether, or else alcohols, such as methanol, ethanol, isopropanol, but also water. [0838]
  • The process (O) according to the invention is generally carried out under atmospheric pressure. [0839]
  • The reaction temperatures are generally between −20° C. and 100° C., preferably between 0° C. and 50° C. [0840]
  • The process (P) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-8-a) are in each case reacted with (P-α) compounds of the formula (XXI), if appropriate in the presence of a diluent and if appropriate in the presence of a catalyst, or (P-β) with compounds of the formula (XXII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder. [0841]
  • In the preparation process (P-α), approximately one mol of isocyanate of the formula (XXI) is reacted per mole of starting material of the formulae (I-1-a) to (I-8-a), at from 0 to 100° C., preferably at from 20 to 50° C. [0842]
  • Suitable diluents which are added if appropriate are all inert organic solvents, such as ethers, amides, nitrites, sulphones, sulphoxides. [0843]
  • If appropriate, catalysts may be added to accelerate the reaction. Very advantageously, the catalysts which are employed are organotin compounds, such as, for example, dibutyltin dilaurate. The reaction is preferably carried out at atmospheric pressure. [0844]
  • In the preparation process (P-β), approximately 1 mol of carbamoyl chloride of the formula (XXII) is reacted per mole of starting material of the formulae (I-1-a) to (I-8-a), at from −20 to 150° C., preferably from 0 to 70° C. um. [0845]
  • Suitable diluents which are added if appropriate are all inert polar organic solvents, such as ethers, amides, sulphones, sulphoxides or halogenated hydrocarbons. [0846]
  • Preference is given to using dimethyl sulphoxide, tetrahydrofuran, dimethylformamide or methylene chloride. [0847]
  • If, in a preferred embodiment, the enolate salt of the compounds (I-1-a) to (I-8-a) is prepared by addition of strong deprotonating agents (such as, for example, sodium hydride or potassium tert-butoxide), it is not necessary to add further acid binders. [0848]
  • If acid binders are employed, these are customary inorganic or organic bases, for example sodium hydroxide, sodium carbonate, potassium carbonate, triethylamine or pyridine. [0849]
  • The reaction can be carried out at atmospheric pressure or under elevated pressure and is preferably carried out at atmospheric pressure. Work-up is carried out by customary methods. [0850]
  • The active compounds are suitable for controlling animal pests, preferably arthropods and nematodes, in particular insects and arachnids, which are encountered in agriculture, in forestry, in the protection of stored products and of materials, and in the hygiene sector. They are active against normally sensitive and resistant species and against all or some stages of development. The abovementioned pests include: [0851]
  • From the order of the Isopoda, for example, Oniscus asellus, Armadillidium vulgare and Porcellio scaber. [0852]
  • From the order of the Diplopoda, for example, [0853] Blaniulus guttulatus.
  • From the order of the Chilopoda, for example, [0854] Geophilus carpophagus and Scutigera spp.
  • From the order of the Symphyla, for example, [0855] Scutigerella immaculata.
  • From the order of the Thysanura, for example, [0856] Lepisma saccharina.
  • From the order of the Collembola, for example, [0857] Onychiurus armatus.
  • From the order of the Orthoptera, for example, [0858] Blatta orientalis, Periplaneta americana, Leucophaea maderae, Blattella germanica, Acheta domesticus, Gryllotalpa spp., Locusta migratoria migratorioides, Melanoplus differentialis and Schistocerca gregaria.
  • From the order of the Dermaptera, for example, Forficula auricularia. [0859]
  • From the order of the Isoptera, for example, Reticuliternes spp. [0860]
  • From the order of the Anoplura, for example, Phylloxera vastatrix, Pemphigus spp., [0861] Pediculus humanus corporis, Haematopinus spp., Linognathus spp.,
  • From the order of the Mallophaga, for example, Trichodectes spp. and Damalinia spp. [0862]
  • From the order of the Thysanoptera, for example, [0863] Frankliniella occidentalis, Hercinothrips femoralis, Thrips palmi and Thrips tabaci.
  • From the order of the Heteroptera, for example, Eurygaster spp., [0864] Dysdercus intermedius, Piesma quadrata, Cimex lectularius, Rhodnius prolixus and Triatoma spp.
  • From the order of the Homoptera, for example, [0865] Aleurodes brassicae, Bemisia tabaci, Trialeurodes vaporariorum, Aphis gossypii, Brevicoryne brassicae, Cryptomyzus ribis, Aphis fabae, Doralis pomi, Eriosoma lanigerum, Hyalopterus arundinis, Macrosiphum avenae, Myzus spp., Phorodon humuli, Rhopalosiphum padi, Empoasca spp., Euscelis bilobatus, Nephotettix cincticeps, Lecanium cormi, Saissetia oleae, Laodelphax striatellus, Nilaparvata lugens, Aonidiella aurantii, Aspidiotus hederae, Pseudococcus spp. and Psylla spp.
  • From the order of the Lepidoptera, for example, [0866] Pectinophora gossypiella, Bupalus piniarius, Cheimatobia brumata, Lithocolletis blancardella, Hyponomeuta padella, Plutella maculipennis, Malacosoma neustria, Euproctis chrysorrhoea, Lymantria spp., Bucculatrix thurberiella, Phyllocnistis citrella, Agrotis spp., Euxoa spp., Feltia spp., Earias insulana, Heliothis spp., Spodoptera exigua, Mamestra brassicae, Panolis flammea, Prodenia litura, Spodoptera spp., Trichoplusia ni, Carpocapsa pomonella, Pieris spp., Chilo spp., Pyrausta nubilalis, Ephestia kuehniella, Galleria mellonella, Tineola bisselliella, Tinea pellionella, Hofmannophila pseudospretella, Cacoecia podana, Capua reticulana, Choristoneura fumiferana, Clysia ambiguella, Homona magnanima and Tortrix viridana.
  • From the order of the Coleoptera, for example, [0867] Anobium punctatum, Rhizopertha dominica, Acanthoscelides obtectus, Hylotrupes bajulus, Agelastica alni, Leptinotarsa decemlineata, Phaedon cochleariae, Diabrotica spp., Psylliodes chrysocephala, Epilachna varivestis, Atomaria spp., Oryzaephilus surinamensis, Anthonomus spp., Sitophilus spp., Otiorrhynchus sulcatus, Cosmopolites sordidus, Ceuthorrhynchus assimilis, Hypera postica, Dermnestes spp., Trogoderma spp., Anthrenus spp., Attagenus spp., Lyctus spp., Meligethes aeneus, Ptinus spp., Niptus hololeucus, Gibbium psylloides, Tribolium spp., Tenebrio molitor, Agriotes spp., Conoderus spp., Melolontha melolontha, Amphimallon solstitialis and Costelytra zealandica.
  • From the order of the Hymenoptera, for example, Diprion spp., Hoplocampa spp., Lasius spp., Monomorium pharaonis and Vespa spp. [0868]
  • From the order of the Diptera, for example, Aedes spp., Anopheles spp., Culex spp., [0869] Drosophila melanogaster, Musca spp., Fannia spp., Calliphora erythrocephala, Lucilia spp., Chrysomyia spp., Cuterebra spp., Gastrophilus spp., Hyppobosca spp., Liriomyza spp., Stomoxys spp., Oestrus spp., Hypoderma spp., Tabanus spp., Tannia spp., Bibio hortulanus, Oscinella frit, Phorbia spp., Pegomyia hyoscyami, Ceratitis capitata, Dacus oleae and Tipula paludosa.
  • From the order of the Siphonaptera, for example, [0870] Xenopsylla cheopis and Ceratophyllus spp.
  • From the order of the Arachnida, for example, [0871] Scorpio maurus, Latrodectus mactans.
  • From the order of the Acarina for example, [0872] Acarus siro, Argas spp., Ornithodoros spp., Dermanyssus gallinae, Eriophyes ribis, Phyllocoptruta oleivora, Boophilus spp., Rhipicephalus spp., Amblyonrma spp., Hyalonmma spp., Ixodes spp., Psoroptes spp., Chorioptes spp., Sarcoptes spp., Tarsonemus spp., Bryobia praetiosa, Panonychus spp. and Tetranychus spp.
  • The active compounds according to the invention have high insecticidal and acaridical activity after foliar and soil application. [0873]
  • They can be employed particularly successfully for controlling plant-damaging insects, such as, for example, against the larvae of the mustard beetle ([0874] Phaedon cochleariae), against the larvae of the green rice leafhopper (Nephotettix cincticeps) and against the larvae of the green peach aphid (Myzus persicae).
  • The active compounds according to the invention can further be used as defoliants, desiccants, haulm killers and, especially, as weed killers. By weeds in the broadest sense there are to be understood all plants which grow in locations where they are undesired. Whether the substances according to the invention act as total or selective herbicides depends essentially on the amount used. [0875]
  • The dosages of the active compounds according to the invention required for controlling weeds are between 0.001 and 10 kg/ha, preferably between 0.005 and 5 kg/ha. [0876]
  • The active compounds according to the invention can be used, for example, in connection with the following plants: [0877]
  • Dicotyledonous Weeds of the Genera: [0878]
  • Sinapis, Lepidium, Galium, Stellaria, Matricaria, Anthemis, Galinsoga, Chenopodium, Urtica, Senecio, Amaranthus, Portulaca, Xanthium, Convolvulus, Ipomoea, Polygonum, Sesbania, Ambrosia, Cirsium, Carduus, Sonchus, Solanum, Rorippa, Rotola, Lindernia, Lamium, Veronica, Abutilon, Emex, Datura, Viola, Galeopsis, Papaver, Centaurea, Trifolium, Ranunculus, Taraxacum. [0879]
  • Dicotyledonous Crops of the Genera: [0880]
  • Gossypium, Glycine, Beta, Daucus, Phaseolus, Pisum, Solanum, Linum, Ipomoea, Vicia, Nicotiana, Lycopersicon, Arachis, Brassica, Lactuca, Cucumis, Cucurbita. [0881]
  • Monocotyledonous Weeds of the Genera: [0882]
  • Echinochloa, Setaria, Panicum, Digitaria, Phleum, Poa, Festuca, Eleusine, Brachiaria, Lolium, Bromus, Avena, Cyperus, Sorghum, Agropyron, Cycnodon, Monochoria, Fimbristylis, Sagittaria, Eleocharis, Scirpus, Paspalum, Ischaemum, Sphenoclea, Dactyloctenium, Agrostis, Alopecurus, Apera. [0883]
  • Monocotyledonous Crops of the Genera: [0884]
  • Oryza, Zea, Triticum, Hordeum, Avena, Secale, Sorghum, Panicum, Sachharum, Ananas, Asparagus, Allium. [0885]
  • However, the use of the active compounds according to the invention is in no way restricted to these genera, but also extends in the same manner to other plants. [0886]
  • Depending on the concentration, the compounds are suitable for total weed control, for example on industrial terrain and rail tracks and on paths and areas with or without tree growth. Equally, the compounds can be employed for controlling weeds in perennial crops, for example forests, ornamental tree plantings, orchards, vineyards, citrus groves, nut orchards, banana plantations, coffee plantations, tea plantations, rubber plantations, oil palm plantations, cocoa plantations, soft fruit plantings and hop fields, on lawns and turf and pastures and for selective weed control in annual crops. [0887]
  • The active compounds according to the invention are highly suitable for selective control of monocotyledonous weeds in dicotyledonous crops, by the pre-emergence and by the post-emergence method. In cotton or sugar beet, for example, they can be employed with very good results for controlling harmful grass. [0888]
  • The active compounds can be converted to the customary formulations, such as solutions, emulsions, wettable powders, suspensions, powders, dusts, pastes, soluble powders, granules, suspension-emulsion concentrates, natural and synthetic materials impregnated with active compound and microencapsulations in polymeric substances. [0889]
  • These formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is, liquid solvents, and/or solid carriers, optionally with the use of surfactants, that is emulsifiers and/or dispersants, and/or foam-formers. [0890]
  • If the extender used is water, it is also possible to employ for example organic solvents as auxiliary solvents. Essentially, suitable liquid solvents are: aromatics such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons such as cyclohexane or paraffins, for example petroleum fractions, mineral and vegetable oils, alcohols such as butanol or glycol and also their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide and dimethyl sulphoxide, and also water. [0891]
  • As solid carriers there are suitable: [0892]
  • for example ammomnum salts and ground natural minerals such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals, such as highly disperse silica, alumina and silicates; as solid carriers for granules there are suitable: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, and also synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks; as emulsifiers and/or foam-formers there are suitable: for example nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates and also protein hydrolysates; as dispersants there are suitable: for example lignin-sulphite waste liquors and methylcellulose. [0893]
  • Tackifiers such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, as well as natural phospholipids such as cephalins and lecithins, and synthetic phospholipids, can be used in the formulations. Other additives can be mineral and vegetable oils. [0894]
  • It is possible to use colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs, such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc. [0895]
  • The formulations generally comprise between 0.1 and 95% by weight of active compound, preferably between 0.5 and 90% and, in addition, preferably extenders and/or surfactants. [0896]
  • The active compound according to the invention can be present in its commercially available formulations and in the use forms, prepared from these formulations, as a mixture with other active compounds, such as insecticides, attractants, sterilizing agents, acaricides, nematicides, flugicides, growth-regulating substances or herbicides. The insecticides include, for example, phosphoric acid esters, carbarnates, carboxylates, chlorinated hydrocarbons, phenylureas and substances produced by microorganisms, inter alia. [0897]
  • Particularly favourable examples of co-components in mixtures are the following compounds: [0898]
  • Fungicides: [0899]
  • 2-aminobutane; 2-anilino-4-methyl-6-cyclopropyl-pyrimidine; 2′,6′-dibromo-2-methyl-4′-trifluoromethoxy-4′-trifluoromethyl-1,3-thiazole-5-carboxanilide; 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide; (E)-2-methoxyimino-N-methyl-2-(2-phenoxyphenyl)-acetamide; 8-hydroxyquinoline sulphate; methyl (E)-2-{2-[6-(2-cyano-phenoxy)-pyrimidin-4-yloxy]-phenyl}-3-methoxyacrylate; methyl (E)-methoximino-[alpha-(o-tolyloxy)-o-tolyllacetate; 2-phenylphenol (OPP), [0900]
  • aldimorph, ampropylfos, anilazine, azaconazole, [0901]
  • benalaxyl, benodanil, benomyl, binapacryl, biphenyl, bitertanol, blasticidin-S, bromuconazole, bupirimate, buthiobate, [0902]
  • calcium polysulphide, captafol, captan, carbendazim, carboxin, quinomethionate, chloroneb, chloropicrin, chlorothalonil, chlozolinate, cufraneb, cymoxanil, cyproconazole, cyprofuram, [0903]
  • dichlorophen, diclobutrazole, diclofluanid, diclomezine, dicloran, diethofencarb, difenoconazole, dimethirimol, dimethomorph, diniconazole, dinocap, diphenylamine, dipyrithione, ditalimfos, dithianon, dodine, drazoxolon, [0904]
  • edifenphos, epoxiconazole, ethirimol, etridiazole, [0905]
  • fenarimol, fenbuconazole, fenfuram, fenitropan, fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, ferbam, ferimzone, fluazinam, fluoromide, fluquinconazole, flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetyl-aluminium, fthalide, fuberidazole, furalaxyl, furmecyclox, [0906]
  • guazatine, [0907]
  • hexachlorobenzene, hexaconazole, hymexazole, [0908]
  • imazalil, imibenconazole, iminoctadine, iprobenfos (1BP), iprodione, irurnamycin, isoprothiolane, [0909]
  • kasugamycin, copper preparations, such as: copper hydroxide, copper naphthenate, copper oxychloride, copper sulphate, copper oxide, oxine-copper and Bordeaux mixture, [0910]
  • mancopper, mancozeb, maneb, mepanipyrim, mepronil, metalaxyl, metconazole, methasulfocarb, methfuroxam, metirarn, metsulfovax, myclobutanil, [0911]
  • nickel dimethyldithiocarbamate, nitrothal-isopropyl, nuarimol, [0912]
  • ofurace, oxadixyl, oxamocarb, oxycarboxim, [0913]
  • pefurazoate, penconazole, pencycuron, phosdiphen, phthalide, pimaricin, piperalin, polycarbamate, polyoxin, probenazole, prochloraz, procymidone, propamocarb, propiconazole, propineb, pyrazophos, pyrifenox, pyrimethanil, pyroquilon, [0914]
  • quintozene (PCNB), [0915]
  • sulphur and sulphur preparations, [0916]
  • tebuconazole, tecloftalam, tecnazene, tetraconazole, thiabendazole, thicyofen, thiophanate-methyl, thiram, tolclofos-methyl, tolylfluanid, triadimefon, triadimenol, triazoxide, trichlamide, tricyclazole, tridemorph, triflumizole, triforine, triticonazole, [0917]
  • validamycin A, vinclozolin, [0918]
  • zineb, ziram. [0919]
  • Bactericides: [0920]
  • bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, fuirancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations. [0921]
  • Insecticides/Acaricides/Nematicides: [0922]
  • abamectin, AC[0923] 303 630, acephate, acrinathrin, alanycarb, aldicarb, alphamethrin, amitraz, avermectin, AZ 60541, azadirachtin, azinphos A, azinphos M, azocyclotin,
  • [0924] Bacillus thuringiensis, bendiocarb, benfuracarb, bensultap, betacyfluthrin, bifenthrin, BPMC, brofenprox, bromophos A, bufencarb, buprofezin, butocarboxim, butylpyridaben,
  • cadusafos, carbaryl, carbofuran, carbophenothion, carbosulfan, cartap, CGA 157 419, CGA 184699, chloethocarb, chlorethoxyfos, chlorfenvinphos, chlorfluazuron, chlorrnephos, chlorpyrifos, chlorpyrifos M, cis-resmethrin, clocythrin, clofentezine, cyanophos, cycloprothrin, cyfluthrin, cyhalothrin, cyhexatin, cypermethrin, cyromazine, [0925]
  • deltamethrin, demeton M, demeton S, demeton-S-methyl, diafenthiuron, diazinon, dichlofenthion, dichlorvos, dicliphos, dicrotophos, diethion, diflubenzuron, dimethoate, dimethylvinphos, dioxathion, disulfoton, [0926]
  • edifenphos, emamectin, esfenvalerate, ethiofencarb, ethion, ethofenprox, ethoprophos, etrimfos, [0927]
  • fenamiphos, fenazaquin, fenbutatin oxide, fenitrothion, fenobucarb, fenothiocarb, fenoxycarb, fenpropathrin, fenpyrad, fenpyroximate, fenthion, fenvalerate, fipronil, fluazinam, flucycloxuron, flucythrinate, flufenoxuron, flufenprox, fluvalinate, fonophos, formothion, fosthiazate, fubfenprox, furathiocarb, [0928]
  • HCH, heptenophos, hexaflumuron, hexythiazox, [0929]
  • imidacloprid, iprobenfos, isazophos, isofenphos, isoprocarb, isoxathion, ivermectin, [0930]
  • lambda-cyhalothrin, lufenuron, [0931]
  • malathion, mecarbam, mevinphos, mesulfenphos, metaldehyde, methacrifos, methamidophos, methidathion, methiocarb, methomyl, metolcarb, milbemectin, monocrotophos, moxidectin, [0932]
  • naled, NC[0933] 184, NI 25, nitenpyram,
  • omethoate, oxamyl, oxydemethon M, oxydeprofos, [0934]
  • parathion A, parathion M, permethrin, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimicarb, pirimiphos M, pirimiphos A, profenofos, promecarb, propaphos, propoxur, prothiofos, prothoate, pymetrozine, pyrachlophos, pyridaphenthion, pyresmethrin, pyrethrum, pyridaben, pyrimidifen, pyriproxyfen, [0935]
  • quinalphos, [0936]
  • RH 5992, [0937]
  • salithion, sebufos, silafluofen, sulfotep, sulprofos, [0938]
  • tebufenozide, tebufenpyrad, tebupirimiphos, teflubenzuron, tefluthrin, temephos, terbam, terbufos, tetrachlorvinphos, thiafenox, thiodicarb, thiofanox, thiomethon, thionazine, thuringiensin, thionazine, tralomethrin, triarathene, triazophos, triazuron, trichlorfon, triflumuron, trimethacarb, [0939]
  • vamidothion, XMC, xylylcarb, YI 5301/5302, zetamethrin. [0940]
  • Herbicides: [0941]
  • for example anilides such as, for example, diflufenican and propanil; arylcarboxylic acids such as, for example, dichloropicolinic acid, dicamba and picloram; aryloxyalkanoic acids such as, for example, 2,4-D, 2,4-DB, 2,4-DP, fluroxypyr, MCPA, MCPP and triclopyr; aryloxy-phenoxy-alkanoic esters such as, for example, diclofop-methyl, fenoxaprop-ethyl, fluazifop-butyl, haloxyfop-methyl and quizalofop-ethyl; azinones such as, for example, chloridazon and norflurazon; carbamates such as, for example, chlorpropham, desmedipham, phenmedipham and propham; chloroacetanilides such as, for example, alachlor, acetochlor, butachlor, metazachlor, metolachlor, pretilachlor and propachlor; dinitroanilines such as, for example, oryzalin, pendimethalin and trifluralin; diphenyl ethers such as, for example, acifluorfen, bifenox, fluoroglycofen, fomesafen, halosafen, lactofen and oxyfluorfen; ureas such as, for example, chlortoluron, diuron, fluometuron, isoproturon, linuron and methabenzthiazuron; hydroxylamines such as, for example, alloxydim, clethodim, cycloxydim, sethoxydim and tralkoxydim; imidazolinones such as, for example, imazethapyr, imazamethabenz, imazapyr and imazaquin; nitriles such as, for example, bromoxynil, dichlobenil and ioxynil; oxyacetamides such as, for example, mefenacet; sulphonylureas such as, for example, amidosulphuron, bensulphuron-methyl, chlorimuron-ethyl, chlorsulphuron, cinosulphuron, metsulphuron-methyl, nicosulphuron, primisulphuron, pyrazosulphuron-ethyl, thifensulphuron-methyl, triasulphuron and tribenuron-methyl; thiolcarbamates such as, for example, butylate, cycloate, diallate, EPTC, esprocarb, molinates, prosulphocarb, thiobencarb and triallates; triazines such as, for example, atrazine, cyanazine, simazine, simetryne, terbutryne and terbutylazine; triazinones such as, for example, hexazinone, metamitron and metribuzin; others such as, for example, aminotriazole, benfuresate, bentazone, cinmethylin, clomazone, clopyralid, difenzoquat, dithiopyr, ethofumesate, fluorochloridone, glufosinate, glyphosate, isoxaben, pyridate, quinchlorac, quinmerac, sulphosate and tridiphane. [0942]
  • The active compound according to the invention can furthermore be present in its commercially available formulations and in the use forms, prepared from these formulations, as a mixture with synergistic agents. Synergistic agents are compounds which increase the action of the active compounds, without it being necessary for the synergistic agent added to be active itself. [0943]
  • The active compound content of the use forms prepared from the commercially available formulations can vary within wide limits. The active compound concentration of the use forms can be from 0.0000001 to 95% by weight of active compound, preferably between 0.0001 and 1% by weight. [0944]
  • The compounds are employed in a customary manner appropriate for the use forms. [0945]
  • When used against hygiene pests and pests of stored products, the active compound is distinguished by an excellent residual action on wood and clay as well as a good stability to alkali on limed substrates. [0946]
  • The active compounds according to the invention act not only against plant, hygiene and stored product pests, but also in the veterinary medicine sector against animal parasites (ectoparasites), such as hard ticks, soft ticks, mange mites, leaf mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, feather lice and fleas. These parasites include: [0947]
  • From the order of the Anoplurida, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp. and Solenopotes spp. [0948]
  • From the order of the Mallophagida and the suborders Amblycerina and Ischnocerina, for example, Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Wemeckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp. and Felicola spp. [0949]
  • From the order of the Diptera and the suborders Nematocerina and Brachycerina, for example, Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp. and Melophagus spp. [0950]
  • From the order of the Siphonapterida, for example Pulex spp., Ctenocephalides spp., Xenopsylla spp. and Ceratophyllus spp. [0951]
  • From the order of the Heteropterida, for example, Cimex spp., Triatoma spp., Rhodnius spp. and Panstrongylus spp. [0952]
  • From the order of the Blattarida, for example Blatta orientalis, Periplaneta americana, Blattela gernanica and Supella spp. [0953]
  • From the subclass of the Acaria (Acarida) and the orders of the Meta- and Mesostigmata, for example, Argas spp., Omithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Boophilus spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp. and Varroa spp. [0954]
  • From the order of the Actinedida (Prostigmata) und Acaridida (Astigmata), for example, Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp. [0955]
  • The active compounds of the formula (I) according to the invention are also suitable for controlling arthropods which infest agricultural productive livestock, such as, for example, cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese and bees, other pets, such as, for example, dogs, cats, caged birds and aquarium fish, and also so-called test animals, such as, for example, hamsters, guinea pigs, rats and mice. By controlling these arthropods, cases of death and reduction in productivity (for meat, milk, wool, hides, eggs, honey etc.) should be diminished, so that more economic and easier animal husbandry is possible by use of the active compounds according to the invention. [0956]
  • The active compounds according to the invention are used in the veterinary sector in a known manner by enteral administration in the form of, for example, tablets, capsules, potions, drenches, granules, pastes, boluses, the feed-through process and suppositories, by parenteral administration, such as, for example, by injection (intramuscular, subcutaneous, intravenous, intraperitoneal and the like), implants by nasal administration, by dermal use in the form, for example, of dipping or bathing, spraying, pouring on and spotting on, washing and powdering, and also with the aid of molded articles containing the active compound, such as collars, ear marks, tail marks, limb bands, halters, marking devices and the like. [0957]
  • When used for cattle, poultry, pets and the like, the active compounds of the formula (1) can be used as formulations (for example powders, emulsions, free-flowing compositions), which comprise the active compounds in an amount of 1 to 80% by weight, directly or after 100 to 10 000-fold dilution, or they can be used as a chemical bath. [0958]
  • It has furthermore been found that the compounds of the formula (I) according to the invention also have a strong insecticidal action against insects which destroy industrial materials. [0959]
  • The following insects may be mentioned as examples and as preferred—but without a limitation: [0960]
  • Beetles, such as [0961]
  • Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinus pecticomis, Dendrobium pertinex, Emobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthes rugicollis, Xyleborus spec. Tryptodendron spec. Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec. Dinoderus minutus. [0962]
  • Hymenopterons, such as [0963]
  • Sirex juvencus, Urocerus gigas, Urocerus gigas taignus, Urocerus augur. [0964]
  • Termites, such as [0965]
  • Kaloterrnes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermnes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis, Coptoterrnes formosanus. [0966]
  • Bristletails, such as [0967]
  • Lepisma saccarina. [0968]
  • Industrial materials in the present connection are to be understood as meaning non-living materials, such as, preferably, plastics, adhesives, sizes, papers and cards, leather, wood and processed wood products and coating compositions. [0969]
  • Wood and processed wood products are materials to be protected, especially preferably, from insect infestation. [0970]
  • Wood and wood processed wood products which can be protected by the agents according to the invention or mixtures comprising these are to be understood as meaning, for example: building timber, wooden beams, railway sleepers, bridge components, boat jetties, wooden vehicles, boxes, pallets, containers, telegraph poles, wood panelling, wooden windows and doors, plywood, chipboard, joinery or wooden products which are used quite generally in house-building or in building joinery. [0971]
  • The active compounds can be used as such, in the form of concentrates or in generally customary formulations, such as powders, granules, solutions, suspensions, emulsions or pastes. [0972]
  • The formulations mentioned can be prepared in a manner known per se, for example by mixing the active compounds with at least one solvent or diluent, emulsifier, dispersing agent and/or binder or fixing agent, a water repellent, if appropriate siccatives and UV stabilizers and if appropriate dyestuffs and pigrnents, and also other processing auxiliaries. [0973]
  • The insecticidal compositions or concentrates used for the preservation of wood and wood-derived timber products comprise the active compound according to the invention in a concentration of 0.0001 to 95% by weight, in particular 0.001 to 60% by weight. [0974]
  • The amount of the compositions or concentrates employed depends on the nature and occurrence of the insects and on the medium. The optimum amount employed can be determined for the use in each case by a series of tests. In general, however, it is sufficient to employ 0.0001 to 20% by weight, preferably 0.001 to 10% by weight, of the active compound, based on the material to be preserved. [0975]
  • Solvents and/or diluents which are used are an organic chemical solvent or solvent mixture and/or an oily or oil-like organic chemical solvent or solvent mixture of low volatility and/or a polar organic chemical solvent or solvent mixture and/or water, and if appropriate an emulsifier and/or wetting agent. [0976]
  • Organic chemical solvents which are preferably used are oily or oil-like solvents having an evaporation number above 35 and a flashpoint above 30° C., preferably above 45° C. Substances which are used as such oily or oil-like water-insoluble solvents of low volatility are appropriate mineral oils or aromatic fractions thereof, or solvent mixtures containing mineral oils, preferably white spirit, petroleum and/or alkylbenzene. [0977]
  • Mineral oils having a boiling range from 170 to 220° C., white spirit having a boiling range from 170 to 220° C., spindle oil having a boiling range from 250 to 350° C., petroleum and aromatics having a boiling range from 160 to 280° C., terpentine oil and the like, are advantageously employed. [0978]
  • In a preferred embodiment, liquid aliphatic hydrocarbons having a boiling range from 180 to 210° C. or high-boiling mixtures of aromatic and aliphatic hydrocarbons having a boiling range from 180 to 220° C. and/or spindle oil and/or monochloronaphthalene, preferably α-monochloronaphthalene, are used. [0979]
  • The organic oily or oil-like solvents of low volatility which have an evaporation number above 35 and a flashpoint above 30° C., preferably above 45° C., can be replaced in part by organic chemical solvents of high or medium volatility, providing that the solvent mixture likewise has an evaporation number above 35 and a flashpoint above 30° C., preferably above 45° C., and that the insecticide/fungicide mixture is soluble or emulsifiable in this solvent mixture. [0980]
  • According to a preferred embodiment, some of the organic chemical solvent or solvent mixture is replaced by an aliphatic polar organic chemical solvent or solvent mixture. Aliphatic organic chemical solvents containing hydroxyl and/or ester and/or ether groups, such as, for example, glycol ethers, esters or the like, are preferably used. [0981]
  • Organic chemical binders which are used in the context of the present invention are the synthetic resins and/or binding drying oils which are known per se, are water-dilutable and/or are soluble or dispersible or emulsifiable in the organic chemical solvents employed, in particular binders consisting of or comprising an acrylate resin, a vinyl resin, for example polyvinyl acetate, polyester resin, polycondensation or polyaddition resin, polyurethane resin, alkyd resin or modified alkyd resin, phenolic resin, hydrocarbon resin, such as indene-cumarone resin, silicone resin, drying vegetable oils and/or drying oils and/or physically drying binders based on a natural and/or synthetic resin. [0982]
  • The synthetic resin used as the binder can be employed in the form of an emulsion, dispersion or solution. Bitumen or bituminous substances can also be used as binders in an amount of up to 10% by weight. Dyestuffs, pigments, water-repelling agents, odour correctants and inhibitors or anticorrosive agents and the like which are known per se can additionally be employed. [0983]
  • It is preferred according to the invention for the composition or concentrate to comprise, as the organic chemical binder, at least one alkyd resin or modified alkyd resin and/or one drying vegetable oil. Alkyd resins having an oil content of more than 45% by weight, preferably 50 to 68% by weight, are preferably used according to the invention. [0984]
  • All or some of the binder mentioned can be replaced by a fixing agent (mixture) or a plasticizer (mixture). These additives are intended to prevent evaporation of the active compounds and crystallization or precipitation. They preferably replace 0.01 to 30% of the binder (based on 100% of the binder employed). [0985]
  • The plasticizers originate from the chemical classes of phthalic acid esters, such as dibutyl, dioctyl or benzyl butyl phthalate, phosphoric acid esters, such as tributyl phosphate, adipic acid esters, such as di-(2-ethylhexyl) adipate, stearates, such as butyl stearate or amyl stearate, oleates, such as butyl oleate, glycerol ethers or higher molecular weight glycol ethers, glycerol esters and p-toluenesulphonic acid esters. [0986]
  • Fixing agents are based chemically on polyvinyl alkyl ethers, such as, for example, polyvinyl methyl ether or ketones, such as benzophenone or ethylenebenzophenone. [0987]
  • Possible solvents or diluents are, in particular, also water, if appropriate as a mixture with one or more of the abovementioned organic chemical solvents or diluents, emulsifiers and dispersing agents. [0988]
  • Particularly effective preservation of wood is achieved by impregnation processes on a large industrial scale, for example vacuum, double vacuum or pressure processes. [0989]
  • The ready-to-use compositions can also comprise other insecticides, if appropriate, and also one or more fungicides, if appropriate. [0990]
  • Possible additional mixing partners are, preferably, the insecticides and fungicides mentioned in WO 94/29 268. The compounds mentioned in this document are an explicit constituent of the present application. [0991]
  • Especially preferred mixing partners which may be mentioned are insecticides, such as chlorpyriphos, phoxim, silafluofin, alphamethrin, cyfluthrin, cypermethrin, deltamethrin, permetlrin, imidacloprid, NI-25, flufenoxuron, hexaflumuron and triflumuron, and also fungicides, such as epoxyconazole, hexaconazole, azaconazole, propiconazole, tebuconazole, cyproconazole, metconazole, imazalil, dichlorfluanid, tolylfluanid, 3-iodo-2-propinyl-butyl carbamate, N-octyl-isothiazolin-3-one and 4,5-dichloro-N-octylisothiazolin-3-one. [0992]
  • The preparation and the use of the active compounds according to the invention is illustrated by the examples below. [0993]
    • EXAMPLE I-1-a-1
  • [0994]
    Figure US20030096806A1-20030522-C00164
  • At room temperature and under argon, 1.7 g of the bromine compound shown above (Example I-1-a-6 known from WO 97/01535) in 40 ml of 1,2-dimethoxyethane are admixed with 1 g of 4-chlorophenylboronic acid and 150 mg of tetrakis-(triphenylphosphine)-palladium, and the mixture is stirred for 15 minutes. 25 ml of 20% strength aqueous sodium carbonate solution are then added, and the mixture is stirred at about 80° C. for 1 day. The mixture is concentrated and the residue is taken up in water and acidified with hydrochloric acid. The mixture is extracted with methylene chloride and the extract is dried and concentrated. The residue is clromatographed over silica gel (mobile phase: methylene chloride/ethyl acetate 3/1). [0995]
  • Yield: 0.2 g (11% of theory); m.p.: 276° C., [0996]
    • EXAMPLE I-1-a-11
  • [0997]
    Figure US20030096806A1-20030522-C00165
  • At 60° C., 9.5 g of the compound of Example II-1 in 15 ml of dimethylformamide are added dropwise to a solution of 5.8 g of potassium tert-butoxide in 30 ml of dimethylformamide, and the mixture is stirred at 80° C. for 4 h. The mixture is concentrated and the residue is taken up in 120 ml of water and, at 0-10° C., acidified with concentrated hydrochloric acid until a pH of 2 is reached. The precipitate is filtered off with suction and purified over silica gel. [0998]
  • Yield: 1.85 g (22% of theory); m.p.: >245° C. [0999]
  • The following compounds of the formula (1-II-a) are obtained analogously and/or in accordance with the general preparation procedures: [1000]
    (I-1-a)
    Figure US20030096806A1-20030522-C00166
    Ex. No. B A D W X Y Z isomer m.p.
    I-1-a-2 —(CH2)2—CHOC2H5—(CH2)2— H H Cl 4-Cl—Ph* CH3 β >240° C.
    I-1-a-3 —(CH2)2—CHCH3—(CH2)2— H H Cl 4-Cl—Ph* CH3 β 248
    I-1-a-4 —(CH2)2—CHOC2H5—(CH2)2— H H CH3 4-Cl—Ph* Cl β 183
    I-1-a-5 —(CH2)2—CHOCH3—(CH2)2— H H Cl 3-Cl—Ph* CH3 β 141
    I-1-a-6 —(CH2)2—CHOC2H5—(CH2)2— H H Cl Ph* CH3 β 158
    I-1-a-7 —(CH2)2—CHOC2H5—(CH2)2— H H Cl 4-Cl—Ph* CH3 α 185
    I-1-a-8 —(CH2)2—O—(CH2)2— H H CH3 4-Cl—Ph* CH3 — >250 
    I-1-a-9 —(CH2)2—CHOC2H5—(CH2)2— H H CH3 4-Cl—Ph* CH3 β >240 
     I-1-a-10 —(CH2)2—CHOCH3—(CH2)2— H H CH3 4-Cl—Ph* CH3 β 185
     I-1-a-11 —CH2—CHCH3—(CH2)3— H H CH3 4-Cl—Ph* CH3 β >245 
     I-1-a-12 —(CH2)2—CHCH3—(CH2)2— H H CH3 4-Cl—Ph* CH3 β >250 
     I-1-a-13 H —CH2—S—(CH2)2— H CH3 4-Cl—Ph* CH3 — >250 
     I-1-a-14 H —(CH2)4— H CH3 4-Cl—Ph* CH3 — >250 
     I-1-a-15 —CH2—O—(CH2)3— H H CH3 4-Cl—Ph* CH3 — >235 
    • EXAMPLE I-1-b-1
  • [1001]
    Figure US20030096806A1-20030522-C00167
  • At about 80° C., 0.25 g of ethoxyacetyl chloride in 5 ml of ethyl acetate is added to a mixture of 1.6 g of the compound of Example I-1-a-2, 30 ml of ethyl acetate and 0.3 ml of triethylamine, and the mixture is stirred at this temperature for 1 day. The mixture is concentrated and the residue is taken up in methylene chloride and extracted with 0.5 N aqueous sodium hydroxide solution. The mixture is dried and concentrated and the residue is chromatographed over silica gel (mobile phase: methylene chloride/ethyl acetate 5/3). [1002]
  • Yield: 0.9 g (48% of theory); m.p.: 115° C. [1003]
  • The following compounds of the formula (I-1-b) are obtained analogously and/or in accordance with the general preparation procedures: [1004]
    Figure US20030096806A1-20030522-C00168
         		(I-1-b)
    Ex. No. B A D W X Y Z R1 m.p.
    I-1-b-2 —(CH2)2—CHOC2H5—(CH2)2— H H Cl 4-Cl—Ph CH3 Ph 148° C.
    I-1-b-3 —(CH2)2—CHOC2H3—(CH2)2— H H Cl 4-Cl—Ph CH3 —CH(CH3)2 165° C.
    • EXAMPLE I-1-c-1
  • [1005]
    Figure US20030096806A1-20030522-C00169
  • At about 0° C., 0.22 g of ethyl chloroformate in 5 ml of methylene chloride is added to a mixture of 1.6 g of the compound of Example I-1-a-2, 30 ml of methylene chloride and 0.35 ml of triethylamine, and the mixture is stirred at room temperature for 1 day. Work-up and chromatography are carried out as described in Example I-1-b-1. [1006]
  • Yield: 0.9 g (50% of theory); m.p.: 129° C. [1007]
    • EXAMPLE I-1-c-2
  • [1008]
    Figure US20030096806A1-20030522-C00170
  • At about 0° C., 0.13 g of ethyl chloroformate in 1 ml of methylene chloride is added to a mixture of 0.55 g of the compound of Example I-1-a-3, 30 ml of methylene chloride and 0.2 ml of triethylamine, and the mixture is stirred at room temperature for 1 day. Work-up and chromatography are carried out as described in Example I-1-b-1. [1009]
  • Yield: 0.25 g (63% of theory); m.p.: 213° C. [1010]
    • EXAMPLE I-2-a-1
  • [1011]
    Figure US20030096806A1-20030522-C00171
  • Under protective gas, 1.6 g of 4-chloro-phenylboronic acid and 0.6 g of tetrakis-(triphenylphosphine)-palladium are added to a mixture of 3.5 g of the bromine compound shown above (Ex. I-2-a-7 known from WO 97/01535) in 40 ml of dimethoxyethane, and the mixture is stirred at room temperature for 15 min. 44 ml of a 20% strength sodium carbonate solution are added, and the mixture is stirred at 80° C. for 8 h. The reaction mixture is acidified using citric acid and extracted with methylene chloride, dried and concentrated. [1012]
  • Yield: 3.52 g; m.p.: 244-246° C. [1013]
  • The following compounds are obtained analogously to Example I-2-a-1 and/or in accordance with the general procedures for preparing compounds of the formula (I-2-a) [1014]
    Figure US20030096806A1-20030522-C00172
         		(I-2-a)
    Ex. No. A B W X Y Z m.p. ° C.
    I-2-a-2 —(CH2)2—CHOCH3—(CH2)2— H Cl 4-Cl—Ph* CH3 210-212
    • EXAMPLE I-2-b-1
  • [1015]
    Figure US20030096806A1-20030522-C00173
  • At room temperature, 0.33 g of isobutyryl chloride is added to a mixture of 1.3 g of the compound of Example I-2-a-2, 20 ml of methylene chloride and 0.32 g of triethylamine, and the mixture is stirred at room temperature for 1 day. [1016]
  • The organic phase is initially washed with dilute citric acid and then with 1N sodium hydroxide solution, dried and concentrated, and the residue is purified over a silica gel column. [1017]
  • Yield: 0.92 g [1018]
  • [1019] 1H-NMR (300 MHz; CDCl3): δ=1.20 (d, 6H), 1.50-2.40 (m, 9H), 2.25 (s, 3H), 2.70 (2m, 1H), 3.40 (2s, 3H), 3.25/3.60 (2m, 1H), 7.15-7.70 (m, 6H) ppm.
    • EXAMPLE I-2-c-1
  • [1020]
    Figure US20030096806A1-20030522-C00174
  • At room temperature, 0.38 g of isopropyl chlorofomiate in 3.1 ml of toluene (1 M sol.) is added to a mixture of 1.3 g of the compound of Example I-2-a-1, 20 ml of methylene chloride and 0.32 g of triethylamine, and the mixture is stirred at room temperature for 1 day. [1021]
  • Work-up and chromatography are carried out as described in Example I-2-b-1. [1022]
  • Yield: 1.42 g. [1023]
  • [1024] 1H-NMR (300 MHz; CDCl3): δ=1.15 (d, 6H), 1.50-2.40 (m, 8H), 2.35 (2s, 3H), 3.25/3.60 (2m, 1H), 3.40 (2s, 3H), 4.70 (m, 1H), 7.10-7.50 (m, 6H) ppm.
    • EXAMPLE I-3-a-1
  • [1025]
    Figure US20030096806A1-20030522-C00175
  • A mixture of 42.1 g of the compound of Example IV-1 in 86 ml of trifluoroacetic acid and 200 ml of toluene is heated under reflux for 8 h. [1026]
  • The mixture is concentrated, the residue is taken up in 600 ml of water and 200 ml of methyl tert-butyl ether (MTBE), sodium hydroxide is added until a pH of 14 has been reached, the mixture is extracted twice with MTBE and the aqueous phase is acidified with hydrochloric acid and stirred for 1 h. The precipitate is separated off and dried. [1027]
  • Yield: 15 g (49% of theory); m.p.: 225° C. [1028]
    • EXAMPLE I-3-c-1
  • [1029]
    Figure US20030096806A1-20030522-C00176
  • At 0° C., 0.71 g of ethyl chloroformate in 3 ml of methylene chloride is added to a mixture of 2.0 g of the compound of Example I-3-a-1, 20 ml of methylene chloride and 0.76 g of triethylamine, and the mixture is stirred at room temperature for 2 h. [1030]
  • Work-up and chromatography are carried out as described in Example I-2-b-1. [1031]
  • Yield: 1.9 g (81% of theory). [1032]
  • [1033] 1H-NMR (400 MHz; CDCl3): =1.2 (t, 3H, CH2 CH 3 ), 1.3-2.0 (m, 10H, CH2), 2.05, 2.15 (2s, 2×3H, Ar—CH3), 4.3 (q, 2H, CH 2CH3), 7.0-7.5 (m, 6H, ArH) ppm.
    • EXAMPLE I-7-a-1
  • [1034]
    Figure US20030096806A1-20030522-C00177
  • 8.24 g of potassium tert-butoxide are added to a mixture of 20 g of the compound of Example X-1 in 50 ml of absolute dimethylformamide, and the mixture is stirred at 80° C. for 1 h. [1035]
  • The mixture is added dropwise with ice-cooling to about 2.01 of 1N hydrochloric acid, and the precipitate is then filtered and dried. [1036]
  • Yield: 22 g (100% of theory); m.p.: 197-199° C. [1037]
    • EXAMPLE I-7-b-1
  • [1038]
    Figure US20030096806A1-20030522-C00178
  • At about 0° C., 0.82 g of isovaleryl chloride in 3 ml of methylene chloride is added to a mixture of 2.0 g of the compound of Example I-7-a-1, 20 ml of methylene chloride and 0.8 g of triethylamine, and the mixture is stirred at room temperature for 2 h. Work-up and chromatography are carried out as described in Example I-2-b-1. [1039]
  • Yield: 2.1 g (86% of theory). [1040]
  • [1041] 1H-NMR (400 MHz; CDCl3): δ=0.8 (d, 2×3H, CH—CH 3), 1.2-1.8 (m, 10H, cyclohexyl-H); 1.95 (m, 1H, CH), 2.05, 2.15 (s, 2×3H, Ar—CH3), 2.3-2.4 (dd, 2H, CH 2CH); 6.9-7.5 (m, 6H, ArH) ppm.
    • EXAMPLE I-7-c-1
  • [1042]
    Figure US20030096806A1-20030522-C00179
  • At 0° C., 0.74 g of ethyl chloroformate in 3 ml of methylene chloride is added to a mixture of 2.0 g of the compound of Example I-7-a-1, 20 ml of methylene chloride and 0.8 g of triethylamine, and the mixture is stirred at room temperature for 2 h. Work-up and chromatography are carried out as described in Example I-2-b-1. [1043]
  • Yield: 1.75 g (74% of theory). [1044]
  • [1045] 1H-NMR (400 MHz; CDCl3): δ=1.2 (t, 3H, CH2—CH 3), 1.3-1.8 (m, 10H, cyclohexyl-H); 2.05, 2.15 (s, 2×3H, Ar—CH 3), 4.25 (q, 2H, CH2CH 3); 6.9-7.5 (m, 6H, ArH) ppm.
    • EXAMPLE I-8-a-1
  • [1046]
    Figure US20030096806A1-20030522-C00180
  • 1.44 g of potassium tert-butoxide are added to a mixture of 3.3 g of the compound of Example XI-1 in 15 ml of absolute dimethylformamide, and the mixture is stirred at 80° C. for 1 h. [1047]
  • Work-up is carried out according to Example I-7-a-1. [1048]
  • Yield: 2.7 g (89.5% of theory); m.p.: 172-175° C. [1049]
    • EXAMPLE I-8-a-2
  • [1050]
    Figure US20030096806A1-20030522-C00181
  • 3.9 g of potassium tert-butoxide are added to a mixture of 8.9 g of methyl 6-(4-(4-chlorophenyl)-2,5-dimethyl-phenyl)-3,3-dimethyl-5-oxo-hexanecarboxylate in 30 ml of absolute dimethylformamide, and the mixture is stirred at 80° C. for 1 h. [1051]
  • Work-up is carried out according to Example I-7-a-1. [1052]
  • Yield: 7.5 g (92% of theory); m.p.: 183-185° C. [1053]
    • EXAMPLE I-8-b-1
  • [1054]
    Figure US20030096806A1-20030522-C00182
  • At 0° C., 0.66 g of isovaleryl chloride in 2 ml of methylene chloride is added to a mixture of 1.5 g of the compound of Example I-8-a-2, 10 ml of methylene chloride and 0.64 g of triethylamine, and the mixture is stirred at room temperature for 2 h. Work-up and chromatography are carried out as described in Example I-2-b-1. [1055]
  • Yield: 1.7 g (92% of theory). [1056]
  • [1057] 1H-NMR (400 MHz; CDCl3): δ=0.6 (d, 2×3H, CH—(CH 3)2); 1.15 (s, 2×3H, C—(CH3)2); 1.65 (m, 1H, CH—(CH3)2); 2.05, 2.15 (s, 2×3H, Ar—CH3), 2.6-2.7 (m, 3×2H, CH2); 6.8-7.5 (m, 6H, ArH) ppm.
    • EXAMPLE I-8-c-1
  • [1058]
    Figure US20030096806A1-20030522-C00183
  • At 0° C., 0.60 g of ethyl chloroformate in 2 ml of methylene chloride is added to a mixture of 1.5 g of the compound of Example I-8-a-2, 20 ml of methylene chloride and 0.64 g of triethylamine, and the mixture is stirred at room temperature for 2 h. Work-up and chromatography are carried out as described in Example I-2-b-1. [1059]
  • Yield: 1.55 g (86% of theory). [1060]
  • [1061] 1H-NMR (400 MHz; CDCl3): δ=1.1 (t, 3H, CH2—CH 3); 1.15 (s, 2×3H, C—(CH3)2; 2.05, 2.15 (s, 2×3H, Ar—CH3), 2.45/2.7 (s, 2×2H, cyclohexyl-CH2); 4.1 (q, 2H, CH2CH3); 6.8-7.5 (m, 6H, ArH) ppm.
    • EXAMPLE II-1
  • [1062]
    Figure US20030096806A1-20030522-C00184
  • At about 5° C., 10 g of ground potassium carbonate are added to a mixture of 4.57 g of methyl 3-methyl-1-amino-cyclohexane-carboxylate×HCl in 20 ml of acetonitrile. Over a period of about 15 min, 5.86 g of 2,5-dimethyl-4-(4-chloro-phenyl)-phenylacetyl chloride in 10 ml of acetonitrile are added dropwise, and the mixture is stirred at room temperature for 3 hours. The reaction mixture is added to 200 ml of ice-water and seeded. [1063]
  • The precipitate is filtered off with suction, washed with water and taken up in methylene chloride, dried and concentrated. The residue is recrystallized from MTB ether/n-hexane. [1064]
  • Yield: 10.3 g (99% of theory), m.p. 112° C. [1065]
    • EXAMPLE II-2
  • [1066]
    Figure US20030096806A1-20030522-C00185
  • At about 30-40° C., 8.1 g [lacuna] of Example XXIX-1 in 100 ml of methylene chloride are added to 12 g of concentrated sulphuric acid, and the mixture is stirred at 30-40° C. for 2 hours. 15 ml of absolute methanol are then added dropwise such that an internal temperature of 40° C. results. Stirring is continued at 40-70° C. for a further 6 hours. [1067]
  • The solution is poured onto 200 g of ice and extracted with methylene chloride, and the extract is washed with a sodium bicarbonate solution. The extract is dried and concentrated. The residue is recrystallized from MTB ether/n-hexane. [1068]
  • Yield: 5 g (57% of theory); m.p.: 126° C. [1069]
  • The following compounds are obtained analogously to Example II-1 and II-2 and/or in accordance with the general procedures for preparing compounds of the formula II [1070]
    (II)
    Figure US20030096806A1-20030522-C00186
    Ex. No. W X Y Z B A D R8 m.p. ° C. Isomer
    II-3 H CH3 4-Cl—Ph* CH3 —(CH2)2—O—(CH2)2— H CH3 169 —
    II-4 H CH3 4-Cl—Ph* CH3 —(CH2)3—O—CH2— H CH3 108 —
    II-5 H CH3 4-Cl—Ph* CH3 —CH2—CHCH3—O—(CH2)2— H CH3 139 β
    II-6 H CH3 4-Cl—Ph* Cl —(CH2)2—CHOCH3—(CH2)2— H CH3 114 β
    II-7 H CH3 4-Cl—Ph* CH3 —(CH2)2—CHOC2H5—(CH2)2— H CH3 118 β
    II-8 H CH3 4-Cl—Ph* CH3 H —(CH2)4— C2H5 oil —
    II-9 H CH3 4-Cl—Ph* CH3 —(CH2)2—CHOCH3—(CH2)2— H CH3 142 β
     II-10 H CH3 4-Cl—Ph* CH3 —(CH2)2—CHCH3—(CH2)2— H CH3  76 β
     II-11 H CH3 4-Cl—Ph* CH3 H —(CH2)2—S—CH2— C2H5 oil —
    • EXAMPLE IV-1
  • [1071]
    Figure US20030096806A1-20030522-C00187
  • A: 9.63 g of thionyl chloride are added to a mixture of 15 g of 1-(4-methoxy-benzyl)-mercapto-cyclohexanecarboxylic acid in 100 ml of toluene and 1 drop of dimethylformamide, and the mixture is stirred at room temperature for 5 min. The mixture is then stirred at 100° C. until the evolution of gas has ceased. The mixture is concentrated. [1072]
  • B: At 0° C., 26.4 g of methyl 2,5-dimethyl-4(4-chlorophenyl)-phenylacetate in 30 ml of tetrahydrofuran are added to a mixture of 45.8 ml of lithium diisopropylamide (LDA) solution in 100 ml of tetrahydrofuran, and the mixture is stirred at 0° C. for 30 min. The acyl chloride A in 30 ml of tetrahydrofuran is then added dropwise at 0° C., and the mixture is stirred at room temperature for 1 h. 300 ml of MTB ether and a few drops of water are added. The mixture is washed twice with 10% ammonium chloride solution, dried and concentrated. [1073]
  • Yield: 42.1 g (100% of theory). [1074]
  • [1075] 1H-NMR (400 MHz; CDCl3): δ=3.2 (dd, 2H, SCH2); 3.6 (s, 2×3H, 2×OCH3); 6.7-7.5 (m, 10H, ArH) ppm.
    • EXAMPLE X-1
  • [1076]
    Figure US20030096806A1-20030522-C00188
  • 23.2 g of potassium carbonate and 71.7 g of methyl iodide are added to a mixture of 67.3 g of the compound of Example XXXVM-1 in 400 ml of acetone, and the mixture is stirred under reflux for 16 h. The reaction mixture is filtered and concentrated. The residue is purified by silica gel chromatography (mobile phase methylene chloride/petroleum ether 2:1, towards the end mobile phase 100% methylene chloride). [1077]
  • Yield: 20 g (40% of theory). [1078]
  • [1079] 1H-NMR (400 MHz; CDCl3): δ=2.1/2.15 (s, 2×3H, 2×Ar—CH3); 3.55 (s, 3H, OCH3); 7.35/7.5 (d, 2×2H, p-Cl-aromatic) ppm.
    • EXAMPLE XI-1
  • [1080]
    Figure US20030096806A1-20030522-C00189
  • 43.7 g of methyl iodide are added to a mixture of 38 g of the compound of Example XLII-1 in 250 ml of acetone and 14.1 g of potassium carbonate, and the mixture is stirred under reflux for 16 h. Work-up is carried out according to Example X-1. [1081]
  • Yield: 3.5 g (8.4% of theory). [1082]
  • [1083] 1H-NMR (400 MHz; CDCl3): δ=1.1 (s, 6H, 2×C—CH3); 2.15/2.20 (s, 2×3H, 2×ArCH3); 3.6 (s, 3H, OCH3); 7.35/7.5 (d, 2×2H, p-Cl aromatic) ppm.
    • EXAMPLE XXIX-1
  • [1084]
    Figure US20030096806A1-20030522-C00190
  • Over a period of 15 min, 8.79 g of 2,5-dimethyl-4-(chloro-phenyl)-phenylacetyl chloride in 15 ml of acetonitrile are added at 5-10° C. to a mixture of 3.7 g of 2-amino-2,3-dimethylbutyronitrile in 30 ml of acetonitrile and 13.8 g of ground potassium carbonate, and the mixture is stirred at room temperature for 3 h. [1085]
  • Work-up is carried out according to Example II-1. [1086]
  • Yield: 8.9 g (81% of theory); m.p.: 99° C. [1087]
    • EXAMPLE XXXII-1
  • [1088]
    Figure US20030096806A1-20030522-C00191
  • 98 ml of a 1M sodium carbonate solution are added to a mixture of 11.97 g of methyl 4-bromo-2,5-dimethyl-phenylacetate in 130 ml of dimethoxyethane. Furthermore, 9.15 g of 4-chlorophenylboranic acid and 0.275 g of bis-(triphenylphosphine)-palladium(II) chloride are added, and the mixture is stirred under reflux for 8 h. [1089]
  • The mixture is taken up in water and extracted with ethyl acetate, and the extract is washed with ammonium chloride, water and sodium chloride solution. The extract is dried and concentrated. The residue is purified by silica gel chromatography (mobile phase: petroleum ether/ethyl acetate 15/1). [1090]
  • Yield: 9 g (70% of rheory); m.p.: 38° C. [1091]
    • EXAMPLE XXXII-2
  • [1092]
    Figure US20030096806A1-20030522-C00192
  • 64 g of 88% pure potassium hydroxide in 1000 ml of methanol are added to 81 g of the compound of Example XLV-1. [1093]
  • The mixture is stirred under reflux for 8 h, then acidified at room temperature with 50 ml of concentrated sulphuric acid and stirred under reflux for 1 h. The solid is filtered off and washed with methanol. Purification is carried out by silica gel chromatography (mobile phase: petroleum ether/ethyl acetate 20/1). [1094]
  • Yield: 2 g (8% of theory). [1095]
    • EXAMPLE XXXVIII-1
  • [1096]
    Figure US20030096806A1-20030522-C00193
  • At −15° C., a solution of 54.06 g of methyl 2,5-dimethyl-4-(4-chlorophenyl)-phenylacetate in 80 ml of tetrahydrofuran is added dropwise to a solution of 100 ml of LDA in 200 ml of tetrahydrofaran, and the mixture is stirred at 0° C. for 1 h. [1097]
  • At −15° C., a solution of 17.04 g of 2,2-pentamethylenesuccinic anhydride in 30 ml of tetrahydrofuran is then added dropwise, and the mixture is stirred at room temperature for 2 h. 300 ml of water and 80 g of ammonium chloride are then added, and the mixture is acidified with hydrochloric acid. The mixture is extracted with diethyl ether and the extract is concentrated. The residue is heated under reflux with 200 g of potassium hydroxide in 660 ml of water for 2 days. [1098]
  • The mixture is cooled, acidified with concentrated hydrochloric acid and extracted with diethyl ether. The crude product is directly reacted further. [1099]
  • Yield: 67.3 g (100% of theory). [1100]
    • EXAMPLE XLII-1
  • [1101]
    Figure US20030096806A1-20030522-C00194
  • At −15° C., a solution of 32.4 g of methyl 2,5-dimethyl-4-(4-chlorophenyl)-phenylacetate in 40 ml of tetrahydrofuran is added dropwise to a solution of 60 ml of LDA in 120 ml of tetrahydrofuran, and the mixture is stirred at 0° C. for 1 h. [1102]
  • At −15° C., a solution of 10.3 g of 2,2-dimethylglutaric anhydride in 30 ml of tetrahydrofuran is then added dropwise, and the mixture is stirred at room temperature for 2 h. 180 ml of water and 48 g of ammonium chloride are then added, and the mixture is acidified with hydrochloric acid. The mixture is extracted with diethyl ether and the extract is concentrated. The residue is heated under reflux with 120 g of potassium hydroxide in 400 ml of water for 2 days. [1103]
  • The mixture is cooled, acidified with concentrated hydrochloric acid and extracted with diethyl ether. The crude product is directly reacted further. [1104]
  • Yield: 38.5 g (96% of theory). [1105]
    • EXAMPLE XXVII-1
  • [1106]
    Figure US20030096806A1-20030522-C00195
  • A solution of 0.54 g of 98% lithium hydroxide in 100 ml of water is added dropwise to a mixture of 6 g of the compound of Example XXXII-1 in 100 ml of tetra-hydrofuran. 25 ml of ethanol are added, and the mixture is stirred for 8 h. The mixture is concentrated, taken up in water and extracted with MTBE. [1107]
  • The mixture is then acidified using concentrated hydrochloric acid, and the precipitate is filtered off with suction and dried. [1108]
  • Yield: 5 g (96% of theory); m.p.: 153° C. [1109]
    • EXAMPLE XLV-1
  • [1110]
    Figure US20030096806A1-20030522-C00196
  • 20.5 g of isopentylnitrite in 60 ml of acetonitrile and 18 g of anhydrous copper(ll) chloride in 139 ml of dichloroethene are. [1111]
  • Added dropwise at about 30° C. to a mixture of 31 g of the compound of Example XLVI-I in acetonitrile, and the mixture is stirred at room temperature for 8 h. The mixture is taken up in 800 ml of ice-cooled 20% strength hydrochloric acid and extracted with MTBE, and the extract is dried and concentrated. [1112]
  • The crude product is reacted without any further purification. [1113]
  • Yield: 40 g (91% of theory) [1114]
    • EXAMPLE XLVI-1
  • [1115]
    Figure US20030096806A1-20030522-C00197
  • At room temperature, 48.8 ml of a 1N sodium carbonate solution are added to a mixture of 5 g of the amine compound shown above in 65 ml of dimethoxyethane. Furthermore, 4.57 g of 4-chlorophenylboronic acid and 0.11 g of bis-(triphenyl-phosphine)-palladium-(II) chloride are added, and the mixture is stirred under reflux for 8 h. The mixture is taken up in water and extracted with ethyl acetate, and the extract is washed with ammonium chloride solution, water and sodium chloride solution, dried and concentrated. The residue is purified by silica gel chromatography (mobile phase petroleum ether/ethyl acetate 3/1). [1116]
  • Yield: 4 g (82% of theory). [1117]
    • USE EXAMPLES EXAMPLE A
  • Phaedon Larvae Test [1118]
    Solvent: 7 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentration. [1119]
  • Cabbage leaves ([1120] Brassica oleracea) are treated by being dipped into the preparation of active compound of the desired concentration and are populated with mustard beetle larvae (Phaedon cochleariae) whilst the leaves are still moist.
  • After the desired period of time, the plants are populated with mustard beetle larvae ([1121] Phaedon cochleariae). In each case after 3 days, the kill in % is determined. 100% means that all beetle larvae have been killed; 0% means that none of the beetle larvae have been killed.
  • In this test, for example, the compound of Preparation Example (I-1-a-2) effected, at an exemplary active compound concentration of 1%, a kill of 90% after 7 days. [1122]
    • EXAMPLE B
  • Tetranychus Test (OP-Resistant/Dip Treatment) [1123]
    Solvent: 7 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentrations. Bean plants ([1124] Phaseolus vulgaris) which are heavily infested by all development stages of the greenhouse red spider mite or bean spider mite (Tetranychus urticae) are dipped into a preparation of active compound of the desired concentration.
  • After the desired period of time, the kill in % is determined. 100% means that all spider mites have been killed; 0% means that none of the spider mites have been killed. [1125]
  • In this test, for example, the compound of Preparation Example (I-1-a-2) had, at an exemplary active compound concentration of 0.1%, an effect of 95% after 13 days. [1126]

Claims (27)

1. Compounds of the formula (I)
Figure US20030096806A1-20030522-C00198
in which
X represents halogen, alkyl, alkoxy, alkenyloxy, alkylthio, alkyl-sulphinyl, alkylsulphonyl, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro, cyano or in each case optionally substituted phenyl, phenoxy, phenylthio, phenylalkoxy or phenylalkylthio,
Y represents in each case optionally substituted cycloalkyl, aryl or hetaryl,
W represents hydrogen, halogen, alkyl, alkoxy, alkenyloxy, halo-genoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro or cyano,
Z represents halogen, alkyl, alkoxy, alkenyloxy, halogenoalkyl, halogenoalkoxy, halogenoalkenyloxy, nitro or cyano,
CKE represents one of the groups
Figure US20030096806A1-20030522-C00199
 in which
A represents hydrogen, in each case optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, saturated or unsaturated, optionally substituted cycloalkyl in which optionally at least one ring atom is replaced by a heteroatom, or in each case optionally halogen-, alkyl-, halogenoalkyl-, alkoxy-, halogenoalkoxy-, cyano- or nitro-substituted aryl, arylalkyl or hetaryl,
B represents hydrogen, alkyl or alkoxyalkyl, or
A and B together with the carbon atom to which they are attached represent a saturated or unsaturated unsubstituted or substituted cycle which optionally contains at least one heteroatom,
D represents hydrogen or an optionally substituted radical selected from the series consisting of alkyl, alkenyl, alkinyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, saturated or unsaturated cycloalkyl in which one or more ring members are optionally replaced by heteroatoms, arylalkyl, aryl, hetarylalkyl or hetaryl or
A and D together with the atoms to which they are attached represent a saturated or unsaturated cycle which is unsubstituted or substituted in the A,D moiety and which optionally contains at least one (in the case where CKE=(4) further) heteroatom, or
A and Q1 together represent alkanediyl or alkenediyl, each of which is optionally substituted by in each case optionally substituted alkyl, hydroxyl, alkoxy, alkylthio, cycloalkyl, benzyloxy or aryl, or
Q1 represents hydrogen or alkyl,
Q2, Q4, Q5 and Q6 independently of one another each represent hydrogen or alkyl,
Q3 represents hydrogen, alkyl, alkoxyalkyl, alkylthioalkyl, optionally substituted cycloalkyl (in which optionally one methylene group is replaced by oxygen or sulphur) or optionally substituted phenyl, or
Q3 and Q4 together with the carbon atom to which they are attached represent a saturated or unsaturated unsubstituted or substituted cycle which optionally contains a heteroatom,
G represents hydrogen (a) or represents one of the groups
Figure US20030096806A1-20030522-C00200
 in which
E represents a metal ion equivalent or an ammonium ion,
L represents oxygen or sulphur,
M represents oxygen or sulphur,
R1 represents in each case optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, alkylthioalkyl, polyalkoxy-alkyl or optionally halogen-, alkyl- or alkoxy-substituted cycloalkyl which may be interrupted by at least one heteroatom, in each case optionally substituted phenyl, phenylalkyl, hetaryl, phenoxyalkyl or hetaryloxyalkyl,
R2 represents in each case optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl or represents in each case optionally substituted cycloalkyl, phenyl or benzyl,
R3, R4 and R5 independently of one another each represent in each case optionally halogen-substituted alky, alkoxy, alkylamino, dialkylamino, alkylthio, alkenylthio, cycloalkylthio and represent in each case optionally subsituted phenyl, benzyl, phenoxy or phenylthio,
R6 and R7 independently of one another each represent hydrogen, in each case optionally halogen-substituted alkyl, cycloalkyl, alkenyl, alkoxy, alkoxyalkyl, represent optionally substituted phenyl, represent optionally substituted benzyl, or together with the nitrogen atom to which they are attached represent a cycle which is optionally interrupted by oxygen or sulphur.
2. Compounds of the formula (I) according to claim 1 in which
X represents halogen, C1-C6-alkyl, C1-C6-halogenoalkyl, C1-C6-alkoxy, C3-C6-alkenyloxy, C1-C6-alkylthio, C1-C6-alkylsulphinyl, C1-C6-alkylsulphonyl, C1-C6-halogenoalkoxy, C3-C6-halogenoalkenyloxy, nitro, cyano or in each case optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenoxy, phenylthio, benzyloxy or benzylthio,
Y represents one of the radicals
Figure US20030096806A1-20030522-C00201
V1 represents hydrogen, halogen, C1-C12-alkyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-alkylsulphinyl, C1-C6-alkylsulphonyl, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, nitro, cyano or phenyl, phenoxy, phenoxy-C1-C4-alkyl, phenyl-C1-C4-alkoxy, phenylthio-C1-C4-alkyl or phenyl-C1-C4-alkylthio, each of which is optionally mono- or polysubstituted by halogen, C1-C6-alkyl, C1-C6-alkoxy, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, nitro or cyano.
V2 and V3 independently of one another each represent hydrogen, halogen, C1-C6-alkyl, C1-C6-alkoxy, C1-C4-halogenoalkyl or C1-C4-halogenoalkoxy.
W represents hydrogen, halogen, C1-C6-alkyl, C1-C6-halogenoalkyl, C1-C6-alkoxy, C1-C6-halogenoalkoxy, nitro or cyano.
Z represents halogen, C1-C6-alkyl, C1-C6-halogenoalkyl, C1-C6-alkoxy, C1-C6-halogenoalkoxy, nitro or cyano.
CKE represents one of the groups
Figure US20030096806A1-20030522-C00202
A represents hydrogen or in each case optionally halogen-substituted C1-C12-alkyl, C3-C8-alkenyl, C1-C10-alkoxy-C1-C8-alkyl, poly-C1-C8-alkoxy-C1-C8-alkyl, C1-C10-alkylthio-C1-C6-alkyl, optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl in which optionally one or two not directly adjacent ring members are replaced by oxygen and/or sulphur or represents in each case optionally halogen-, C1-C6-alkyl-, C1-C6-halogenoalkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkoxy-, cyano- or nitro-substituted C6- or C10-aryl (phenyl or naphthyl), hetaryl having 5 to 6 ring atoms (for example, furanyl, pyridyl, imidazolyl, triazolyl, pyrazolyl, pyrimidyl, thiazolyl or thienyl) or C6- or C10-aryl-C1-C6-alkyl (phenyl-C1-C6-alkyl or naphthyl-C1-C6-alkyi).
B represents hydrogen, C1-C12-alkyl or C1-C8-alkoxy-C1-C6-alkyl or
A, B and the carbon atom to which they are attached represent saturated C3-C10-cycloalkyl or unsaturated C5-C10-cycloalkyl in which in each case optionally one ring member is replaced by oxygen or sulphur and which are optionally mono- or disubstituted by C1-C8-alkyl, C3-C10-cycloalkyl, C1-C8-halogenoalkyl, C1-C8-alkoxy, C1-C8-alkylthio, halogen or phenyl or
A, B and the carbon atom to which they are attached represent C3-C6-cycloalkyl which is substituted by an alkylenedilyl group which optionally contains one or two not directly adjacent oxygen and/or sulphur atoms, or by an alkylenedioxyl group or by an alkylenedithioyl group which, together with, the carbon atom to which it is attached, forms a further five- to eight-membered ring, or
A, B and the carbon atom to which they are attached represent C3-C8-cycloalkyl or C5-C8-cycloalkenyl, in which two substituents together with the carbon atoms to which they are attached represent in each case optionally C1-C6-alkyl-, C1-C6-alkoxy- or halogen-substituted C2-C6-alkanediyl, C2-C6-alkenediyl or C4-C6-alkanedienediyl in which optionally one methylene group is replaced by oxygen or sulphur,
D represents hydrogen, in each case optionally halogen-substituted C1-C<2-alkyl, C3-C8-alkenyl, C3-C8-alkinyl, C1-C10-alkoxy-C2-C8-alkyl, poly-C1-C8-alkoxy-C2-C8-alkyl, C1-C10-alkylthio-C2-C8-alkyl, optionally halogen-, C1-C4-alkyl-, C1-C4-alkoxy- or C1-C4-halogenoalkyl-substituted C3-C8-cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur or in each case optionally halogen-, C1-C6-alkyl-, C1-C6-halogenoalkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkoxy-, cyano- or nitro-substituted phenyl, hetaryl having 5 or 6 ring atoms (for example furanyl, imidazolyl, pyridyl, thiazolyl, pyrazolyl, pyrimidyl, pyrrolyl, thienyl or triazolyl), phenyl-C1-C6-alkyl or hetaryl-C1-C6-alkyl having 5 or 6 ring atoms (for example furanyl, imidazolyl, pyridyl, thiazolyl, pyrazolyl, pyrimidyl, pyrrolyl, thienyl or triazolyl), or
A and D together represent in each case optionally substituted C3-C6-alkane-diyl or C3-C6-alkenediyl in which optionally one methylene group is replaced by oxygen or sulphur,
possible substituents in each case being:
halogen, hydroxyl, mercapto or in each case optionally halogen-substituted C1-C10-alkyl, C1-C6-alkoxy, C1-C6-alkylthio, C3-C7-cycloalkyl, phenyl or benzyloxy, or a further C3-C6-alkanediyl grouping, C3-C6-alkenediyl grouping or a butadienyl grouping which is optionally substituted by C1-C6-alkyl or in which optionally two adjacent substituents together with the carbon atoms to which they are attached form a further saturated or unsaturated cycle having 5 or 6 ring atoms (in the case of the compound of the formula (I-1), A and D, together with the atoms to which they are attached, then represent, for example, the groups AD-1 to AD-10 mentioned further below) which cycle may contain oxygen or sulphur, or which may optionally contain one of the groups below
Figure US20030096806A1-20030522-C00203
A and Q1 together represent C3-C6-alkanediyl or C4-C6-alkenediyl, each of which is optionally mono- or disubstituted by identical or different substituents selected from the group consisting of halogen, hydroxyl; C1-C10-alkyl, C1-C6-alkoxy, C1-C6alkylthio, C3-C7-cycloalkyl, each of which is optionally mono- to trisubstituted by identical or different halogens; and benzyloxy and phenyl, each of which is optionally mono- to trisubstituted by identical or different substituents selected from the group consisting of halogen, C1-C6-alkyl or C1-C6-alkoxy, and which furthermore optionally contains one of the groups below
Figure US20030096806A1-20030522-C00204
 or is bridged by a C1-C2-alkanediyl group or by an oxygen atom, or
Q1 represents hydrogen or C1-C4-alkyl,
Q2, Q4, Q5 and Q6 independently of one another each represent hydrogen or C1-C4-alkyl.
Q3 represents hydrogen, C1-C6-alkyl, C1-C6-alkoxy-C1-C2-alkyl, C1-C6-alkylthio-C1-C2-alkyl, optionally C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C8-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur or optionally halogen-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C2-halogenoalkyl-, C1-C2-halogenoalkoxy-, cyano- or nitro-substituted phenyl, or
Q3 and Q4 together with the carbon atom to which they are attached represent an optionally C1-C4-alkyl-, C1-C4-alkoxy- or C1-C4-alkoxy or C1-C2-halogenoalkyl-substituted C3-C7 ring in which optionally one ring member is replaced by oxygen or sulphur.
G represents hydrogen (a) or represents one of the groups
Figure US20030096806A1-20030522-C00205
 in which
E represents a metal ion or an ammonium ion,
L represents oxygen or sulphur and
M represents oxygen or sulphur.
R1 represents in each case optionally halogen-substituted C1-C20-alkyl, C2-C20-alkenyl, C1-C8-alkoxy-C1-C8-alkyl, C1-C8-alkylthio-C1-C8-alkyl, poly-C1-C8-alkoxy-C1-C8-alkyl or optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl in which optionally one or.more not directly adjacent ring members are replaced by oxygen and/or, sulphur,
represents optionally halogen-, cyano-, nitro-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl-, C1-C6-halogenoalkoxy-, C1-C6-alkylthio- or C1-C6-alkylsulphonyl-substituted phenyl,
represents optionally halogen-, nitro-, cyano-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl- or C1-C6-halogenoalkoxy-substituted phenyl-C1-C6-alkyl,
represents optionally halogen- or C1-C6-alkyl-substituted 5- or 6-membered hetaryl (for example pyrazolyl, thiazolyl, pyridyl, pyrimidyl, fiuranyl or thienyl), represents optionally halogen- or C1-C6-alkyl-substituted phenoxy-C1-C6-alkyl or
represents optionally halogen-, amino- or C1-C6-alkyl-substituted 5- or 6-membered-hetaryloxy-C1-C6-alkyl (for example pyridyloxy-C1-C6-alkyl, pyrimidyloxy-C1-C6-alkyl or thiazolyloxy-C1-C6-alkyl).
R2 represents in each case optionally halogen-substituted C1-C20-alkyl, C2-C20-alkenyl, C1-C8-alkoxy-C2-C8-alkyl, poly-C1-C8-alkoxy-C2-C8-alkyl,
represents optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl or
represents in each case optionally halogen-, cyano-, nitro-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl- or C1-C6-halogenoalkoxy-substituted phenyl or benzyl,
R3 represents optionally halogen-substituted C1-C8-alkyl or represents in each case optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, cyano- or nitro-substituted phenyl or benzyl.
R4 and R5 independently of one another each represent in each case optionally halogen-substituted C1-C8-alkyl, C1-C8-alkoxy, C1-C8-alkylamino, di-(C1-C8-alkyl)amino, C1-C8-alkylthio, C2-C8-alkenylthio, C3-C7-cycloalkylthio or represent in each case optionally halogen-, nitro-, cyano-, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, C1-C4-alkylthio-, C1-C4-halogenoalkylthio-, C1-C4-alkyl- or C1-C4-halogenoalkyl-substituted phenyl, phenoxy or phenylthio,
R6 and R7 independently of one another each represent hydrogen, represent in each case optionally halogen-substituted C1-CS-alkyl, C3-C8-cycloalkyl, C1-C8-alkoxy, C3-C8-alkenyl, C1-C8-alkoxy-C1-C8-alkyl, represent optionally halogen-, C1-CS-halogenoalkyl-, C1-C8-alkyl- or C1-C8-alkoxy-substituted phenyl, optionally halogen-, C1-C8-alkyl-, C1-C8-halogenoalkyl- or C1-C8-alkoxy-substituted benzyl or together represent an optionally C1-C4-alkyl-substituted C3-C6-alkylene radical in which optionally one carbon atom is replaced by oxygen or sulphur.
R13 represents hydrogen, represents in each case optionally halogen-substituted C1-C8-alkyl or C1-C8-alkoxy, represents optionally halogen-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C8-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or represents in each case optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenyl-C1-C4-alkyl or phenyl-C1-C4-alkoxy.
R14 represents hydrogen or C1-C8-alkyl, or
R13 and R14 together represent C4-C6-alkanediyl.
R15 and R16 are identical or different and each represent C1-C6-alkyl, or
R15 and R16 together represent a C2-C4-alkanediyl radical which is optionally substituted by C1-C6-alkyl, C1-C6-halogenoalkyl or by optionally halogen-, C1-C6-alkyl-, C1-C4-halogenoalkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl.
R17 and R18 independently of one another each represent hydrogen, represent optionally halogen-substituted C1-C8-alkyl or represent optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl, or
R17 and R18 together with the carbon atom to which they are attached represent a carbonyl group or represent optionally halogen-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C5-C7-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur.
R19 and R20 independently of one another each represent C1-C10-alkyl, C2-C10-alkenyl, C1-C10-alkoxy, C1-C10-alkylamino, C3-C10-alkenylamino, di-(C1-C10-alkyl)amino or di-(C3-C10-alkenyl)amino.
3. Compounds of the formula (I) according to claim 1 in which
X represents fluorine, chlorine, bromine, C1-C4-alkyl, C1-C4-alkoxy, C3-C4-alkenyloxy, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, C3-C4-halogenoalkenyloxy, nitro or cyano,
Y represents one of the radicals
Figure US20030096806A1-20030522-C00206
V1 represents hydrogen, fluorine, chlorine, bromine, C1-C6-alkyl, C1-C4-alkoxy, C1-C2-halogenoalkyl, C1-C2-halogenoalkoxy, nitro, cyano or phenyl, phenoxy, phenoxy-C1-C2-alkyl, phenyl-C1-C2-alkoxy, phenylthio-C1-C2-alkyl or phenyl-C1-C2-alkylthio, each of which is optionally mono- or disubstituted by fluorine, chlorine, bromine, C1-C4-alkyl, C1-C4-alkoxy, C1-C2-halogenoalkyl, C1-C2-halogenoalkoxy, nitro or cyano.
V2 and V3 independently of one another each represent hydrogen, fluorine, chlorine, bromine, C1-C4-alkyl, C1-C4-alkoxy, C1-C2-halogenoalkyl or C1-C2-halogenoalkoxy,
W represents hydrogen, fluorine, chlorine, bromine, C1-C4-alkyl, C1-C4-halogenoalkyl, C1-C4-alkoxy or C1-C4-halogenoalkoxy.
Z represents fluorine, chlorine, bromine, C1-C4-alkyl, C1-C4-halogenoalkyl, C1-C4-alkoxy or C1-C4-halogenoalkoxy,
CKE represents one of the groups
Figure US20030096806A1-20030522-C00207
A represents hydrogen, in each case optionally fluorine- or chlorine-substituted C1-C10-alkyl, C1-C8-alkoxy-C1-C6-alkyl, optionally fluorine-, chlorine-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C7-cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-5), (I-7) and (I-8)) in each case optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-halogenoalkyl-, C1-C4-alkoxy- or C1-C4-halogenoalkoxy-substituted phenyl, furanyl, pyridyl, imidazolyl, triazolyl, pyrazolyl, pyrimidyl, thiazolyl, thienyl or phenyl-C1-C4-alkyl.
B represents hydrogen or C1-C6-alkyl, or
A, B and the carbon atom to which they are attached represent saturated or unsaturated C5-C7-cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur and which is optionally monosubstituted by C1-C6-alkyl, C5-C8-cycloalkyl, C1-C3-halogenoalkyl, C1-C6-alkoxy, fluorine, chlorine or phenyl, or
A, B and the carbon atom to which they are attached represent C5-C6-cycloalkyl which is substituted by an alkylenediyl group which optionally contains one or two not directly adjacent oxygen or sulphur atoms or by an alkylenedioxyl group or by an alkylenedithiol group which, together with the carbon atom to which it is attached, forms a further five- or six-membered ring, or
A, B and the carbon atom to which they are attached represents C3-C6-cycloalkyl or C5-C6-cycloalkenyl in which two substituents together with the carbon atoms to which they are attached represent in each case optionally C1-C5-alkyl-, C1-C5-alkoxy-, fluorine-, chlorine- or bromine-substituted C2-C4-alkanediyl, C2-C4-alkenediyl, in which optionally one methylene group is replaced by oxygen or sulphur, or butadienediyl.
D represents hydrogen, represents in each case optionally fluorine- or chlorine-substituted C1-C10-alkyl, C3-C6-alkenyl, C1-C8-alkoxy-C2-C6-alkyl or C1-C8-alkylthio-C2-C6-alkyl, represents optionally fluorine-, chlorine-, C1-C4-alkyl-, C1-C4-alkoxy- or C1-C2-halogenoalkyl-substituted C3-C7-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-1) and (I-4)) represents in each case optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-halogenoalkyl-, C1-C4-alkoxy- or C1-C4-halogenoalkoxy-substituted phenyl, furanyt, imidazolyl, pyridyl, thiazolyl, pyrazolyl, pyrimidyl, pyrrolyl, thienyl, triazolyl or phenyl-C1-C4-alkyl, or
A and D together represent optionally substituted C3-C5-alkanediyl in which one methylene group may be replaced by a carbonyl group, oxygen or sulphur, possible substituents being hydroxyl, C1-C6-alkyl or C1-C4-alkoxy, or
A and D (in the case of the compounds of the formula (I-1)) together with the atoms to which they are attached represent one of the groups AD-1 to AD-10:
Figure US20030096806A1-20030522-C00208
A and Q1 together represent C3-C4-alkanediyl or C3-C4-alkenediyl, each of which is optionally mono- or disubstituted by identical or different substituents selected from the group consisting of fluorine, chlorine, hydroxyl, and C1-C8-alkyl and C1-C4-alkoxy, each of which is optionally mono- to trisubstituted by fluorine, or Q1 represents hydrogen.
Q2 represents hydrogen.
Q4, Q5 and Q6 independently of one another each represent hydrogen or C1-C3-alkyl.
Q3 represents hydrogen, C1-C4-alkyl, C1-C4-alkoxy-C1-C2-alkyl, C1-C4-alkylthio-C1-C2-alkyl or optionally methyl- or methoxy-substituted C3-C6-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or
Q3 and Q4 together with the carbon atom to which they are attached represent an optionally C1-C4-alkyl- or C1-C4-alkoxy-substituted saturated C5-C6 ring in which optionally one ring member is replaced by oxygen or sulphur.
G represents hydrogen (a) or represents one of the groups
Figure US20030096806A1-20030522-C00209
 in which
E represents a metal ion or an ammonium ion,
L represents oxygen or sulphur and
M represents oxygen or sulphur.
R1 represents in each case optionally fluorine- or chlorine-substituted C1-C16-alkyl, C2-C16-alkenyl, C1-C6-alkoxy-C1-C6-alkyl, C1-C6-alkylthio-C1-C6-alkyl, poly-C1-C6-alkoxy-C1-C6-alkyl or optionally fluorine-, chlorine-, C1-C5-alkyl- or C1-C5-alkoxy-substituted C3-C7-cycloalkyl in which optionally one or two not directly adjacent ring members are replaced by oxygen and/or sulphur, i
represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl-, C1-C3-halogenoalkoxy-, C1-C4-alkylthio- or C1-C4-alkylsulphonyl-substituted phenyl,
represents optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl- or C1-C3-halogenoalkoxy-substituted phenyl-C1-C4-alkyl,
represents in each case optionally fluorine-, chlorine-, bromine- or C1-C4-alkyl-substituted pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl or thienyl,
represents optionally fluorine-, chlorine-, bromine- or C1-C4-alkyl-substituted phenoxy-C1-C3-alkyl or represents in each case optionally fluorine-, chlorine-, bromine-, amino- or C1-C4-alkyl-substituted pyridyloxy-C1-C3-alkyl, pyrimidyloxy-C1-C3-alkyl or thiazolyloxy-C1-C3-alkyl.
R2 represents in each case optionally fluorine-substituted C1-C16-alkyl, C2-C16-alkenyl, C1-C6-alkoxy-C2-C6-alkyl or poly-C1-C6-alkoxy-C2-C6-alkyl,
represents optionally fluorine-, chlorine-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C7-cycloalkyl or represents in each case optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C1-C4-alkyl-, C1-C3-alkoxy-, C1-C3-halogenoalkyl- or C1-C3-halogenoalkoxy-substituted phenyl or benzyl;.
R3 represents optionally fluorine-substituted C1-C6-alkyl or represents in each case optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl-, C1-C3-halogenoalkoxy-, cyano- or nitro-substituted phenyl or benzyl,
R4 and R5 independently of one another each represent C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylamino, di-(C1-C6-alkyl)amino, C1-C6-alkylthio, C3-C4-alkenylthio, C3-C6-cycloalkylthio or represent in each case optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, C1-C3-alkoxy-, C1-C3-halogenoalkoxy-, C1-C3-alkylthio-, C1-C3-halogenoalkylthio-, C1-C3-alkyl- or C1-C3-halogenoalkyl-substituted phenyl, phenoxy or phenylthio.,
R6 and R7 independently of one another each represent hydrogen, C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C3-C6-alkenyl, C1-C6-alkoxy-C1-C6-alkyl, represent optionally fluorine-, chlorine-, bromine-, C1-C3-halogenoalkyl-, C1-C4-alkyl- or C1-C4-alkoxy-substituted phenyl, represent optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C3-halogenoalkyl- or C1-C4-alkoxy-substituted benzyl, or together represent an optionally methyl- or ethyl-substituted C4-C5-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
4. Compounds of the formula (I) according to claim 1 in which
X represents fluorine, chlorine, methyl, ethyl, propyl, iso-propyl, methoxy, etboxy, propoxy, iso-propoxy, allyloxy, methallyloxy, trifluoromethyl, difluoromethoxy, trifluoromethoxy, nitro or cyano.
Y represents one of the radicals
Figure US20030096806A1-20030522-C00210
V1 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, trifluoromethyl, trifluoromethoxy, nitro, cyano or phenyl which is optionally monosubstituted by fluorine, chlorine, methyl, methoxy, trifluoromethyl or trifluoromethoxy.
V2 and V3 independently of one another each represent hydrogen, fluorine, chlorine, methyl, ethyl, n-propyl, iso-propyl, methoxy, ethoxy, trifluoromethyl or trifluoromethoxy.
W represents hydrogen, fluorine, chlorine, methyl, ethyl, n-propyl, methoxy, ethoxy or n-propoxy,
Z represents fluorine, chlorine, methyl, ethyl, n-propyl, methoxy, ethoxy or propoxy.
CKE represents one of the groups
Figure US20030096806A1-20030522-C00211
A represents hydrogen, in each case optionally fluorine-substituted C1-C8-alkyl or C1-C6-alkoxy-C1-C4-alkyl, optionally fluorine-, methyl-, ethyl- or methoxy-substituted C3-C6-cycloalkyl in which optionally one ring member is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-5), (I-7) and (I-8)) represents in each case optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substituted phenyl or benzyl,
B represents hydrogen or C1-C4-alkyl, or
A, B and the carbon atom to which they are attached represent saturated C5-C6-cycloalkyl or C5-C6-cycloalkenyl in which optionally one ring member is replaced by oxygen or sulphur and which is optionally monosubstituted by methyl, ethyl, propyl, isopropyl, butyl, iso-butyl, sec-butyl, tert-butyl, trifluoromethyl, methoxy, ethoxy, n-propoxy, iso-propoxy, butoxy, iso-butoxy, sec-butoxy, tert-butoxy, fluorine or chlorine, or
A, B and the carbon atom to which they are attached represent C5-C6-cycloalkyl or C5-C6-cycloalkenyl in which two substituents together with the carbon atoms to which they are attached represent C2-C4-alkanediyl or C2-C4-alkenediyl in which in each case optionally one methylene group is replaced by oxygen or sulphur, or, butadienediyt.
D represents hydrogen, represents in each case optionally fluorine- or chlorine-substituted C1-C8-alkyl, C3-C4-alkenyl, C1-C6-alkoxy-C2-C4-alkyl, C1-C4-alkylthio-C2-C4-alkyl or C3-C6-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur or (but not in the case of the compounds of the formulae (I-1) and (I-4)) represents in each case optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted phenyl, furanyl, pyridyl, thienyl or benzyl,
or
A and D together represent optionally substituted C3-C4-alkanediyl in which optionally one carbon atom is replaced by sulphur and which is optionally substituted by hydroxyl, methyl, ethyl, methoxy or ethoxy, or
A and D (in the case of the compounds of the formula (I-1)) together with the atoms to which they are attached represent one of the following groups AD:
Figure US20030096806A1-20030522-C00212
A and Q1 together represent C3-C4-alkanediyl or butenediyl, each of which is optionally mono- or disubstituted by fluorine, hydroxyl, methyl or methoxy, or
Q1 represents hydrogen,
Q2 represents hydrogen.
Q4, Q5 and Q6 independently of one another each represent hydrogen, methyl or ethyl,
Q3 represents hydrogen, methyl, ethyl or C3-C6-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or
Q3 and Q4 together with the carbon atom to which they are attached represent an optionally methyl- or methoxy-substituted saturated C5-C6 ring in which optionally one ring member is replaced by oxygen or sulphur.
G represents hydrogen (a) or represents one of the groups
Figure US20030096806A1-20030522-C00213
 in which
E represents a metal ion or an ammonium ion,
L represents oxygen or sulphur and
M represents oxygen or sulphur.
R1 represents in each case optionally fluorine- or chlorine-substituted C1-C14-alkyl, C2-C14-alkenyl, C1-C4-alkoxy-C1-C6-alkyl, C1-C4-alkylthio-C1-C6-alkyl, poly-C1-C4-alkoxy-C1-C4-alkyl or optionally fluorine-, chlorine-, methyl-, ethyl-, propyl-, i-propyl-, butyl-, i-butyl-, tert-butyl-, methoxy-, ethoxy-, n-propoxy- or iso-propoxy-substituted C3-C6-cycloalkyl in which optionally one or two not directly adjacent ring members are replaced by oxygen and/or sulphur,
represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, etboxy-, trifluoromethyl-, trifluoromethoxy-, methylthio-, ethylthio-, methylsulphonyl- or ethylsulphonyl-substituted phenyl,
represents optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoro-methoxy-substituted benzyl,
represents in each case optionally fluorine-, chlorine-, bromine-, methyl- or ethyl-substituted fuiranyl, thienyl, pyridyl, pyrimidyl, thiazolyl or pyrazolyl,
represents optionally fluorine-, chlorine, methyl- or ethyl-substituted phenoxy-C1-C2-alkyl or
represents in each case optionally fluorine-, chlorine-, amino-, methyl- or ethyl-substituted pyridyloxy-C1-C2-alkyl, pyrimidyloxy-C1-C2-alkyl or thiazolyloxy-C1-C2-alkyl.
R2 represents in each case optionally fluorine-substituted C1-C14-alkyl, C2-C14-alkenyl, C1-C4-alkoxy-C2-C6-alkyl or poly-C1-C4-alkoxy-C2-C6-alkyl,
represents optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, iso-propyl- or methoxy-substituted C3-C6-cycloalkyl,
or represents in each case optionally fluorine-, chlorine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted phenyl or benzyl.
R3 represents in each case optionally fluorine-substituted methyl, ethyl, n-propyl, isopropyl or in each case optionally fluorine-, chlorine-, bromine-, methyl-, tert-butyl-, methoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substitued phenyl or benzyl,
R4 and R5 independently of one another each represent C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylamino, di-(C1-C4-alkyl)amino, C1-C4-alkylthio or represent in each case optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, C1-C2-alkoxy-, C1-C2-fluoroalkoxy-, C1-C2-alkylthio-, C1-C2-fluoroalkylthio- or C1-C3-alkyl-substituted phenyl, phenoxy or phenylthiQ.
R6 and R7 independently of one another each represent hydrogen, represent C1-C4-alkyl, C3-C6-cycloalkyl, C1-C4-alkoxy, C3-C4-alkenyl, C1-C4-alkoxy-C1-C4-alkyl, represent optionally fluorine-, chlorine-, bromine-, trifluoromethyl-, methyl- or methoxy-substituted phenyl, represent optionally fluorine-, chlorine-, bromine-, methyl-, trifluoromethyl- or methoxy-substituted benzyl, or together represent a C5-C6-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
5. Process for preparing compounds of the formula (I) according to claim 1, characterized in that
(A) Compounds of the formula (I-1-a)
Figure US20030096806A1-20030522-C00214
 in which
A, B, D, WI X, Y and Z are each as defined in claim 1
 are obtained by the intramolecular condensation of
N-acylamino acid esters of the formula (II)
Figure US20030096806A1-20030522-C00215
 in which
A, B, D, W, X, Y and Z are each as defined above,
and
R8 represents alkyl,
 in the presence of a diluent and in the presence of a base,
(B) Compounds of the formula (I-2-a)
Figure US20030096806A1-20030522-C00216
 in which
A, B, W, X, Y and Z are each as defined above,
 are obtained by the intramolecular condensation of
carboxylic esters of the formula (1E)
Figure US20030096806A1-20030522-C00217
 in which
A, B, X, Y, Z and R8 are each as defined above,
 in the presence of a diluent and in the presence of a base,
(C) Compounds of the formula (I-3-a)
Figure US20030096806A1-20030522-C00218
 in which
A, B, W, X, Y and Z are each as defined above,
 are obtained by the intramolecular cyclization of
β-ketocarboxylic esters of the formula (IV)
Figure US20030096806A1-20030522-C00219
 in which
A, B, X, Y, Z and R8 are each as defined above and
W represents hydrogen, halogen, alkyl or alkoxy,
 if appropriate in the presence of a diluent and in the presence of an acid,
(D) Compounds of the formula (I-4-a)
Figure US20030096806A1-20030522-C00220
 in which
A, D, W, X, Y and Z are each as defined above,
 are obtained by reacting
(α) halogenocarbonyl ketenes of the formula (V)
Figure US20030096806A1-20030522-C00221
 in which
W, X, Y and Z are each as defined above
and
Hal represents halogen,
 or by reacting
(β) malonic acid derivatives of the formula (VI)
Figure US20030096806A1-20030522-C00222
 in which
R8, W, X, Y and Z are each as defined above,
 with hydrazines of the formula (VII)
A—NH—NH-D  (VII)
 in which
A and D are each as defined above,
 if appropriate in the presence of a diluent and if appropriate in the presence of a base,
(E) Compounds of the formula (I-5-a)
Figure US20030096806A1-20030522-C00223
 in which
A, D, W, X, Y and Z are each as defined above,
 are obtained by reacting
 carbonyl compounds of the formula (VIII)
Figure US20030096806A1-20030522-C00224
 in which
A and D are each as defined above,
 or their silyl enol ethers of the formula (VIlla)
Figure US20030096806A1-20030522-C00225
 in which
A, D and R8 are each as defined above,
 with ketene acid halides of the formula (V)
Figure US20030096806A1-20030522-C00226
 in which
W, X, Y and Z are each as defined above and
Hal represents halogen,
 if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor,
(F) Compounds of the formula (I-6-a)
Figure US20030096806A1-20030522-C00227
 in which
A, W, X, Y and Z are each as defined above,
 are obtained by reacting thioamides of the formula (IX)
Figure US20030096806A1-20030522-C00228
 in which
A is as defined above,
 with ketene acid halides of the formula (V)
Figure US20030096806A1-20030522-C00229
 in which
Hal, W, X, Y and Z are each as defined above,
 if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor,
(G) Compounds of the formula (I-7-a)
Figure US20030096806A1-20030522-C00230
 in which
A, B, Q1, Q2, W. X, Y and Z are each as defined in claim 1
 are obtained by intramolecular cyclization of
ketocarboxylic esters of the formula (X)
Figure US20030096806A1-20030522-C00231
 in which
A, B, Q1, Q2, W, X, Y and Z are each as defined above and
R8 represents alkyl,
 if appropriate in the presence of a diluent and in the presence of a base,
(H) Compounds of the formula (I-8-a)
Figure US20030096806A1-20030522-C00232
 in which
A, B, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined in claim 1
 are obtained by intramolecular condensation of
6-aryl-5-keto-hexanoic esters of the formula (XI)
Figure US20030096806A1-20030522-C00233
 in which
A, B, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined above
and
R8 represents alkyl,
 in the presence of a diluent and in the presence of a base,
(I) Compounds of the formulae (I-8-a) shown above in which A, B, D, Q1, Q2, Q3, Q4, Q5, Q6, X, Y and Z are each as defined above are obtained by reacting compounds of the formulae (I-1′-a) to (I-8′-a),
Figure US20030096806A1-20030522-C00234
 in which
A, B, D, Q1, Q2, Q3, Q4, Q5, Q6, W, X and Z are each as defined above and
Y′ represents chlorine, bromine or iodine
 with boronic acids of the formula (XII)
Figure US20030096806A1-20030522-C00235
 in which
Y is as defined above,
 in the presence of a solvent, a base and a catalyst and subsequently reacting the resulting compounds of the formulae (I-1-a) to (I-8-a) in each case
(Jα) with acyl halides of the formula (Xffl)
Figure US20030096806A1-20030522-C00236
 in which
R1 is as defined in claim 1 and
Hal represents halogen
or
(β) with carboxylic anhydrides of the formula (XIV)
R1-CO—O—CO—R1  (XIV)
 in which
R1 is as defined above,
 if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder, or in each case
(K) with chloroformic esters or chloroformic thioesters of the formula (XV)
R2—M—CO—Cl  (XV)
 in which
R2 and M are each as defined in claim 1,
 if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder, or in each case
(L) with chloromonothioformic esters or chloroditbiofoimic esters of the formula (XVI)
Figure US20030096806A1-20030522-C00237
 in which
M and R2 are each as defined above,
 if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder, or in each case
(M) with sulphonyl chlorides of the formula (XVII)
R3—SO2—Cl  (XVH)
 in which
R3 is as defined in claim 1,
 if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder, or in each case
(N) with phosphorus compounds of the formula (XVIII)
Figure US20030096806A1-20030522-C00238
 in which
L, R4 and R5 are each as defined in claim 1 and
Hal represents halogen,
 if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder, or in each case
(L) with metal compounds or amines of the formulae (XIX) or (XX)
Me(OR10)t  (XIX)
Figure US20030096806A1-20030522-C00239
 in which
Me represents a mono- or divalent metal,
t represents the number 1 or 2 and
R10, R11, R12 independently of one another each represent hydrogen or alkyl,
 if appropriate in the presence of a diluent, or in each case
(Pα) with isocyanates or isothiocyanates of the formula (XXI)
R6—N═C=L  (XXI)
 in which
R6 and L are each as defined in claim 1,
 if appropriate in the presence of a diluent and if appropriate in the presence of a catalyst, or in each case
(β) with carbamoyl chlorides or thiocarbamoyl chlorides of the formula (XXII)
Figure US20030096806A1-20030522-C00240
 in which
L, R6 and R7 are each as defined in claim 1,
 if appropriate in the presence of a diluent and if appropriate in the presence of an acid binder.
6. Compounds of the formula (II)
Figure US20030096806A1-20030522-C00241
in which
A, B, D, W, X, Y and Z are each as defined in claim 1 and
R8 represents alkyl.
7. Compounds of the formula (XXIV)
Figure US20030096806A1-20030522-C00242
in which
W, X, Y and Z are each as defined in claim 1 and
Hal represents chlorine or bromine.
8. Compounds of the formula (XXV)
Figure US20030096806A1-20030522-C00243
in which
A, B, D, W, X, Y and Z are each as defined in claim 1.
9. Compounds of the formula (XXIX)
Figure US20030096806A1-20030522-C00244
in which
A, B, D, W, X, Y and Z are each as defined in claim 1.
10. Compounds of the formula (m)
Figure US20030096806A1-20030522-C00245
in which
A, B, W, X, Y and Z are each as defined above and
R8 represents lkyl.
11. Compounds of the formula (XXVI)
Figure US20030096806A1-20030522-C00246
in which
W, X, Y and Z are each as defined in claim 1.
12. Compounds of the formula (XXXII)
Figure US20030096806A1-20030522-C00247
in which
W, X, Y and Z are each as defined in claim 1 and
R8 represents alkyl.
13. Compounds of the formula (XXVII-b)
Figure US20030096806A1-20030522-C00248
in which
W, X and Z are each as defined in claim 1.
14. Compounds of the formula (IV)
Figure US20030096806A1-20030522-C00249
in which
A, B, W, W1, X, Y and Z are each as defined in claim 1 and
R8 represents alkyl.
15. Compounds of the formula (V)
Figure US20030096806A1-20030522-C00250
in which
W, X, Y and Z are each as defined in claim 1 and
Hal represents chlorine or bromine.
16. Compounds of the formula (XXXVII)
Figure US20030096806A1-20030522-C00251
in which
W, X, Y and Z are each as defined in claim 1.
17. Compounds of the formula (VI)
Figure US20030096806A1-20030522-C00252
in which
W, X, Y and Z are each as defined in claim 1 and
R8 represents alkyl.
18. Compounds of the formula (X)
Figure US20030096806A1-20030522-C00253
in which
A, B, Q1, Q2, W, X, Y and Z are each as defined in claim 1 and
R8 represents alkyl.
19. Compounds of the formula (XXXVIII)
Figure US20030096806A1-20030522-C00254
in which
W, X, Y, Z, A, B, Q1 and Q2 are each as defined in claim 1.
20. Compounds of the formula (XXXIX)
Figure US20030096806A1-20030522-C00255
in which
A, B, D1, D2, W, X, Y and Z are each as defined in claim 1 and
R8 and R8′ each represent alkyl.
21. Compounds of the formula (XI)
Figure US20030096806A1-20030522-C00256
in which
A, B, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined in claim 1 and
R8 represents alkyl.
22. Compounds of the formula (XLII)
Figure US20030096806A1-20030522-C00257
in which
A, B, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined in claim 1.
23. Compounds of the formula (XLIII)
Figure US20030096806A1-20030522-C00258
in which
A, B, Q3, Q4, Q5, Q6, W, X, Y and Z are each as defined in claim 1 and
R8 and R8 each represent alky.
24. Pesticides and/or herbicides, characterized in that they contain at least one compound of the formula (If according to claim 1.
25. The use of compounds of the formula (I) according to claim 1 for controlling pests in crop protection, in the domestic sector, in the hygiene sector and in the protection of stored products.
26. Method for controlling pests in crop protection, in the domestic sector, in the hygiene sector and in the protection of stored products, characterized in that compounds of the formula (I) according to claim 1 are allowed to act on the pests and/or their habitat.
27. Method for preparing pesticides and/or herbicides) characterized in that compounds of the formula (I) according to claim 1 are mixed with extenders and/or surfactants.
US10/192,361 1998-04-27 2002-07-10 Arylphenyl-substituted cyclic ketoenols Abandoned US20030096806A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/192,361 US20030096806A1 (en) 1998-04-27 2002-07-10 Arylphenyl-substituted cyclic ketoenols

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19818732.7 1998-04-27
DE19818732A DE19818732A1 (en) 1998-04-27 1998-04-27 New aryl substituted cyclic ketoenol compounds useful for control of insects and as herbicides
US09/673,907 US6451843B1 (en) 1998-04-27 1999-04-14 Arylphenyl-substituted cyclic keto enols
US10/192,361 US20030096806A1 (en) 1998-04-27 2002-07-10 Arylphenyl-substituted cyclic ketoenols

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09/673,907 Division US6451843B1 (en) 1998-04-27 1999-04-14 Arylphenyl-substituted cyclic keto enols
PCT/EP1999/002488 Division WO1999055673A1 (en) 1998-04-27 1999-04-14 Arylphenyl-substituted cyclic keto enols

Publications (1)

Publication Number Publication Date
US20030096806A1 true US20030096806A1 (en) 2003-05-22

Family

ID=7865908

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/673,907 Expired - Fee Related US6451843B1 (en) 1998-04-27 1999-04-14 Arylphenyl-substituted cyclic keto enols
US10/192,361 Abandoned US20030096806A1 (en) 1998-04-27 2002-07-10 Arylphenyl-substituted cyclic ketoenols

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/673,907 Expired - Fee Related US6451843B1 (en) 1998-04-27 1999-04-14 Arylphenyl-substituted cyclic keto enols

Country Status (7)

Country Link
US (2) US6451843B1 (en)
EP (1) EP1075465A1 (en)
JP (1) JP2002513002A (en)
AU (1) AU3421599A (en)
BR (1) BR9910034A (en)
DE (1) DE19818732A1 (en)
WO (1) WO1999055673A1 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148999A1 (en) * 2000-06-29 2003-08-07 Reiner Fischer Combinations of active ingredients, which exhibit insecticidal and acaricidal properties
US20040161757A1 (en) * 2000-12-14 2004-08-19 Reiner Fischer Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect
US20050054535A1 (en) * 2001-08-10 2005-03-10 Reiner Fischer Selective herbicides based on substituted cyclic keto-enols and safeners
US20050090400A1 (en) * 2001-11-29 2005-04-28 Reiner Fischer 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
US20060160847A1 (en) * 2003-01-20 2006-07-20 Reiner Fischer 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives
US20070032539A1 (en) * 2002-07-11 2007-02-08 Thomas Himmler Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides
US7183238B2 (en) 2001-12-06 2007-02-27 Bayer Cropscience Ag [1,2]-oxazine-3,5-diones
US20070093391A1 (en) * 2003-08-14 2007-04-26 Reiner Fischer 4-Biphenyl-substituted pyrazolidin-3 5-diones pesticide agent and/or microbicide and/or herbicide
US20070142463A1 (en) * 2003-07-08 2007-06-21 Reiner Fischer Active agents combination exhibiting insecticidal and acaricide properties
US20070275858A1 (en) * 2002-08-28 2007-11-29 Reiner Fischer Substituted spirocyclic ketoenols
US20070298968A1 (en) * 2004-03-25 2007-12-27 Bayer Cropscience Ag 2,4,6-Phenyl-Substituted Cyclic Ketoenols
US20090029858A1 (en) * 2004-06-25 2009-01-29 Bayer Cropscience Aktiengesellschaft Spirocyclic 3'-Alkoxytetramic Acids and -Tetronic Acids
US20090209513A1 (en) * 2005-12-13 2009-08-20 Bayer Cropscience Ag Insecticidal Compositions Having Improved Effect
US7888285B2 (en) 2003-03-14 2011-02-15 Bayer Cropscience Ag 2,4,6-phenyl substituted cyclic ketoenols
US8202875B2 (en) 2004-07-20 2012-06-19 Bayer Cropscience Ag Selective insecticides based on substituted cyclic ketoenols and safeners
US8629084B2 (en) 2004-09-16 2014-01-14 Bayer Cropscience Ag Iodine-phenyl-substituted cyclic cetoenols
US8710238B2 (en) 2011-03-11 2014-04-29 Bayer Intellectual Property Gmbh Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives
US8859782B2 (en) 2011-01-25 2014-10-14 Bayer Cropscience Ag Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives
US8946124B2 (en) 2011-02-17 2015-02-03 Bayer Intellectual Property Gmbh Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy and halogen-substituted spirocyclic ketoenols
US9101133B2 (en) 2010-11-02 2015-08-11 Bayer Intellectual Property Gmbh Phenyl-substituted bicyclooctane-1,3-dione-derivatives
US9204640B2 (en) 2011-03-01 2015-12-08 Bayer Intellectual Property Gmbh 2-acyloxy-pyrrolin-4-ones

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19935963A1 (en) 1999-07-30 2001-02-01 Bayer Ag Biphenyl substituted cyclic ketoenols
DE10007411A1 (en) * 2000-02-18 2001-08-23 Bayer Ag Active ingredient combinations with insecticidal and acaricidal properties
DE10013914A1 (en) 2000-03-21 2001-09-27 Bayer Ag Synergistic pesticidal composition comprising 4-hydroxy-3-phenyl-furan-2(5H)-one derivative and bifenazate, abamectin or bifenthrin, are useful as insecticide, acaricide, ectoparasiticide or antifouling agents
DE10015310A1 (en) * 2000-03-28 2001-10-04 Bayer Ag Active ingredient combinations with insecticidal and acaricidal properties
DE10016544A1 (en) 2000-04-03 2001-10-11 Bayer Ag New phenyl-substituted cyclic keto-enol compounds useful e.g. as insecticides, acaricides, nematocides, acaricides, herbicides, ectoparasiticides, antifouling agents or intermediates
DE10017881A1 (en) * 2000-04-11 2001-10-25 Bayer Ag Active ingredient combinations with insecticidal and acaricidal properties
DE10018370A1 (en) * 2000-04-14 2001-10-18 Bayer Ag Synergistic pesticidal composition containing phenyl-substituted furanone compound and e.g. chlorfluazuron, emamectin, endosulfan, fibronil or azadirachtin, especially useful as insecticide or acaricide
DE10024934A1 (en) * 2000-05-19 2001-11-22 Bayer Ag Pesticidal agent contains synergistic mixture of 3-aryl-4-hydroxy-2-oxo-pyrroline derivative and nicotinergic acetylcholine receptor agonist or antagonist
DE10042736A1 (en) 2000-08-31 2002-03-14 Bayer Ag Active ingredient combinations with insecticidal and acaricidal properties
DE10043610A1 (en) * 2000-09-05 2002-03-14 Bayer Ag Active ingredient combinations with insecticidal and acaricidal properties
DE10055941A1 (en) * 2000-11-10 2002-05-23 Bayer Ag Pesticidal agent containing mixture of aryl-substituted pyrrolidine enol ethers and known insecticides or acaricides
DE10103416A1 (en) 2001-01-26 2002-08-01 Bayer Ag Electroluminescent devices
DE10213051B4 (en) * 2002-03-23 2013-03-07 Grünenthal GmbH Substituted 4-aminocyclohexanols
DE10249055A1 (en) 2002-10-22 2004-05-06 Bayer Cropscience Ag 2-Phenyl-2-substituted-1,3-diketones
GB0225548D0 (en) * 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
DE10301806A1 (en) * 2003-01-20 2004-07-29 Bayer Cropscience Ag Herbicidal composition, used especially for selective weed control in crops such as cereals, contains cyclic dicarbonyl compound herbicide and safener, e.g. cloquintocet-mexyl or mefenpyr-diethyl
DE10326386A1 (en) 2003-06-12 2004-12-30 Bayer Cropscience Ag N-heterocyclyl-phenyl-substituted cyclic ketoenols
DE10330724A1 (en) 2003-07-08 2005-01-27 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
CL2004002015A1 (en) 2003-08-06 2005-05-13 Senomyx Inc AMIDA DERIVATIVES, PRODUCTS THAT CONTAIN THEM, USEFUL TO MODIFY THE FLAVOR OF FOODS AND MEDICINES.
DE10337497A1 (en) 2003-08-14 2005-03-10 Bayer Cropscience Ag 4-biphenyl-pyrazolidine-3,5-dione derivatives
GB0323581D0 (en) * 2003-10-08 2003-11-12 Glaxo Group Ltd Novel compounds
GB0323585D0 (en) * 2003-10-08 2003-11-12 Glaxo Group Ltd Compounds
GB0323584D0 (en) * 2003-10-08 2003-11-12 Glaxo Group Ltd Compounds
DE10353281A1 (en) * 2003-11-14 2005-06-16 Bayer Cropscience Ag Combination of active ingredients with insecticidal and acaricidal properties
DE10354629A1 (en) 2003-11-22 2005-06-30 Bayer Cropscience Ag 2-ethyl-4,6-dimethyl-phenyl substituted spirocyclic tetramic acid derivatives
DE10354628A1 (en) 2003-11-22 2005-06-16 Bayer Cropscience Ag 2-ethyl-4,6-dimethylphenyl-substituted tetramic acid derivatives
DE102004021566A1 (en) * 2003-12-04 2005-06-30 Bayer Cropscience Ag Synergistic composition for control of insects and other animal pests, useful e.g. in plant protection or veterinary medicine, includes anthranilic amide compound and e.g. phenylpyrazolone compound or amitraz
EP1691608B2 (en) 2003-12-04 2015-04-08 Bayer CropScience AG Active substance combination having insecticidal and acaricidal properties
GB0410121D0 (en) * 2004-05-06 2004-06-09 Glaxo Group Ltd Compounds
US20060045953A1 (en) * 2004-08-06 2006-03-02 Catherine Tachdjian Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
DE102004053191A1 (en) * 2004-11-04 2006-05-11 Bayer Cropscience Ag 2,6-diethyl-4-methyl-phenyl substituted tetramic acid derivatives
DE102004053192A1 (en) 2004-11-04 2006-05-11 Bayer Cropscience Ag 2-alkoxy-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
DE102005003076A1 (en) * 2005-01-22 2006-07-27 Bayer Cropscience Ag Use of tetramic acid derivatives for controlling insects of the genus of plant lice (Sternorrhyncha)
WO2006084186A2 (en) * 2005-02-04 2006-08-10 Senomyx, Inc. Compounds comprising linked hetero aryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
JP2008530017A (en) * 2005-02-04 2008-08-07 セノミックス インコーポレイテッド Molecules containing organic moieties linked as flavor modifiers for food compositions
DE102005008021A1 (en) 2005-02-22 2006-08-24 Bayer Cropscience Ag New spiroketal-substituted cyclic ketoenol compounds used for combating animal parasites, undesired plant growth and/or undesired microorganisms
TW200715993A (en) * 2005-06-15 2007-05-01 Senomyx Inc Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
DE102005051325A1 (en) 2005-10-27 2007-05-03 Bayer Cropscience Ag Alkoxyalkyl spirocyclic tetramic and tetronic acids
DE102005059891A1 (en) 2005-12-15 2007-06-28 Bayer Cropscience Ag New spiro-cyclopentyl-pyrrole or -furan derivatives, useful as pesticides, herbicides and fungicides, also new intermediates
DE102006000971A1 (en) * 2006-01-07 2007-07-12 Bayer Cropscience Ag 2,4,6-trialkylphenyl-substituted cyclopentane-1,3-diones
DE102006007882A1 (en) * 2006-02-21 2007-08-30 Bayer Cropscience Ag New cyclic keto enol derivatives useful for controlling animal pests and/or unwanted plant growth
DE102006014653A1 (en) * 2006-03-28 2007-10-04 Bayer Cropscience Ag Use of tetramic acid derivatives to control animal pests by drenching, drip application or soil injection
KR101387563B1 (en) 2006-04-21 2014-04-25 세노믹스, 인코포레이티드 Comestible compositions comprising high potency savory flavorants, and processes for producing them
DE102006018828A1 (en) * 2006-04-22 2007-10-25 Bayer Cropscience Ag Alkoxyalkyl-substituted cyclic ketoenols
DE102006022821A1 (en) 2006-05-12 2007-11-15 Bayer Cropscience Ag Use of tetramic acid derivatives for controlling insects of the order of beetles (Coleoptera), thrips (Tysanoptera), bugs (Hemiptera), flies (Diptera) and cicadas (Auchenorrhynchae)
DE102006025874A1 (en) * 2006-06-02 2007-12-06 Bayer Cropscience Ag Alkoxyalkyl-substituted cyclic ketoenols
DE102006027731A1 (en) 2006-06-16 2007-12-20 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
DE102006027730A1 (en) * 2006-06-16 2007-12-20 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
DE102006027732A1 (en) 2006-06-16 2008-01-10 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
DE102006033154A1 (en) 2006-07-18 2008-01-24 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
DE102006039912A1 (en) * 2006-08-25 2008-03-20 Bayer Healthcare Ag Substituted spirotetronic acids and their use
DE102006050148A1 (en) 2006-10-25 2008-04-30 Bayer Cropscience Ag New trifluoromethoxy-phenyl substituted tetramic acid-derivatives useful to combat parasites including insects, arachnid, helminth, nematode and mollusk and/or undesirable plant growth and in hygienic sectors
DE102006057036A1 (en) 2006-12-04 2008-06-05 Bayer Cropscience Ag New biphenyl substituted spirocyclic ketoenol derivatives useful for the manufacture of herbicides and for combating parasites
DE102006057037A1 (en) * 2006-12-04 2008-06-05 Bayer Cropscience Ag New cis-alkoxyspirocyclic biphenyl-substituted acid derivatives used in pesticides and/or herbicides, for combating animal parasites and undesirable plant growth and as insecticides and/or acaricides in crop protection
DE102007009957A1 (en) * 2006-12-27 2008-07-03 Bayer Cropscience Ag Process for improving the use of the productive potential of a transgenic plant e.g. maize, soya bean, cotton, tobacco, rice, comprises treating the plant with 3-aryl-pyrrolidin-2,4-dione compound
DE102007001866A1 (en) * 2007-01-12 2008-07-17 Bayer Cropscience Ag Spirocyclic tetronic acid derivatives
EP2014169A1 (en) 2007-07-09 2009-01-14 Bayer CropScience AG Water-soluble concentrates of 3-(2-alkoxy 4-chlorine-6-alkyl-phenyl)-substituted tetramates with their corresponding enols
EP2020413A1 (en) 2007-08-02 2009-02-04 Bayer CropScience AG Oxaspirocyclical spiro-substituted tetram and tetron acid derivatives
EP2039248A1 (en) * 2007-09-21 2009-03-25 Bayer CropScience AG Active agent combinations with insecticide and acaricide properties
EP2045240A1 (en) * 2007-09-25 2009-04-08 Bayer CropScience AG Halogen alkoxy spirocyclic tetram and tetron acid derivatives
EP2103615A1 (en) 2008-03-19 2009-09-23 Bayer CropScience AG 4'4'-Dioxaspiro-spirocyclic substituted tetramates
KR20100134066A (en) * 2008-03-27 2010-12-22 바이엘 크롭사이언스 아게 Use of tetronic acid derivatives for fighting insects and red spider mites by watering on the ground, droplet application or immersion application
US8404260B2 (en) 2008-04-02 2013-03-26 Bayer Cropscience Lp Synergistic pesticide compositions
EP2113172A1 (en) 2008-04-28 2009-11-04 Bayer CropScience AG Method for improved utilisation of the production potential of transgene plants
EP2127522A1 (en) 2008-05-29 2009-12-02 Bayer CropScience AG Active-agent combinations with insecticidal and acaricidal properties
US8367873B2 (en) * 2008-10-10 2013-02-05 Bayer Cropscience Ag Phenyl-substituted bicyclooctane-1,3-dione derivatives
TW201031327A (en) * 2008-11-14 2010-09-01 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US8389443B2 (en) * 2008-12-02 2013-03-05 Bayer Cropscience Ag Geminal alkoxy/alkylspirocyclic substituted tetramate derivatives
US8846946B2 (en) 2008-12-02 2014-09-30 Bayer Cropscience Ag Germinal alkoxy/alkylspirocyclic substituted tetramate derivatives
WO2010081686A1 (en) * 2009-01-19 2010-07-22 Bayer Cropscience Ag Bicyclic 1,3-diones and their use as inseciticides, acaricides and/or fungicides
WO2010081688A2 (en) * 2009-01-19 2010-07-22 Bayer Cropscience Ag 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones and their use as insecticides, acaricides and/or fungicides
AR075126A1 (en) 2009-01-29 2011-03-09 Bayer Cropscience Ag METHOD FOR THE BEST USE OF THE TRANSGENIC PLANTS PRODUCTION POTENTIAL
CN102348684B (en) 2009-03-11 2014-11-12 拜尔农作物科学股份公司 Halogenalkylmethylenoxy-phenyl-substituted ketoenols
BRPI1011208B1 (en) * 2009-05-19 2018-01-02 Bayer Intellectual Property Gmbh Herbicide and pesticide compounds derived from spiroheterocyclic tetronic acid, method for the manufacture of compounds, agents for controlling pests and / or unwanted plant growth, method for controlling animal pests and / or unwanted plant growth, use of compounds, method of manufacturing agents and use of agents
DE102009028001A1 (en) 2009-07-24 2011-01-27 Bayer Cropscience Ag Use of an active agent combination (comprising a 3-phenyl-1-aza-spiro(4.5)dec-3-en-2-one compound, and an agent e.g. alanycarb, aldicarb, acephate, camphechlor or chlordane) for combating animal pests e.g. insects, acarids and helminths
CN102834378B (en) 2010-02-10 2016-07-06 拜耳知识产权有限责任公司 The ring-type keto-enol that xenyl replaces
WO2011098443A1 (en) 2010-02-10 2011-08-18 Bayer Cropscience Ag Spiroheterocyclical substituted tetramic acid derivatives
DE102010008642A1 (en) 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 New 5'-biphenyl substituted cyclic ketoenol compounds are acetyl-coenzyme A carboxylase 1 inhibitors, useful for treating cancer e.g. breast cancer, pancreatic cancer, renal cell carcinoma, hepatocellular carcinoma and skin tumors
DE102010008644A1 (en) 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 Cyclic ketoenols for therapy
DE102010008643A1 (en) 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 New 5'-biphenyl substituted cyclic ketoenol compounds are acetyl-coenzyme A carboxylase 1 inhibitors, useful for treating cancer e.g. breast cancer, pancreatic cancer, renal cell carcinoma, hepatocellular carcinoma and skin tumor
EP2560487A1 (en) 2010-04-20 2013-02-27 Bayer Intellectual Property GmbH Insecticidal and/or herbicidal composition having improved activity on the basis of spiro-heterocyclically substituted tetramic acid derivatives
KR101999937B1 (en) 2010-12-22 2019-07-12 바이엘 인텔렉쳐 프로퍼티 게엠베하 Method for producing cis-1-ammonium-4-alkoxycyclohexanecarbonitrile salts
DE102011011040A1 (en) 2011-02-08 2012-08-09 Bayer Pharma Aktiengesellschaft (5s, 8s) -3- (4'-chloro-3'-fluoro-4-methylbiphenyl-3-yl) -4-hydroxy-8-methoxy-1-azaspiro [4.5] dec-3-en-2- on (compound A) for therapy
DE102011080405A1 (en) 2011-08-04 2013-02-07 Bayer Pharma AG New substituted 3-biphenyl-3-yl-8,8-difluoro-4-hydroxy-1-azaspiro(4.5)dec-3-en-2-one derivatives useful for prophylaxis or therapy of tumor diseases comprising breast cancer, prostate cancer, colorectal cancer or non-small cell lung cancer
DE102011080406A1 (en) 2011-08-04 2013-02-07 Bayer Pharma AG Substituted 3- (biphenyl-3-yl) -4-hydroxy-8-methoxy-1-azaspiro8 [4.5] dec-3-ene-2-ones
EP2806741B1 (en) 2012-01-26 2020-03-04 Bayer Intellectual Property GmbH Phenyl-substituted ketoenols for controlling fish parasites
US10156841B2 (en) 2015-12-31 2018-12-18 General Electric Company Identity management and device enrollment in a cloud service
CN108473402B (en) 2016-01-15 2024-07-19 拜耳作物科学股份公司 Process for preparing substituted 2-aryl ethanol
WO2019197652A1 (en) 2018-04-13 2019-10-17 Bayer Aktiengesellschaft Solid formulation of insecticidal mixtures
EP3772938A1 (en) 2018-04-13 2021-02-17 Bayer CropScience Aktiengesellschaft Use of tetramic acid derivatives for controlling pests by watering or droplet application
WO2019197618A1 (en) 2018-04-13 2019-10-17 Bayer Cropscience Aktiengesellschaft Use of tetramic acid derivatives for controlling specific insects
WO2019197620A1 (en) 2018-04-13 2019-10-17 Bayer Cropscience Aktiengesellschaft Use of tetramic acid derivatives for controlling specific insects
WO2019197617A1 (en) 2018-04-13 2019-10-17 Bayer Cropscience Aktiengesellschaft Use of tetramic acid derivatives for controlling animal pests by watering, drip application plant hole treatment or furrow application
US20220151235A1 (en) 2020-09-30 2022-05-19 Control Solutions, Inc. Powder pest control compositions and methods of using
KR20230165209A (en) 2021-03-01 2023-12-05 컨트롤 솔루션즈, 인코포레이티드 Solid particulate pest control compositions and methods
CN114409664B (en) * 2021-12-24 2023-07-18 河北威远生物化工有限公司 Spiro heterocyclic tetrahydropyran compound and preparation method and application thereof

Citations (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752829A (en) * 1972-08-21 1973-08-14 Smith Kline French Lab 4-cyclohexylvulpinic acid derivatives
US3780064A (en) * 1972-06-30 1973-12-18 Smithkline Corp Thiolpulvinic acid derivatives
US3780065A (en) * 1972-08-10 1973-12-18 Smithkline Corp Phenylvulpinic acid derivatives
US4104043A (en) * 1972-12-12 1978-08-01 Union Carbide Corporation Esters of 3-hydroxyindone compounds as herbicides and miticides
US4175135A (en) * 1978-07-18 1979-11-20 Union Carbide Corporation Method of controlling acarina ectoparasites on warmblooded animals by orally administering to the animal an ectoparasitically effective amount of a 2-aryl-1,3-cyclohexanedione compound, and alkali metal salts, ammonium salts and enol esters thereof
US4209432A (en) * 1975-12-23 1980-06-24 Wacker-Chemie Gmbh Process for rendering building materials hydrophobic
US4256658A (en) * 1977-03-28 1981-03-17 Union Carbide Corporation Method of preparing 2-aryl-1,3-cyclohexanedione compounds
US4256657A (en) * 1977-03-28 1981-03-17 Union Carbide Corporation Method of preparing 2-aryl-1,3-cyclohexanedione compounds
US4256659A (en) * 1977-03-28 1981-03-17 Union Carbide Corporation Method of preparing 2-aryl-1,3-cyclohexanedione compounds
US4257858A (en) * 1977-03-28 1981-03-24 Union Carbide Corporation Photochemical method for producing biocidal 2-aryl-1,3-cyclohexanedione compounds
US4283348A (en) * 1978-09-22 1981-08-11 Union Carbide Corporation Method of preparing 2-aryl-3-cyclopentanedione compounds
US4303669A (en) * 1980-03-25 1981-12-01 Union Carbide Corporation Hybrid 1,3-dione-carbamate compounds
US4338122A (en) * 1979-09-26 1982-07-06 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclopentanedione compounds and alkali metal and ammonium salts thereof
US4351666A (en) * 1980-06-27 1982-09-28 Union Carbide Corporation Enol derivatives of 2-aryl-1,3-cyclohexanedione compound as sugar enhancer for plants
US4409153A (en) * 1980-03-28 1983-10-11 Union Carbide Corporation O-(2-Aryl-3-oxo-1-cyclohexenyl) phosphates
US4422870A (en) * 1977-03-28 1983-12-27 Union Carbide Corporation Biocidal 2-aryl-1, 3-cyclohexanedione enol ester compounds
US4436666A (en) * 1978-09-22 1984-03-13 Union Carbide Corporation Biocidal enol derivatives of 2-aryl-1,3-cycloalkanedione compounds
US4526723A (en) * 1978-09-27 1985-07-02 Union Carbide Corporation Biocidal enol esters of non-ortho substituted 2-aryl-1-3-cycloalkanedione compounds
US4551547A (en) * 1980-11-10 1985-11-05 Union Carbide Corporation Biocidal 2-aryl-1, 3-cyclopentanedione enol ester compounds
US4613617A (en) * 1981-06-26 1986-09-23 Union Carbide Corporation Synergistic insecticidal compositions containing dione esters
US4632698A (en) * 1983-09-02 1986-12-30 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclopentanedione enol ester compounds
US4659372A (en) * 1977-03-28 1987-04-21 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclohexanedione enol ester compounds
US4925868A (en) * 1986-08-29 1990-05-15 Takeda Chemical Industries, Ltd. 4-Hydroxy-3-pyrrolin-2-ones and treatment of circulatory disorders therewith
US4985063A (en) * 1988-08-20 1991-01-15 Bayer Aktiengesellschaft 3-aryl-pyrrolidine-2,4-diones
US5045560A (en) * 1989-01-07 1991-09-03 Bayer Aktiengesellschaft Pesticidal tautomers of 3-aryl-pyrrolidine-2,4-diones and use thereas
US5091537A (en) * 1989-04-26 1992-02-25 Bayer Aktiengesellschaft Intermediates for preparing 3-aryl-pyrrolidine-2,4-diones
US5094681A (en) * 1989-09-23 1992-03-10 Bayer Aktiengesellschaft Herbicidal 5h-furan-2-one derivatives
US5116836A (en) * 1989-09-01 1992-05-26 Bayer Aktiengesellschaft 3-phenyl-pyrrolidine-2,4-dione derivatives having pesticidal activity
US5142065A (en) * 1988-08-20 1992-08-25 Bayer Aktiengesellschaft 3-aryl-pyrrolidine-2,4-diones
US5186737A (en) * 1989-01-07 1993-02-16 Bayer Aktiengesellschaft Pesticidal 3-aryl-pyrrolidine-2,4-diones
US5207817A (en) * 1989-09-23 1993-05-04 Bayer Aktiengesellschaft Herbicidal 5H-furan-2-one derivatives
US5225434A (en) * 1990-02-13 1993-07-06 Bayer Aktiengesellschaft Pesticidal and herbicidal polycyclic 3-aryl-pyrrolidine-2,4-dione derivatives
US5258527A (en) * 1990-05-10 1993-11-02 Bayer Aktiengesellschaft Insecticidal, acaricidal and herbicidal 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
US5262383A (en) * 1991-07-16 1993-11-16 Bayer Ag 3-aryl-4-hydroxy- DELTA 3-dihydrofuranone and 3-aryl-4-hydroxy- DELTA 3-dihydrothiophenone derivatives and pesticidal use
US5332720A (en) * 1991-03-21 1994-07-26 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrazoline derivatives
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
US5462913A (en) * 1992-10-28 1995-10-31 Bayer Aktiengesellschaft Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
US5494890A (en) * 1991-03-19 1996-02-27 Ciba-Geigy Corporation Herbicidally, acaricidally and insecticidally active pyrazolidine compounds
US5504057A (en) * 1993-03-01 1996-04-02 Bayer Aktiengesellschaft Dialkyl-1-H-3-(2,4-dimethylphenyl)-pyrrolidine-2,4-diones, their preparation and their use
US5565430A (en) * 1994-08-02 1996-10-15 Sterling Winthrop Inc. Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
US5567671A (en) * 1993-03-01 1996-10-22 Bayer Aktiengesellschaft Substituted 1-H-3-phenyl-5-cycloalkylpyrrolidine-2,4-diones, their preparation and their use
US5610122A (en) * 1993-09-17 1997-03-11 Bayer Aktiengesellschaft 3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives
US5622917A (en) * 1994-02-09 1997-04-22 Bayer Aktiengesellschaft Substituted 1H--3-aryl-pyrrolidine-2,4-dione derivatives
US5808135A (en) * 1994-07-21 1998-09-15 Bayer Aktiengesellschaft 2-(2,4,6-trimethyl phenyl)cyclopentane-1,3-dione derivatives
US5830826A (en) * 1994-04-05 1998-11-03 Bayer Aktiengesellschaft Alkoxy-alkyl-substituted 1H-3-aryl-pyrrolidine-2, 4-diones used as herbicicides and pesticides
US5840661A (en) * 1994-07-07 1998-11-24 Bayer Aktiengesellschaft 2-aryl cyclopentane-1,3-dione derivatives
US5945444A (en) * 1994-03-25 1999-08-31 Bayer Aktiengesellschaft 3-aryl-4-hydroxy-Δ3 -dihydrothiophenone derivatives
US5977029A (en) * 1995-10-27 1999-11-02 Bayer Aktiengesellschaft 3-aryl-5-halogen-pyrone derivatives as pest control agents
US5994274A (en) * 1995-06-30 1999-11-30 Bayer Aktiengesellschaft Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
US6005000A (en) * 1996-08-22 1999-12-21 Oxis International, Inc. 5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use therefor
US6010685A (en) * 1999-03-08 2000-01-04 Oxis International, Inc. Skin protectant comprising 5-substituted and 5,5-disubstituted 3,4-dihydroxy-2(5H)-furanones
US6017916A (en) * 1993-08-19 2000-01-25 Warner-Lambert Company Nonpeptide endothelin antagonists I
US6057352A (en) * 1995-05-17 2000-05-02 E. I. Du Pont De Nemours And Company Fungicidal cyclic amides
US6071937A (en) * 1995-11-29 2000-06-06 Bayer Aktiengesellschaft Oxymethoxy-3-aryl-pyrone derivatives
US6096895A (en) * 1995-05-17 2000-08-01 E. I. Du Pont De Nemours And Company Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases
US6110872A (en) * 1995-06-28 2000-08-29 Bayer Aktiengesellschaft 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
US6114374A (en) * 1996-08-05 2000-09-05 Bayer Aktiengesellschaft 2-and 2,5-substituted phenylketoenols
US6271180B2 (en) * 1996-04-02 2001-08-07 Bayer Aktiengesellschaft Substituted phenyl keto enols as pesticides and herbicides
US6297274B1 (en) * 1996-04-10 2001-10-02 Warner-Lambert Company Nonpeptide endothelin antagonists with increased water solubility
US6316639B1 (en) * 1999-09-07 2001-11-13 Consortium für elektrochemische Industrie GmbH Process for the preparation of cyclic N-hydroxydicarboximides
US6380246B1 (en) * 1995-05-09 2002-04-30 Bayer Aktiengesellschaft Alkyl-dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
US6417370B1 (en) * 1998-02-27 2002-07-09 Bayer Aktiengesellschaft Arylphenyl-substituted cyclic keto-enols
US6576661B1 (en) * 1999-11-09 2003-06-10 Bayer Aktiengesellschaft Active ingredient combination having insecticidal and acaricidal characteristics
US6589976B1 (en) * 1997-09-26 2003-07-08 Bayer Aktiengesellschaft Utilizing spirocyclic phenyl keto-enols as pesticides and herbicides
US20030185813A1 (en) * 2000-04-14 2003-10-02 Reiner Fischer Active substance combinations with insecticidal and acaricidal properties
US6686390B2 (en) * 2000-05-22 2004-02-03 Dr. Reddy's Laboratories Limited Compounds having antiinflamatory activity: process for their preparation and pharmaceutical compositions containing them
US6693092B2 (en) * 1998-03-26 2004-02-17 Bayer Aktiengesellschaft Arylphenyl-substituted cyclic ketoenols
US6706758B2 (en) * 2000-03-21 2004-03-16 Bayer Aktiengesellschaft Combinations of active ingredients with insecticidal and acaricidal properties
US6716874B1 (en) * 1999-03-24 2004-04-06 Bayer Aktiengesellschaft Synergistic insecticide mixtures
US6746990B2 (en) * 1995-02-13 2004-06-08 Bayer Aktiengesellschaft 2-phenyl-substituted heterocyclic 1,3-ketoenols as herbicides and pesticides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE521334C (en) 1931-03-20 Pohlig Akt Ges J Platform-less suspension for loading paper cement bags
DE4004496A1 (en) 1990-02-14 1991-08-22 Bayer Ag New 3-aryl-pyrrolidine -2,4-di:one deriv(s) - useful as insecticides, acaricides and herbicides, esp. effective against tetranychus urticae
DE4121365A1 (en) * 1991-06-28 1993-01-14 Bayer Ag SUBSTITUTED 1-H-3-ARYL-PYRROLIDIN-2,4-DION DERIVATIVES
GB9210393D0 (en) 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
DE4425617A1 (en) 1994-01-28 1995-08-03 Bayer Ag 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
BR9510256B1 (en) 1994-12-23 2010-08-10 compounds, process for their preparation, pesticidal compositions, use, pest control method and process for preparing compositions.
AU4435396A (en) 1995-01-13 1996-07-31 Novartis Ag 4-aryl- and 4-heteroaryl -5-oxopyrazoline derivatives having pesticidal properties
DE19543864A1 (en) * 1995-02-13 1996-08-14 Bayer Ag Phenyl-substituted cyclic ketoenols
JP2771334B2 (en) 1995-05-16 1998-07-02 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー Fungicidal and fungicidal cyclic amides
WO1996036229A1 (en) 1995-05-17 1996-11-21 E.I. Du Pont De Nemours And Company Fungicidal cyclic amides
DE19538218A1 (en) 1995-10-13 1997-04-17 Bayer Ag Cyclopentane-1,3-dione derivatives
DE19649665A1 (en) 1996-04-02 1997-10-09 Bayer Ag New substituted phenylketoenols

Patent Citations (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780064A (en) * 1972-06-30 1973-12-18 Smithkline Corp Thiolpulvinic acid derivatives
US3780065A (en) * 1972-08-10 1973-12-18 Smithkline Corp Phenylvulpinic acid derivatives
US3752829A (en) * 1972-08-21 1973-08-14 Smith Kline French Lab 4-cyclohexylvulpinic acid derivatives
US4104043A (en) * 1972-12-12 1978-08-01 Union Carbide Corporation Esters of 3-hydroxyindone compounds as herbicides and miticides
US4209432A (en) * 1975-12-23 1980-06-24 Wacker-Chemie Gmbh Process for rendering building materials hydrophobic
US4422870A (en) * 1977-03-28 1983-12-27 Union Carbide Corporation Biocidal 2-aryl-1, 3-cyclohexanedione enol ester compounds
US4659372A (en) * 1977-03-28 1987-04-21 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclohexanedione enol ester compounds
US4256657A (en) * 1977-03-28 1981-03-17 Union Carbide Corporation Method of preparing 2-aryl-1,3-cyclohexanedione compounds
US4256659A (en) * 1977-03-28 1981-03-17 Union Carbide Corporation Method of preparing 2-aryl-1,3-cyclohexanedione compounds
US4257858A (en) * 1977-03-28 1981-03-24 Union Carbide Corporation Photochemical method for producing biocidal 2-aryl-1,3-cyclohexanedione compounds
US4256658A (en) * 1977-03-28 1981-03-17 Union Carbide Corporation Method of preparing 2-aryl-1,3-cyclohexanedione compounds
US4175135A (en) * 1978-07-18 1979-11-20 Union Carbide Corporation Method of controlling acarina ectoparasites on warmblooded animals by orally administering to the animal an ectoparasitically effective amount of a 2-aryl-1,3-cyclohexanedione compound, and alkali metal salts, ammonium salts and enol esters thereof
US4283348A (en) * 1978-09-22 1981-08-11 Union Carbide Corporation Method of preparing 2-aryl-3-cyclopentanedione compounds
US4436666A (en) * 1978-09-22 1984-03-13 Union Carbide Corporation Biocidal enol derivatives of 2-aryl-1,3-cycloalkanedione compounds
US4526723A (en) * 1978-09-27 1985-07-02 Union Carbide Corporation Biocidal enol esters of non-ortho substituted 2-aryl-1-3-cycloalkanedione compounds
US4338122A (en) * 1979-09-26 1982-07-06 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclopentanedione compounds and alkali metal and ammonium salts thereof
US4303669A (en) * 1980-03-25 1981-12-01 Union Carbide Corporation Hybrid 1,3-dione-carbamate compounds
US4409153A (en) * 1980-03-28 1983-10-11 Union Carbide Corporation O-(2-Aryl-3-oxo-1-cyclohexenyl) phosphates
US4351666A (en) * 1980-06-27 1982-09-28 Union Carbide Corporation Enol derivatives of 2-aryl-1,3-cyclohexanedione compound as sugar enhancer for plants
US4551547A (en) * 1980-11-10 1985-11-05 Union Carbide Corporation Biocidal 2-aryl-1, 3-cyclopentanedione enol ester compounds
US4613617A (en) * 1981-06-26 1986-09-23 Union Carbide Corporation Synergistic insecticidal compositions containing dione esters
US4632698A (en) * 1983-09-02 1986-12-30 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclopentanedione enol ester compounds
US4925868A (en) * 1986-08-29 1990-05-15 Takeda Chemical Industries, Ltd. 4-Hydroxy-3-pyrrolin-2-ones and treatment of circulatory disorders therewith
US4985063A (en) * 1988-08-20 1991-01-15 Bayer Aktiengesellschaft 3-aryl-pyrrolidine-2,4-diones
US5142065A (en) * 1988-08-20 1992-08-25 Bayer Aktiengesellschaft 3-aryl-pyrrolidine-2,4-diones
US5045560A (en) * 1989-01-07 1991-09-03 Bayer Aktiengesellschaft Pesticidal tautomers of 3-aryl-pyrrolidine-2,4-diones and use thereas
US5186737A (en) * 1989-01-07 1993-02-16 Bayer Aktiengesellschaft Pesticidal 3-aryl-pyrrolidine-2,4-diones
US5091537A (en) * 1989-04-26 1992-02-25 Bayer Aktiengesellschaft Intermediates for preparing 3-aryl-pyrrolidine-2,4-diones
US5116836A (en) * 1989-09-01 1992-05-26 Bayer Aktiengesellschaft 3-phenyl-pyrrolidine-2,4-dione derivatives having pesticidal activity
US5094681A (en) * 1989-09-23 1992-03-10 Bayer Aktiengesellschaft Herbicidal 5h-furan-2-one derivatives
US5207817A (en) * 1989-09-23 1993-05-04 Bayer Aktiengesellschaft Herbicidal 5H-furan-2-one derivatives
US5225434A (en) * 1990-02-13 1993-07-06 Bayer Aktiengesellschaft Pesticidal and herbicidal polycyclic 3-aryl-pyrrolidine-2,4-dione derivatives
US5258527A (en) * 1990-05-10 1993-11-02 Bayer Aktiengesellschaft Insecticidal, acaricidal and herbicidal 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
US5494890A (en) * 1991-03-19 1996-02-27 Ciba-Geigy Corporation Herbicidally, acaricidally and insecticidally active pyrazolidine compounds
US5506193A (en) * 1991-03-19 1996-04-09 Ciba-Geigy Corporation Herbicidally, acaricidally and insecticidally active pyrazolidine compounds
US5332720A (en) * 1991-03-21 1994-07-26 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrazoline derivatives
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
US5780394A (en) * 1991-03-21 1998-07-14 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrazoline derivatives
US5739389A (en) * 1991-03-21 1998-04-14 Bayer Aktiengesellschaft Aryl carboxylic acid derivatives
US5661110A (en) * 1991-03-21 1997-08-26 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrazoline derivatives
US5262383A (en) * 1991-07-16 1993-11-16 Bayer Ag 3-aryl-4-hydroxy- DELTA 3-dihydrofuranone and 3-aryl-4-hydroxy- DELTA 3-dihydrothiophenone derivatives and pesticidal use
US5462913A (en) * 1992-10-28 1995-10-31 Bayer Aktiengesellschaft Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
US5677449A (en) * 1992-10-28 1997-10-14 Bayer Aktiengesellschaft Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
US5602078A (en) * 1993-03-01 1997-02-11 Bayer Aktiengesellschaft Dialkyl-1-H-3-(2,4-dimethylphenyl)-pyrrolidine-2,4-diones, their preparation and their use
US5504057A (en) * 1993-03-01 1996-04-02 Bayer Aktiengesellschaft Dialkyl-1-H-3-(2,4-dimethylphenyl)-pyrrolidine-2,4-diones, their preparation and their use
US5567671A (en) * 1993-03-01 1996-10-22 Bayer Aktiengesellschaft Substituted 1-H-3-phenyl-5-cycloalkylpyrrolidine-2,4-diones, their preparation and their use
US6017916A (en) * 1993-08-19 2000-01-25 Warner-Lambert Company Nonpeptide endothelin antagonists I
US5610122A (en) * 1993-09-17 1997-03-11 Bayer Aktiengesellschaft 3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives
US5719310A (en) * 1993-09-17 1998-02-17 Bayer Aktiengesellschaft 3-aryl-4-hydroxy-Δ3 -dihydrofuranone derivatives
US5622917A (en) * 1994-02-09 1997-04-22 Bayer Aktiengesellschaft Substituted 1H--3-aryl-pyrrolidine-2,4-dione derivatives
US5945444A (en) * 1994-03-25 1999-08-31 Bayer Aktiengesellschaft 3-aryl-4-hydroxy-Δ3 -dihydrothiophenone derivatives
US5830826A (en) * 1994-04-05 1998-11-03 Bayer Aktiengesellschaft Alkoxy-alkyl-substituted 1H-3-aryl-pyrrolidine-2, 4-diones used as herbicicides and pesticides
US5840661A (en) * 1994-07-07 1998-11-24 Bayer Aktiengesellschaft 2-aryl cyclopentane-1,3-dione derivatives
US6150304A (en) * 1994-07-07 2000-11-21 Bayer Aktiengesellschaft 2-aryl-cyclopentane-1,3-dione derivatives
US5808135A (en) * 1994-07-21 1998-09-15 Bayer Aktiengesellschaft 2-(2,4,6-trimethyl phenyl)cyclopentane-1,3-dione derivatives
US5565430A (en) * 1994-08-02 1996-10-15 Sterling Winthrop Inc. Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
US6746990B2 (en) * 1995-02-13 2004-06-08 Bayer Aktiengesellschaft 2-phenyl-substituted heterocyclic 1,3-ketoenols as herbicides and pesticides
US6380246B1 (en) * 1995-05-09 2002-04-30 Bayer Aktiengesellschaft Alkyl-dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
US6057352A (en) * 1995-05-17 2000-05-02 E. I. Du Pont De Nemours And Company Fungicidal cyclic amides
US6096895A (en) * 1995-05-17 2000-08-01 E. I. Du Pont De Nemours And Company Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases
US6511942B1 (en) * 1995-06-28 2003-01-28 Bayer Aktiengesellschaft 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
US6110872A (en) * 1995-06-28 2000-08-29 Bayer Aktiengesellschaft 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
US5994274A (en) * 1995-06-30 1999-11-30 Bayer Aktiengesellschaft Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
US6251830B1 (en) * 1995-06-30 2001-06-26 Bayer Aktiengesellschaft Dialkyl-halogenophenyl-substituted ketoenols
US5977029A (en) * 1995-10-27 1999-11-02 Bayer Aktiengesellschaft 3-aryl-5-halogen-pyrone derivatives as pest control agents
US6071937A (en) * 1995-11-29 2000-06-06 Bayer Aktiengesellschaft Oxymethoxy-3-aryl-pyrone derivatives
US6271180B2 (en) * 1996-04-02 2001-08-07 Bayer Aktiengesellschaft Substituted phenyl keto enols as pesticides and herbicides
US6297274B1 (en) * 1996-04-10 2001-10-02 Warner-Lambert Company Nonpeptide endothelin antagonists with increased water solubility
US6114374A (en) * 1996-08-05 2000-09-05 Bayer Aktiengesellschaft 2-and 2,5-substituted phenylketoenols
US20020010204A1 (en) * 1996-08-05 2002-01-24 Folker Lieb 2- and 2,5-substituted phenylketoenols
US6265436B1 (en) * 1996-08-22 2001-07-24 Oxis Therapeutics Inc. Substituted 5-biphenyl-3,4-dihydroxy-2(5H)-furanones and method of use therefor
US6005000A (en) * 1996-08-22 1999-12-21 Oxis International, Inc. 5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use therefor
US6589976B1 (en) * 1997-09-26 2003-07-08 Bayer Aktiengesellschaft Utilizing spirocyclic phenyl keto-enols as pesticides and herbicides
US6417370B1 (en) * 1998-02-27 2002-07-09 Bayer Aktiengesellschaft Arylphenyl-substituted cyclic keto-enols
US6716832B2 (en) * 1998-02-27 2004-04-06 Bayer Aktiengesellschaft Arylphenyl-substituted cyclic ketoenols
US6693092B2 (en) * 1998-03-26 2004-02-17 Bayer Aktiengesellschaft Arylphenyl-substituted cyclic ketoenols
US6010685A (en) * 1999-03-08 2000-01-04 Oxis International, Inc. Skin protectant comprising 5-substituted and 5,5-disubstituted 3,4-dihydroxy-2(5H)-furanones
US6716874B1 (en) * 1999-03-24 2004-04-06 Bayer Aktiengesellschaft Synergistic insecticide mixtures
US20040082650A1 (en) * 1999-03-24 2004-04-29 Thomas Bretschneider Synergistic insecticidal mixtures
US6316639B1 (en) * 1999-09-07 2001-11-13 Consortium für elektrochemische Industrie GmbH Process for the preparation of cyclic N-hydroxydicarboximides
US6576661B1 (en) * 1999-11-09 2003-06-10 Bayer Aktiengesellschaft Active ingredient combination having insecticidal and acaricidal characteristics
US6706758B2 (en) * 2000-03-21 2004-03-16 Bayer Aktiengesellschaft Combinations of active ingredients with insecticidal and acaricidal properties
US20030185813A1 (en) * 2000-04-14 2003-10-02 Reiner Fischer Active substance combinations with insecticidal and acaricidal properties
US6686390B2 (en) * 2000-05-22 2004-02-03 Dr. Reddy's Laboratories Limited Compounds having antiinflamatory activity: process for their preparation and pharmaceutical compositions containing them

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722070B2 (en) 2000-06-29 2014-05-13 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US20030148999A1 (en) * 2000-06-29 2003-08-07 Reiner Fischer Combinations of active ingredients, which exhibit insecticidal and acaricidal properties
US20060051386A1 (en) * 2000-06-29 2006-03-09 Reiner Fischer Combinations of active ingredients, which exhibit insecticidal and acaricidal properties
US20040161757A1 (en) * 2000-12-14 2004-08-19 Reiner Fischer Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect
US20050054535A1 (en) * 2001-08-10 2005-03-10 Reiner Fischer Selective herbicides based on substituted cyclic keto-enols and safeners
US8119570B1 (en) 2001-11-29 2012-02-21 Bayer Cropscience Ag 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
US20050090400A1 (en) * 2001-11-29 2005-04-28 Reiner Fischer 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
US7928037B2 (en) 2001-11-29 2011-04-19 Bayer Cropscience Ag 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
US7307044B2 (en) 2001-11-29 2007-12-11 Bayer Cropscience Ag 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
US7183238B2 (en) 2001-12-06 2007-02-27 Bayer Cropscience Ag [1,2]-oxazine-3,5-diones
US20070032539A1 (en) * 2002-07-11 2007-02-08 Thomas Himmler Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides
US7638547B2 (en) 2002-07-11 2009-12-29 Bayer Cropscience Ag Cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives serving as pesticides
US7897803B2 (en) 2002-07-11 2011-03-01 Bayer Cropscience Ag Cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives serving as pesticides
US20100056598A1 (en) * 2002-07-11 2010-03-04 Thomas Himmler Cis-alkoxy-substituted spirocyclic 1h-pyrrolidine-2,4-dione derivatives serving as pesticides
US8314254B2 (en) 2002-08-28 2012-11-20 Bayer Cropscience Ag Substituted spirocyclic ketoenols
US7754654B2 (en) 2002-08-28 2010-07-13 Bayer Cropscience Ag Substituted spirocyclic ketoenols
US20070275858A1 (en) * 2002-08-28 2007-11-29 Reiner Fischer Substituted spirocyclic ketoenols
US20060160847A1 (en) * 2003-01-20 2006-07-20 Reiner Fischer 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives
US7888285B2 (en) 2003-03-14 2011-02-15 Bayer Cropscience Ag 2,4,6-phenyl substituted cyclic ketoenols
US20110092368A1 (en) * 2003-03-14 2011-04-21 Reiner Fischer 2,4,6-Phenyl-substituted cyclic ketoenols
US20070142463A1 (en) * 2003-07-08 2007-06-21 Reiner Fischer Active agents combination exhibiting insecticidal and acaricide properties
US7795303B2 (en) 2003-07-08 2010-09-14 Bayer Cropscience Ag Active agents combination exhibiting insecticidal and acaricide properties
US7569517B2 (en) * 2003-08-14 2009-08-04 Bayer Cropscience Ag 4-biphenyl-substituted pyrazolidin-3 5-diones pesticide agent and/or microbicide and/or herbicide
US20070093391A1 (en) * 2003-08-14 2007-04-26 Reiner Fischer 4-Biphenyl-substituted pyrazolidin-3 5-diones pesticide agent and/or microbicide and/or herbicide
US20070298968A1 (en) * 2004-03-25 2007-12-27 Bayer Cropscience Ag 2,4,6-Phenyl-Substituted Cyclic Ketoenols
US7947704B2 (en) 2004-03-25 2011-05-24 Bayer Cropscience Ag 2,4,6-phenyl-substituted cyclic ketoenols
US20110213160A1 (en) * 2004-03-25 2011-09-01 Bayer Cropscience Ag 2,4,6-Phenyl-Substituted Derivatives
US20090029858A1 (en) * 2004-06-25 2009-01-29 Bayer Cropscience Aktiengesellschaft Spirocyclic 3'-Alkoxytetramic Acids and -Tetronic Acids
US8410289B2 (en) 2004-06-25 2013-04-02 Bayer Cropscience Ag Spirocyclic 3'-alkoxytetramic acids and-tetronic acids
US8202875B2 (en) 2004-07-20 2012-06-19 Bayer Cropscience Ag Selective insecticides based on substituted cyclic ketoenols and safeners
US8629084B2 (en) 2004-09-16 2014-01-14 Bayer Cropscience Ag Iodine-phenyl-substituted cyclic cetoenols
AU2006326300B2 (en) * 2005-12-13 2011-10-27 Bayer Cropscience Aktiengesellschaft Insecticidal compositions having improved effect
US8247351B2 (en) 2005-12-13 2012-08-21 Bayer Cropscience Ag Insecticidal compositions having improved effect
US20090209513A1 (en) * 2005-12-13 2009-08-20 Bayer Cropscience Ag Insecticidal Compositions Having Improved Effect
US9101133B2 (en) 2010-11-02 2015-08-11 Bayer Intellectual Property Gmbh Phenyl-substituted bicyclooctane-1,3-dione-derivatives
US8859782B2 (en) 2011-01-25 2014-10-14 Bayer Cropscience Ag Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives
US9272997B2 (en) 2011-01-25 2016-03-01 Bayer Intellectual Property Gmbh Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives
US8946124B2 (en) 2011-02-17 2015-02-03 Bayer Intellectual Property Gmbh Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy and halogen-substituted spirocyclic ketoenols
US9204640B2 (en) 2011-03-01 2015-12-08 Bayer Intellectual Property Gmbh 2-acyloxy-pyrrolin-4-ones
KR101789527B1 (en) * 2011-03-01 2017-10-25 바이엘 인텔렉쳐 프로퍼티 게엠베하 2-Acyloxypyrrolin-4-ones
US8710238B2 (en) 2011-03-11 2014-04-29 Bayer Intellectual Property Gmbh Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives

Also Published As

Publication number Publication date
AU3421599A (en) 1999-11-16
BR9910034A (en) 2000-12-26
DE19818732A1 (en) 1999-10-28
US6451843B1 (en) 2002-09-17
EP1075465A1 (en) 2001-02-14
WO1999055673A1 (en) 1999-11-04
JP2002513002A (en) 2002-05-08

Similar Documents

Publication Publication Date Title
US6451843B1 (en) Arylphenyl-substituted cyclic keto enols
US6458965B1 (en) Aryl phenyl substituted cyclic ketoenols
US6746990B2 (en) 2-phenyl-substituted heterocyclic 1,3-ketoenols as herbicides and pesticides
US6933261B2 (en) 2,4,5-Trisubstituted phenylketoenols
US6486343B1 (en) Substituted phenyl keto enols as pesticides and herbicides
US6469196B2 (en) Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
US6380246B1 (en) Alkyl-dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
US20020161034A1 (en) Methods of making substituted phenylketoenols

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION